Language selection

Search

Patent 2434284 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2434284
(54) English Title: DEHYDRATING AGENT AND METHOD FOR DEHYDRATING MOIST ARTICLE USING THE AGENT AND DEHYDRATED ARTICLE OBTAINED BY THE METHOD
(54) French Title: AGENT DESHYDRATANT ET PROCEDE DE DESHYDRATATION D'UN ARTICLE HUMIDE A L'AIDE DUDIT AGENT ET ARTICLE DESHYDRATE AINSI OBTENU
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • B01J 20/22 (2006.01)
  • A21D 2/18 (2006.01)
  • A23C 13/12 (2006.01)
  • A23L 3/42 (2006.01)
  • A61K 47/26 (2006.01)
  • A61K 47/40 (2006.01)
  • C07H 3/06 (2006.01)
(72) Inventors :
  • KUBOTA, MICHIO (Japan)
  • NISHIMOTO, TOMOYUKI (Japan)
  • AGA, HAJIME (Japan)
  • FUKUDA, SHIGEHARU (Japan)
  • MIYAKE, TOSHIO (Japan)
(73) Owners :
  • KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
(71) Applicants :
  • KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (Japan)
(74) Agent: MACRAE & CO.
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2002-01-17
(87) Open to Public Inspection: 2002-07-25
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/JP2002/000288
(87) International Publication Number: WO 2002057011
(85) National Entry: 2003-07-09

(30) Application Priority Data:
Application No. Country/Territory Date
2001-10991 (Japan) 2001-01-19

Abstracts

English Abstract


A dehydrating agent comprising a cyclic tetra-saccharide, which is defined in
the specification, as an effective component; a method for dehydrating a moist
article, characterized in that the moist article is incorporated into, is
contacted with, or is caused to be present with a cyclic tetra-saccharide; and
a dehydrated article obtained by the method. The cyclic tetra-saccharide is a
non-reducing saccharide and therefore can be used for dehydrating an article
with no deterioration of the quality of the article.


French Abstract

L'invention concerne un agent déshydratant renfermant un tétra-saccharide cyclique défini, dans la spécification, comme un composé efficace, ainsi qu'un procédé de déshydratation d'un article humide caractérisé en ce que ledit article est incorporé au tétra-saccharide cyclique ou mis en contact avec celui-ci ou est amené à se trouver en présence dudit tétra-saccharide. Cette invention a également trait à un article déshydraté obtenu au moyen de ce procédé. Le tétra-saccharide cyclique est un saccharide non réducteur qu'on peut donc utiliser pour déshydrater un article sans détériorer sa qualité.

Claims

Note: Claims are shown in the official language in which they were submitted.


C L A I M S
1. A dehydrating agent comprising as an effective
ingredient a saccharide having the structure of cyclo{.fwdarw.6)-.alpha.-D-
glucopyranosyl-(1.fwdarw.3)-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-.alpha.-D-
glucopyranosyl-(1.fwdarw.3)-.alpha.-D-glucopyranosyl-(1.fwdarw.}.
2. The agent of claim 1, wherein said saccharide is
a member selected from the group consisting of crystalline
anhydrous-, crystalline monohydrous-, and anhydrous amorphous-
saccharide having dehydrating ability and the structure of
cyclo{.fwdarw.6) -.alpha.-D-glucopyranosyl- (1.fwdarw.3) -.alpha.-D-
glucopyranosyl-(1.fwdarw.6)-.alpha.-D-
glucopyranosyl-(1.fwdarw.3)-.alpha.-D-glucopyranosyl-(1.fwdarw.}.
3. The agent of claim 2, wherein said anhydrous
crystalline saccharide is one prepared by keeping a syrup of a
saccharide having the structure of cyclo{.fwdarw.6)-.alpha.-D-glucopyranosyl
(1.fwdarw.3)-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-.alpha.-D-glucopyranosyl-
(1.fwdarw.3)-.alpha.-D
glucopyranosyl-(1.fwdarw.} with a moisture content of less than 15%
(w/w), in the presence of a seed crystal, at a temperature from
50 to 180° C to crystallize said anhydrous crystal; and
collecting the crystal.
4. The agent of claim 2, wherein said crystalline
monohydrous saccharide is one prepared by drying either a syrup
of a saccharide having the structure of cyclo{.fwdarw.6)-.alpha.-D-
glucopyranosyl-(1.fwdarw.3)-.alpha.-D-glucopyranosyl- (1.fwdarw.6) -.alpha.-D-
glucopyranosyl-(1.fwdarw.3)-.alpha.-D-glucopyranosyl-(1.fwdarw.}, or a crystal
of
said saccharide in a penta- or hexa-hydrous form; and collecting
the resulting crystalline monohydrous saccharide.
5. The agent of any one of claims 1 to 4, wherein
said saccharide having the structure of cyclo{.fwdarw.6)-.alpha.-D-
-136-

glucopyranosyl-(1.fwdarw.3)-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-.alpha.-D-
glucopyranosyl-(1.fwdarw.3)-.alpha.-D-glucopyranosyl-(1.fwdarw.} is derived
from an
amylaceous substance.
6. A method for dehydrating a hydrous matter, which
comprises a step of either incorporating, contacting or
coexisting any one of the agents of claims 1 to 5, into, with,
or in a hydrous matter.
7. The method of claim 6, wherein a crystalline
penta- ar hexa-hydrous saccharide having the structure of
cyclo{.fwdarw.6)-.alpha.-D-glucopyranosyl-(1.fwdarw.3)-.alpha.-D-
glucopyranosyl-(1.fwdarw.6)-.alpha.-D-
glucopyranosyl-(1.fwdarw.3)-.alpha.-D-glucopyranosyl-(1.fwdarw.} is formed
through
a step of dehydrating the hydrous matter.
8. The method of claim 6 or 7, wherein one part by
weight of said hydrous matter is either incorporated, contacted
or coexisted into, with, or in 0.001-200 parts by weight of any
one of the agents of claims 1 to 5.
9. The method of claim 6, 7 or 8, wherein said
hydrous matter comprises a gelatinized starch, alcohol, oil-
soluble substance, or physiologically active substance.
10. A dehydrated product obtainable by either
incorporating, contacting or coexisting any one of the agents
of claims 1 to 5 into, with, or in a hydrous matter.
11. The dehydrated product of claim 10, which is a
food product, cosmetic, pharmaceutical, or material or
processing intermediate thereof.
-137-

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02434284 2003-07-09
DESCRIPTION
DEHYDRATING AGENT, METHOD FOR DEHYDRATING HYDROUS MATTERS USING
THE SAME, AND DEHYDRATED PRODUCTS PREPARED BY THE METHOD
Technical Field
The present invention relates to a dehydrating agent
comprising, as an effective ingredient, a saccharide having the
structure of cyclof-~6)-a-D-glucopyranosyl-(1-->3)-a-D
glucopyranosyl-(1-~6)-a-D-glucopyranosyl-(1-~3)-a-D
glucopyranosyl-(1~} (referred to as "cyclotetrasaccharide" based
on the structure, throughout the specification hereinafter); a
method for dehydrating hydrous matters using the same; and
dehydrated products prepared by the method.
Background Art
As disclosed in Japanese Patent Kokai Nos . 136, 240/87,
152,536/87, 152,537/87, 170,221/94, etc., by the present
inventors, methods for dehydrating hydrous matters using
saccharides are those which exert dehydrating powers of
anhydrous saccharides by allowing them to entrap moisture and
to be converted into their hydrous crystalline forms. Unlike
heat drying, these methods do not require severe conditions and
have features that they convert hydrous matters into dehydrated
products without denaturing or deteriorating them.
However, it was revealed that, among the above
methods, the one disclosed in Japanese Patent Kokai No.
- 1 -

CA 02434284 2003-07-09
152,536/87, where anhydrous aldohexoses such as anhydrous
glucose and anhydrous galactose are used, has poor preservation
stability of dehydrated products because, in spite of their
relatively high dehydration powers, the saccharides are highly
reactive or easily react with amino acids, peptides, etc., and
cause browning reaction. It was also found that such anhydrous
aldohexoses are not converted into any hydrous form even under
a relatively high humid condition and have only a poor
dehydrating power. As for the methods using anhydrous maltose
and palatinose, which are respectively disclosed in Japanese
Patent Kokai Nos. 136,240/87 and 152,537/87, it was found that
there still remains anxiety about stability of dehydrated
products when preserved for a relatively long period of time,
because of their inherent reducibilities, though they are
relatively low. In addition, these methods have the demerit
that they require a relatively large amount of anhydrous maltose
or palatinose as a dehydrating agent because these saccharides
have only a relatively-low-moisture-entrapping power as low as
about 5~ (w/w) to each of their weights.
Since the non-reducing anhydrous glycosyl fructosides
such as anhydrous raffinose, anhydrous erlose, and anhydrous
melezitose, which are disclosed in Japanese Patent Kokai No.
152,537/87, have no reducing power, these saccharides would be
neither react with amino acids and peptides nor cause browning
reaction, and they also have advantageous stability for a
relatively long period of time. The above saccharides, however,
have an intramolecular fructoside bond poor in acid tolerance,
speculating that they should not necessarily be appropriately
used as dehydrating agents for acid hydrous matters.
- 2 -

CA 02434284 2003-07-09
Accordingly, there still remains anxiety about the stability of
dehydrated products produced thereby. While anhydrous a,a-
trehalose, disclosed in Japanese Patent Kokai No. 170,221/94,
has no reducing power and satisfactory stabilizes dehydrated
products for a relatively long period of time. Due to an
activity of entrapping a relatively large amount of moisture as
high as about 10$ (w/w), a,a-trehalose would be more suitably
used than the above-mentioned other saccharide. The method,
however, still needs a relatively large amount of anhydrous a, a-
trehalose for dehydration, and therefore another dehydrating
agent having a higher moisture and/or drying efficiency have
been in great demand.
Disclosure of Invention
To overcome the demerits in conventional dehydration
methods using saccharides, the present inventors have screened
natural non-reducing saccharides in an anhydrous form and
energetically studied to establish an improved dehydrating agent
and uses thereof.
The present inventors previously established a method
for producing cyclotetrasaccharide, which had been known to be
only prepared in a laboratory demonstration, at a lesser cost
and on an industrial scale from material amylaceous saccharides.
They also revealed that cyclotetrasaccharide exists at least in
the form of a mono-, penta- or hexa-hydrous crystal as a hydrous
crystalline form; or of anhydrous crystal or anhydrous amorphous
as an anhydrous form. In later, they further found that
cyclotetrasaccharide in the form of an anhydrous crystal,
- 3 -

CA 02434284 2003-07-09
monohydrous crystal, or anhydrous amorphous absorbs moisture and
easily changes into its crystalline, penta- or hexa-hydrous
form, as a hydrous form.
The present inventors further studied on applying the
above features to dehydrating agents and resulted in a finding
that the above-mentioned cyclotetrasaccharide in the form of an
anhydrous crystal, monohydrous crystal, or anhydrous amorphous,
has a satisfactory dehydrating ability; the dehydrated products
produced therewith are highly stable. Thus, such a cyclotetra-
saccharide can be widely applicable and more suitably used as
a dehydrating agent as compared with conventional saccharides.
In other words, the present inventors found that a cyclotetra-
saccharide with dehydrating ability, i.e., a saccharide selected
from cyclotetrasaccharides in the form of an anhydrous crystal,
monohydrous crystal, or anhydrous amorphous can be incorporated
into, contacted with, or coexisted in hydrous matters such as
hydrous food products and hydrous pharmaceuticals to be
converted into crystalline cyclotetrasaccharide, penta- or hexa-
hydrate, whereby the cyclotetrasaccharide entraps a relatively
large amount of moisture as a crystal water, acts as a
dehydrating agent with a remarkably high dehydration power, and
has a satisfactory stability. Thus, they found that such a
cyclotetrasaccharide can be extensively used in hydrous matters
including acid hydrous matters and confirmed that the
cyclotetrasaccharide facilitates the production of dehydrated
products such as high-quality dehydrated food products with
satisfactory flavor, and dehydrated pharmaceuticals with
satisfactory activity and stability. Thus the present inventors
accomplished this invention.
- 4 -

CA 02434284 2003-07-09
The present invention is characterized in that it was
made by appropriately selecting the desired cyclotetrasaccharide
which had not been focused on its use as a dehydrating agent,
particularly, it was firstly made by the present invention the
method for dehydrating hydrous matters by incorporating,
contacting, or coexisting a cyclotetrasaccharide with
dehydrating ability into, with, or in hydrous matters.
Brief Description of Drawings
FIG. 1 is an elution pattern of a saccharide, obtained
by the enzymatic reaction with a-isomaltosyl-transferring
enzyme, when determined on high-performance liquid
chromatography.
FIG. 2 is a nuclear resonance spectrum (1H-NMR) of
cyclotetrasaccharide, obtained by the enzymatic reaction with
a-isomaltosyl-transferring enzyme.
FIG. 3 is a nuclear resonance spectrum (13C-NMR) of
cyclotetrasaccharide, obtained by the enzymatic reaction with
a-isomaltosyl-transferring enzyme.
FIG. 4 shows that cyclotetrasaccharide has the
structure of cyclo[-~6)-a-D-glucopyranosyl-(1~3)-a-D-
glucopyranosyl-(1-~6)-a-D-glucopyranosyl-(1~3)-a-D-
glucopyranosyl- ( 1-~ } .
FIG. 5 shows the thermal influence on the enzymatic
activity of a-isomaltosylglucosaccharide-forming enzyme from a
microorganism of the species Bacillus globisporus C9 strain.
FIG. 6 shows the pH influence on the enzymatic
activity of a-isomaltosylglucosaccharide-forming enzyme from a
- 5 -

CA 02434284 2003-07-09
microorganism of the species Bacillus globisporus C9 strain.
FIG. 7 shows the thermal stability of a-
isomaltosylglucosaccharide-forming enzyme from a microorganism
of the species Bacillus globisporus C9 strain.
FIG. 8 shows the pH stability of a-
isomaltosylglucosaccharide-forming enzyme from a microorganism
of the species Bacillus globisporus C9 strain.
FIG. 9 shows the thermal influence on the enzymatic
activity of a-isomaltosyl-transferring enzyme from a
microorganism of the species Bacillus globisporus C9 strain.
FIG. 10 shows the pH influence on the enzymatic
activity of a-isomaltosyl-transferring enzyme from a
microorganism of the species Bacillus globisporus C9 strain.
FIG. 11 shows the thermal stability of a-isomaltosyl-
transferring enzyme from a microorganism of the species Bacillus
globisporus C9 strain.
FIG. 12 shows the pH stability of a-isomaltosyl-
transferring enzyme from a microorganism of the species Bacillus
globisporus C9 strain.
FIG. 13 shows the thermal influence on the enzymatic
activity of a-isomaltosylglucosaccharide-forming enzyme from a
microorganism of the species Bacillus globisporus C11 strain.
FIG. 14 shows the pH influence on a
isomaltosylglucosaccharide-forming enzyme from a microorganism
of the species Bacillus globisporus C11 strain.
FIG. 15 shows the thermal stability of a-
isomaltosylglucosaccharide-forming enzyme from a microorganism
of the species Bacillus globisporus C11 strain.
- 6 -

CA 02434284 2003-07-09
FIG. 16 shows the pH stability of a-
isomaltosylglucosaccharide-forming enzyme from a microorganism
of the species Bacillus globisporus C11 strain.
FIG. 17 shows the thermal influence on the enzymatic
activity of a-isomaltosyl-transferring enzyme from a
microorganism of the species Bacillus globisporus C11 strain.
FIG. 18 shows the pH influence on the enzymatic
activity of a-isomaltosyl-transferring enzyme from a
microorganism of the species Bacillus globisporus C11 strain.
FIG. 19 shows the thermal stability of a-isomaltosyl-
transferring enzyme from a microorganism of the species Bacillus
globisporus C11 strain.
FIG. 20 shows the pH stability of a-isomaltosyl-
transferring enzyme from a microorganism of the species Bacillus
globisporus C11 strain.
FIG. 21 is a nuclear resonance spectrum ( 1H-NMR ) of a-
isomaltosylmaltotriose, obtained by the enzymatic reaction with
a-isomaltosylglucosaccharide-forming enzyme.
FIG. 22 is a nuclear resonance spectrum ( 1H-NMR ) of a-
isomaltosylmaltotetraose, obtained by the enzymatic reaction
with a-isomaltosylglucosaccharide-forming enzyme.
FIG. 23 is a nuclear resonance spectrum (13C-NMR) of
a-isomaltosylmaltotriose, obtained by the enzymatic reaction
with a-isomaltosylglucosaccharide-forming enzyme.
FIG. 24 is a nuclear resonance spectrum (13C-NMR) of
a-isomaltosylmaltotetraose, obtained by the enzymatic reaction
with a-isomaltosylglucosaccharide-forming enzyme.
FIG. 25 is a visualized intermediate picture,
_ 7 _

CA 02434284 2003-07-09
displayed on a screen, of a microscopic photo for crystalline
cyclotetrasaccharide, penta- or hexa-hydrate.
FIG. 26 is an x-ray diffraction spectrum for
crystalline cyclotetrasaccharide, penta- or hexa-hydrate, when
determined on x-ray powder diffraction analysis.
FIG. 27 is a thermogravimetric curve for crystalline
cyclotetrasaccharide, penta- or hexa-hydrate, when determined
on thermogravimetric analysis.
FIG. 28 is an x-ray diffraction spectrum for
crystalline cyclotetrasaccharide, monohydrate, used in the
present invention when determined on x-ray powder diffraction
analysis.
FIG. 29 is a thermogravimetric curve for crystalline
cyclotetrasaccharide, monohydrate, used in the present invention
when determined on thermogravimetric analysis.
FIG. 30 is an x-ray diffraction spectrum for a powder
of anhydrous crystalline cyclotetrasaccharide, obtained by
0
drying in vacuo at 40 C crystalline cyclotetrasaccharide, penta-
or hexa-hydrate, when determined on x-ray powder diffraction
analysis.
FIG. 31 is an x-ray diffraction spectrum for a powder
of anhydrous crystalline cyclotetrasaccharide, obtained by
drying in vacuo at 120~C cyclotetrasaccharide crystal, penta-
or hexa-hydrate, when determined on x-ray powder diffraction
analysis.
FIG. 32 is a thermogravimetric curve for an anhydrous
crystalline cyclotetrasaccharide powder used in the present
invention, when determined on thermogravimetric analysis.
FIG. 33 is an x-ray diffraction spectrum for a powder
_ g _

CA 02434284 2003-07-09
of anhydrous crystalline cyclotetrasaccharide, obtained by
lyophilizing and drying in vacuo an aqueous cyclotetrasaccharide
solution.
Best Mode for Carrying Out the Invention
The method for dehydrating hydrous matters according
to the present invention is advantageously applied to those
which contain water, particularly, to those which contain free
water but not bound water such as a crystal water. For example,
the method can be advantageously applied to reduce the water
content in the inner atmosphere of moisture-proof containers,
which hermetically house dried food products, through a step of
coexisting the dehydrating agent of the present invention
therein; or to reduce the free water content of hydrous matters
through a step of incorporating or contacting the dehydrating
agent into or with such hydrous matters, for example, food
products, cosmetics, pharmaceuticals, industrial chemicals, and
their materials and processing intermediates.
When a cyclotetrasaccharide with dehydrating ability
is allowed to contact with or coexisted in the above hydrous
matters, such a cyclotetrasaccharide strongly entraps water, as
a crystal water of crystalline cyclotetrasaccharide, penta- or
hexa-hydrate, in an amount of about 11 to 15~ (w/w) (the term
"$ (w/w)" is abbreviated as "~" throughout the specification)
to the weight of the cyclotetrasaccharide used, from the hydrous
matters, the level of which is 2.2-3-times higher than that of
anhydrous maltose and 1.1-1.5-times higher than that of
anhydrous a,a-trehalose; and effectively lowers the water
-

CA 02434284 2003-07-09
content of the hydrous matters and dehydrates and/or dries them.
It was revealed that the coexistence of a cyclotetra-
saccharide with dehydrating ability, in such a manner of
injecting the saccharide into moisture permeable small bags such
as paper bags and placing the resultants in moisture-proof
containers which enclose hermetically dried foods such as
seasoned layers and cookies, highly lowers the relative humidity
within the containers and stably keeps the high quality of dried
foods or powdery products for a relatively long period of time.
In this case, the cyclotetrasaccharide does not either become
sticky, melt to flow, or stain the dried foods or the containers
even during or after entrapping water and being converted into
crystalline cyclotetrasaccharide, penta- or hexa-hydrate.
As for high moisture content food products, for
example, those in the form of a liquid or paste such as
brandies, vinegars, royal jellies, fresh creams, and
mayonnaises, they can be quite easily processed into high
quality dehydrated food products having only a substantially
reduced water content such as food products in the form of a
massecuite or powder, through the steps of incorporating a
cyclotetrasaccharide with dehydrating ability into such high
moisture content products to effect dehydration while the
saccharide being converted into its crystal, penta- or hexa-
hydrate.
In that case, when the cyclotetrasaccharide is added
to food materials in an amount sufficient to dehydrate the water
in the food materials, the cyclotetrasaccharide is partly
converted into crystalline cyclotetrasaccharide, penta- or hexa-
hydrate. As a result, the resulting dehydrated food products,
- 10 -

CA 02434284 2003-07-09
where the free water content is reduced, are prevented from
quality change and deterioration due to bacterial contamination,
hydrolysis, acidification, or browning; and their satisfactory
quality, flavor, and taste will be retained for a relatively
long period of time.
The dehydrating method of the present invention has
the character that, since the cyclotetrasaccharide used in the
present invention is a non-reducing saccharide and is free of
severe conditions such as heat drying, high water content
products in the form of a liquid or paste can be easily
converted into dehydrated food products with satisfactory flavor
and taste and a reduced water content. Cyclotetrasaccharide per
se is a non-toxic and harmless sweetener having a sweetening
power of about 20~ of that of sucrose, and is free of side
effect.
In the case of applying the dehydrating method to
aqueous solutions of lymphokines or antibiotics and to pasty
pharmaceuticals such as ginseng extracts and turtle extracts,
they can be quite easily converted into high quality dehydrated
pharmaceuticals with substantially reduced water content, for
example, pharmaceuticals in the form of a massecuite or powder,
by incorporating a cyclotetrasaccharide with dehydrating ability
into the above aqueous solutions and the pasty pharmaceuticals
to convert the cyclotetrasaccharide into its crystal, penta- or
hexa-hydrate. According to the dehydrating method, high quality
and stable dehydrated pharmaceuticals are prepared because it
does not require severe conditions such as heat drying and the
cyclotetrasaccharide functions as a dehydrating agent and a
stabilizer for the effective ingredients of pharmaceuticals.
- 11 -

CA 02434284 2003-07-09
For example, solid preparations can be arbitrarily
prepared by placing in vials a cyclotetrasaccharide with a
sufficiently high level of dehydrating ability, injecting into
the vials an aqueous solution containing a physiologically
active substance( s ) such as a lymphokine or hormone, and sealing
the vials. In this case, the cyclotetrasaccharide dehydrates
the aqueous solution and also absorbs/dries the gas spaces of
the vials. The dehydrated solid pharmaceuticals have the
features that they are preparable through a relatively easy
processing, retain their high quality for a relatively long
period of time, and easily dissolve in water in use.
High quality, stable solid preparations can be
prepared by mixing a prescribed amount of an aqueous solution
containing a physiologically active substances) with the
cyclotetrasaccharide with a sufficiently high level of
dehydrating ability under stirring conditions, and directly
placing and sealing the resulting power in a container.
Further, the solid preparations can be arbitrarily processed in
a usual manner into granules or tablets for use.
Unlike conventionally known dehydrating agents such
as a silica gel or calcium oxide, the dehydrating agent of the
present invention, comprising a cyclotetrasaccharide with
dehydrating ability, is a non- or low-caloric saccharide
dehydrating agent that is edible and substantially non-
assimilable when ingested orally, and it can be advantageously
used as a stabilizer for physiologically active substances.
The cyclotetrasaccharide and the one with dehydrating
ability used in the present invention should not be restricted
to their origins and processes. As described later, a
- 12 -

CA 02434284 2003-07-09
cyclotetrasaccharides with dehydrating ability, for example,
those in an anhydrous crystalline- or anhydrous amorphous-form,
can be preferably used because they absorb moisture to be
converted into crystalline cyclotetrasaccharide, penta- or hexa-
hydrate. Similarly, crystalline cyclotetrasaccharide,
monohydrate, also absorbs moisture to be converted into
crystalline cyclotetrasaccharide, penta- or hexa-hydrate,
resulting in an exertion of dehydrating action. Accordingly,
the cyclotetrasaccharide with dehydrating ability used in the
present invention should not be limited to cyclotetrasaccharide
in a completely anhydrous form and includes, for example, those
in a hydrous form as long as they have dehydrating ability
without any inconvenience. Thus, the cyclotetrasaccharide with
dehydrating ability used in the present invention can be defined
by evaluating the moisture content of the saccharide using a
conventional method such as the Karl Fischer method. Of course,
the moisture content of the cyclotetrasaccharide as the
effective ingredient of the dehydrating agent of the present
invention should preferably be as low as possible, desirably,
less than 4~, more desirably, less than 3%. Even a cyclotetra-
saccharide with a moisture content of 4~ or higher but less than
10~ has dehydrating ability, however, such a saccharide merely
has a relatively lower function and efficiency as a dehydrating
agent.
Prior to establishing the present invention, the
present inventors studied methods for producing cyclotetra-
saccharides with dehydrating ability, particularly, anhydrous
crystalline cyclotetrasaccharide; crystalline cyclotetra-
saccharide, monohydrate; and anhydrous amorphous cyclotetra-
- 13 -

CA 02434284 2003-07-09
saccharide.
Methods fox producing such cyclotetrasaccharides
include, for example, an enzymatic method using amylaceous
substances as materials; a method where hydrolytic enzymes,
i.e., alternanase is allowed to act on alternan, as disclosed
in European Journal of Biochemistry, Vol. 226, pp. 641-648
(1994); a method of converting panose prepared from starch into
cyclotetrasaccharide using a-isomaltosyl-transferring enzyme,
as disclosed in Japanese Patent Application Nos. 229,557/2000
and 234,937/2000; and a method of producing cyclotetrasaccharide
from starch using a-isomaltosylglucosaccharide-forming enzyme
and a-isomaltosyl-transferring enzyme in combination. In
addition, as disclosed in the specifications of the above
applications prior to the present application, the present
inventors revealed that, as a method for producing cyclotetra-
saccharide, such an enzymatic method using amylaceous substances
which are more abundant and cheeper than alternan, can be
advantageously used for industrial scale production because it
produces the desired cyclotetrasaccharide at a relatively high
efficiency and a lesser cost. Also they firstly revealed that
cyclotetrasaccharide exists, for example, in the form of a
penta- or hexa-hydrate crystal, anhydrous crystal, monohydrous
crystal, or anhydrous amorphous crystal.
Examples of microorganisms which form a-
isomaltosylglucosaccharide-forming enzyme and a-isomaltosyl-
transferring enzyme include Bacillus globisporus C9 strain and
Bacillus globisporus C11 strain, which were deposited on April
25, 2000, and have been maintained in International Patent
- 14 -

CA 02434284 2003-07-09
Organism Depositary National Institute of Advanced Industrial
Science and Technology Tsukuba Central 6, 1-1, Higashi 1-Chome
Tsukuba-shi, Ibaraki-ken, 305-8566, Japan, under the accession
numbers of FERM BP-7143 and FERM BP-7144, respectively.
The present inventors further studied the process for
producing anhydrous crystalline cyclotetrasaccharide and then
established the following; a process comprising the steps of,
for example, preparing an aqueous solution of cyclotetra-
saccharide, produced from amylaceous substances using any of the
above-mentioned enzymatic methods, into a high concentrated
syrup with a concentration of over 2.0~ but less than 120,
0
keeping the concentrate at a temperature of 50-180 C in the
presence of a seed crystal of anhydrous crystalline
cyclotetrasaccharide, crystallizing anhydrous crystalline
cyclotetrasaccharide, and pulverizing the resulting crystals.
A powdery crystalline cyclotetrasaccharide,
monohydrate, is prepared, for example, by adequately drying a
powdery cyclotetrasaccharide, penta- or hexa-hydrate, at a
temperature of about 100~C to about 180~C.
To produce anhydrous amorphous cyclotetrasaccharide,
for example, an aqueous solution of cyclotetrasaccharide
obtained by any of the above-mentioned methods is lyophilized
0
or dried at a temperature of about 100 C to about 180~C and at
a normal pressure or in vacuo, and pulverizing the resultant.
The above aqueous solution of cyclotetrasaccharide can be
prepared into an about 40-85~ syrup, lyophilized or dried in
vacuo, and pulverized; or can be directly processed into a
powder form by the spraying- and the drying-methods such as the
- 15 -

CA 02434284 2003-07-09
high pressure nozzle method or the rotatory disk method.
As the method for pulverization, apart from the above
spraying and drying methods, for example, conventional methods
such as block pulverization method, extrusion granulation
method, and fluidized-bed granulation method can be
appropriately employed.
The powdery cyclotetrasaccharide with dehydrating
ability thus obtained is a non-reducing, free-flowing, white
powder with a high quality, low sweetness, and is low in
moisture content or substantially anhydrous; usually, the
moisture content is less than 4$, preferably, less than 3% when
determined on the Karl Fisher method. The powder can be made
into an anhydrous crystalline powder, crystalline monohydrate
powder, or anhydrous amorphous powder.
Depending on use, the powdery cyclotetrasaccharide
with dehydrating ability can be arbitrarily sized. In the case
of preparing small portions or tablets such as of medicaments,
a cyclotetrasaccharide with a smaller particle size is more
preferably used because the smaller the particle size of
cyclotetrasaccharide the more the effective ingredients can be
homogeneously dispersed. The particle size of the dehydrating
agent of the present invention can be appropriately controlled
by conventional means for classification using meshes, etc.;
usually those with a particle size of 20-500 dam, preferably, 50-
200 um can be arbitrarily used.
Any powdery cyclotetrasaccharides with dehydrating
ability can be used in the present invention as long as they are
anhydrous cyclotetrasaccharides which exert a strong dehydrating
action during their conversion into crystalline cyclotetra-
- 16 -

CA 02434284 2003-07-09
saccharide, penta- or hexa-hydrate. For example, preferably
used are those which comprise anhydrous cyclotetrasaccharide
supplemented with, as a seed, crystalline cyclotetrasaccharide,
penta- or hexa-hydrate, in the least possible amount, usually,
in an amount of less than 5%, preferably, less than 1%.
When incorporated into hydrous matters such as food
products, cosmetics, pharmaceuticals, and industrial chemicals,
the powdery cyclotetrasaccharides with dehydrating ability thus
obtained act as a strong dehydrating agent for hydrous matters
in such a manner of entrapping and holding the free water in the
hydrous matters as a crystal water of crystalline cyclotetra-
saccharide, penta- or hexa-hydrate.
Appropriate examples, which the dehydrating agent of
the present invention is advantageously applicable to, include
those wherein the agent is placed in moisture-proof containers
to dehydrate or dry the inner atmosphere in the containers, and
methods for producing high-quality dehydrated products in the
form of a massecuite, powder, or solid by contacting the agent
with hydrous matters susceptible to change in quality or
deterioration during heat drying ar drying in vacuo.
Examples of the above application of the dehydrating
agent to dehydrate or dry hydrous matters include those for
preventing seasoned layers, cookies, etc., from absorbing
moisture. According to the present invention, a cyclotetra-
saccharide with dehydrating ability can be used in such a manner
of incorporating it into the following powdery products
susceptible to absorbing moisture and solidifying, and then
sealing the products in containers to lower the relative
humidity within the containers and prevent the adhesion or
- 17 -

CA 02434284 2003-07-09
solidification of the products, resulting in an exertion of
their high quality and satisfactory free-flowing ability just
after their processings: Serial powders such as rice powders,
wheat flours, and soy bean flours; processed serials such as a
hattaiko (a flour of heated and ground rice or wheat), kinako
(a soy bean powder), and ground sesame; premix flours such as
a premix of pudding and hot cake mix; fine granular crystalline
seasonings such as salts and sugars; seasoning powders such as
a powdered soy sauce, powdered miso, powdered vinegar for sushi,
premix of soup stock powder, and powdered complex seasoning;
powdered spices such as a powdered garlic, powdered cinnamon,
powdered nutmeg, powdered pepper, and powdered sage; and other
powdered products such as a powdered yeast extract, powdered
milk, powdered yoghurt, powdered cheese, powdered juice,
powdered herb, powdered vitamin, powdered soup, powdered
bouillon, fish flour, blood meal, bone meal, powdered
preparation of lactic acid bacteria, powdered enzyme
preparation, and granular digestive.
In the case of applying the dehydrating agent of the
present invention to dehydrate hydrous matters, for example, the
agent can be arbitrarily used to dehydrate a variety of hydrous
matters such as organs, tissues, and cells of animals, plants,
and microorganisms, as well as their ground products, extracts,
ingredients, and preparations.
In the case of applying the dehydrating agent of the
present invention to food products and their materials and
intermediates, dehydrated food products with satisfactory
stability, flavor, and taste can be easily processed from those
in the form of a liquid or paste, for example, agricultural
- 18 -

CA 02434284 2003-07-09
products such as a fresh fruit, juice, vegetable extract,
soybean milk, sesame paste, nut paste, raw bean's paste,
gelatinized starch paste, and wheat flour; fishery products such
as a paste of sea urchin, oyster extract, and paste of Japanese
pilchard; livestock products such as a fresh egg, lecithin,
milk, milk serum, cream, yoghurt, butter, and cheese; hydrous
seasonings such as a maple syrup, honey, miso, soy sauce,
mayonnaises, dressing, bonito extract, meat extract, tangle
extract, mushroom extract, licorice extract, stevia extract, and
their enzyme treated products and seasoning liquids for
pickling; alcohols such as a Japanese sake, wine, brandy,
whisky, and medicated liquor; beverages for preference such as
a green tea, tea, and coffee; hydrous spices such as an extract
of mint, Japanese horseradish, garlic, mustard, Japanese pepper,
cinnamon, sage, laurel, pepper, and citrus; hydrous colors such
as Rubia tinctorurn L.; hydrous emulsifiers prepared, for
example, from sucrose fatty acid esters, glycerin fatty acid
esters, and sorbitan fatty acid esters; and preservation liquids
such as smoke solutions and fermented liquids.
Among the dehydrated products thus obtained, the
powdered products of agriculture, fishery, and livestock;
powdered flavors; powdered colors; powdered emulsifiers; and
powdered preservatives can be arbitrarily used as natural bulk
flavors with satisfactory flavor and taste or processing
materials in seasonings such as mayonnaises and soup premixes,
confectioneries such as hard candies and cakes, and premixes
such as hot cake mixes and instant juices.
In the case of applying the dehydrating agent of the
- 19 -

CA 02434284 2003-07-09
present invention to pharmaceuticals and their materials and
processing intermediates, dehydrated pharmaceuticals and health
foods with satisfactory stability and high quality without
losing the effective ingredients and activities in the following
liquid or paste products: Examples of such are liquids
containing lymphokines such as a-, (3- or y-interferon, tumor
necrosis factor-a (TNF-a), tumor necrosis factor-a (TNF-(3),
macrophage migration inhibitory factor, colony-stimulating
factor, transfer factor and interleukin 2; liquids containing
hormones such as insulin, growth hormone, prolactin,
erythropoietin, and follicle-stimulating hormone; liquids
containing biological preparations such as BCG vaccine, Japanese
encephalitis vaccine, measles vaccine, live polio vaccine,
smallpox vaccine, tetanus toxoid, Trimeresurus antitoxin, and
human immunoglobulin; liquids containing antibiotics such as
penicillin, erythromycin, chloramphenicol, tetracycline,
streptomycin, and kanamycin sulfate; liquids containing vitamins
such as thiamine, riboflavin, L-ascorbic acid, cod liver oil,
carotenoid, ergosterol, and tocopherol; liquids containing
enzymes such as lipase, elastase, urokinase, protease, [3-
amylase, isoamylase, glucanase, and lactase; extracts such as
ginseng extract, snapping turtle extract, chlorella extract,
aloe extract, and propolis extract; pastes of viable
microorganisms such as viruses, lactic acid bacteria, and
yeasts; and other liquid or paste products such as royal
jellies.
Similarly as in the above food products and
pharmaceuticals, the dehydrating agent of the present invention
is applied to cosmetics and their materials and processing
- 20 -

CA 02434284 2003-07-09
intermediates such as fresh eggs, lecithin, creams, honeys,
licorice extracts, flavors, colors, and enzymes to dehydrate
them into high quality, dehydrated cosmetics which are
advantageously used as skin-beautifying agents, hair-beautifying
agents, and hair restorers.
In the case of applying the dehydrating agent to
enzyme preparations to be dehydrated, the obtained preparations
can be arbitrarily used as catalysts for processing food
products, pharmaceuticals, and industrial materials; or as
therapeutic agents, digestives, or enzyme detergents.
The methods for incorporating, contacting or
coexisting the cyclotetrasaccharide with dehydrating ability
into, with, or in hydrous matters are mixing, kneading,
dissolving, penetrating, dispersing, applying, spraying, and
injecting, which are appropriately selected before completing
the dehydration of the hydrous matters.
Depending on the water content of hydrous matters to
be dehydrated and the properties of the desired dehydrated
matters, it is varied the amount of a cyclotetrasaccharide with
dehydrating ability to be incorporated into, or contacted with
or coexisted in hydrous matters. If necessary, prior to
incorporate, contact or coexist the cyclotetrasaccharide with
dehydrating ability into, with, or in hydrous matters, the
hydrous matters are preferably partially dehydrated or
concentrated with other conventional dehydrating methods.
Usually, 0.001-200 parts by weight, preferably, 0.01-50 parts
by weight of the cyclotetrasaccharide is used to one part by
weight of a hydrous matter.
To improve the quality of the resulting dehydrated
- 21 -

CA 02434284 2003-07-09
products such as food products, cosmetics, and pharmaceuticals,
appropriate flavors, colors, taste-imparting materials,
stabilizers, and fillers can be arbitrarily used in combination.
Particularly, since the dehydrating method of the present
invention is a quite effective dehydration method using a
cyclotetrasaccharide with strong dehydrating ability, the
aforesaid stabilizers should not be limited to lower molecular
weight compounds such as antioxidants. The following water-
soluble high molecular weight compounds, whose dehydration have
been deemed difficult, can be arbitrarily used as such
stabilizers; soluble starch, dextrin, pullulan, elsinan,
dextran, xanthan gum, gum arabic, locust bean gum, guar gum,
tragacanth gum, tamarind gum, carboxy methyl cellulose, hydroxy
ethyl cellulose, pectin, agar, gelatin, albumin, and casein.
In the case of using the above water-soluble high
molecular compounds, for example, they are first homogeneously
dissolved in hydrous matters in a liquid or paste form, then a
cyclotetrasaccharide with dehydrating ability is incorporated
into the resulting mixtures by the methods such as mixing and
kneading to obtain dehydrated products with fine
cyclotetrasaccharide crystals, penta- or hexa-hydrate.
The above dehydrated matters quite advantageously,
stably retain the flavor and effective ingredients from the
hydrous matters because the ingredients are prevented from
dispersion and deterioration by either the coating with films
of the high molecular substances; the encapsulation in
microcapsules, surrounded with the films, together with the fine
cyclotetrasaccharide crystals, penta- or hexa-hydrate; or the
stabilization of flavor ingredients or effective ingredients by
- 22 -

CA 02434284 2003-07-09
forming inclusion compounds using a cyclotetrasaccharide with
dehydrating ability. In this case, if necessary, a-, a- or y-
cyclodextrin, capable of forming inclusion compounds of flavor
ingredients, can be arbitrarily used as the water-soluble high
molecular substances.
The cyclodextrins usable in the present invention
should not be limited to those with a high purity but
arbitrarily include those with a low purity, which are hard to
be dehydrated and pulverized, for example, glucose derivatives
of cyclodextrins and partial starch hydrolyzates in the form of
a hydrolyzed starch syrup rich in maltodextrins and containing
different types of cyclodextrins.
The methods used for producing the dehydrated products
according to the present invention, particularly, those for
pulverized dehydrated products are variable. For example, a
cyclotetrasaccharide with dehydrating ability is incorporated
to homogeneity into hydrous matters with a relatively high
moisture content such as food products, cosmetics,
pharmaceuticals, and their materials and processing
intermediates to give a moisture content of about 50°s or lower,
preferably, about 10 to 40s to the total weight of the resulting
dehydrated products. The resulting mixtures are then allowed
0
to stand in a vat at a temperature of about 10 C to about 50~C,
for example, at ambient temperature, for about 0.1 to about 5
days to be solidified into blocks through the conversion of the
cyclotetrasaccharide into crystalline cyclotetrasaccharide,
penta- or hexa-hydrate, followed by cutting and pulverizing the
blocks. If necessary, drying and classifying steps can follow
a pulverization step such as cutting and pulverizing.
- 23 -

CA 02434284 2003-07-09
By applying a spraying method, pulverized products can
be directly produced. For example, the methods below can be
suitably used as an industrial scale production method of the
powdery dehydrated products of the present invention: A method
comprising the steps of spraying a prescribed amount of a liquid
or paste hydrous matter over a cyclotetrasaccharide with
dehydrating ability under free-flowing conditions to contact
them each other, granulating the resulting mixture, and
0
optionally aging the resulting granules at about 30 C to about
60~C for about 0.1 to about 10 hours to convert the
cyclotetrasaccharide into crystalline cyclotetrasaccharide,
penta- or hexa-hydrate; or a method comprising the steps of
mixing and kneading a liquid or pasty hydrous matter with a
cyclotetrasaccharide with dehydrating ability, and then
instantly or after initiating the conversion of the
cyclotetrasaccharide into crystalline cyclotetrasaccharide,
penta- or hexa-hydrate, and optionally spraying the resultant
into a powder and optionally aging similarly as above to convert
the remaining cyclotetrasaccharide into crystalline
cyclotetrasaccharide, penta- or hexa-hydrate.
The powdery dehydrated products thus obtained can be
arbitrarily used intact or, if necessary, in combination with
fillers, adjuvants, binders, stabilizers, etc., or after
processed into an appropriate form such as a granule, tablet,
capsule, rod, plate, or cubic.
Since starch generally requires a relatively large
amount of water for swelling and gelatinizing, the resulting
swelled and gelatinized starch is highly susceptible to
bacterial contamination. The cyclotetrasaccharide with
- 24 -

CA 02434284 2003-07-09
dehydrating ability can be effectively used as a dehydrating
agent for such gelatinized starch. For example, gelatinized
starch such as "gyuhi" (a rice paste with sugar) can be
prevented from bacterial contamination by incorporating a
cyclotetrasaccharide with dehydrating ability thereunto to
substantially reduce the water content thereof.
The cyclotetrasaccharide with dehydrating ability can
be easily mixed to homogeneity with gelatinized starch and acts
as a retrogradation preventive as described later, and it can
prolong the shelf-life of processed foods containing gelatinized
starch by a large margin.
In applying a cyclotetrasaccharide with dehydrating
ability over the surface of high moisture content food products,
which are susceptible to bacterial contamination, such as a
pealed banana, orange, sliced steamed/boiled sweet-potato, split
jack, hairtail, raw noodle, boiled noodle, and rice
confectionery, the cyclotetrasaccharide is allowed to contact
with the food products by sprinkling over the surface of the
food products to convert the cyclotetrasaccharide into
crystalline cyclotetrasaccharide, penta- or hexa-hydrate,
resulting in a substantial reduction of the water content on the
surface of the food products and an improvement of their shelf-
life and quality. For this reason the cyclotetrasaccharide with
dehydrating ability can be advantageously used as a food
preservative, stabilizer, or quality-improving agent. In this
case, the shelf-life of the above food products can be further
prolonged by optionally using lactic acid, citric acid, or
ethanol; or by vacuum package, gas-filling package, or
refrigeration.
- 25 -

CA 02434284 2003-07-09
Since the cyclotetrasaccharide with dehydrating
ability has a relatively high affinity to alcohols, it can be
arbitrarily used as a dehydrating agent for water contained in
alcohols and alcohol-soluble products such as methanol, ethanol,
butanol, propylene glycol, glycerine, and polyethylene glycol.
For example, alcohols such as sake, shochu (a
distilled spirit), wine, brandy, whisky, and vodka can be
advantageously processed into a massecuite or powder which
retains the effective ingredients and flavors of these alcohols
by dehydrating the alcohols using a cyclotetrasaccharide with
dehydrating ability to form crystalline cyclotetrasaccharide,
penta- or hexa-hydrate, while allowing to incorporate their
effective ingredients and flavors into the crystal. The powdery
alcohols thus obtained can be used in confectioneries and
premixes which are mixed with water into beverages before use.
When coexisted in dehydrated hydrous matters, the
cyclotetrasaccharide with dehydrating ability used in the
present invention functions as a dehydrating agent or stabilizer
and also exerts an effect as an agent for imparting high-quality
sweetness, body, or adequate viscosity.
By mixing a cyclotetrasaccharide with dehydrating
ability with an alcohol solution such as of iodine and then with
an aqueous solution containing a water-soluble high molecule,
etc., the cyclotetrasaccharide is converted into its crystal,
penta- or hexa-hydrate, resulting in stabilizing the effective
ingredients such as iodine without volatilizing and
deteriorating them, and facilitating the production of ointments
in a massecuite form having an adequate viscosity,
extendibility, and adhesion.
- 26 -

CA 02434284 2003-07-09
Food products such as powdery fats and oils, spices,
flavors, and food colors; cosmetics; and pharmaceuticals such
as powdery vitamins and hormones are advantageously obtainable
by soaking or mixing water-containing-oil-soluble substances,
emulsions, or latexes in or with the cyclotetrasaccharide with
dehydrating ability to convert a cyclotetrasaccharide with
dehydrating ability into its crystal, penta- or hexa-hydrate.
In such a case, the cyclotetrasaccharide with
dehydrating ability functions as a dehydrating agent and as a
stabilizer, property-retaining agent, filler, or carrier even
after converted into cyclotetrasaccharide crystal, penta- or
hexa-hydrate.
The cyclotetrasaccharide with dehydrating ability used
in the present invention can be advantageously used even in food
products containing oil-soluble substances, which are
incompatible with water, such as chocolates and creams. In this
case, the cyclotetrasaccharide is used not only as a dehydrating
agent but used for improving processibility, meltability in
mouth, flavor and taste. The products thus obtained have a
feature of stably retaining their high quality for a relatively
long period of time.
As described above, the present invention was made
based on the finding that a cyclotetrasaccharide with
dehydrating ability strongly absorbs moisture from hydrous
matters, and that the resulting dehydrated products are highly
stable. When used as a dehydrating agent, the cyclotetra-
saccharide with dehydrating ability dehydrates hydrous matters
in a liquid or paste form and facilitates to produce high
quality pharmaceuticals and cosmetics with reduced moisture
_ 27 _

CA 02434284 2003-07-09
content without deteriorating or volatilizing the taste or the
flavor of the hydrous matters by the characteristic enclosing
action of the cyclotetrasaccharide.
The following are the preferred examples for use
according to the present invention:
The cyclotetrasaccharide with dehydrating ability used
in the present invention has a relatively low sweetness and can
be also used as a seasoning free from caries inducibility and
increment of blood cholesterol- and/or blood sugar-levels. If
necessary, the cyclotetrasaccharide can be used, for example,
by mixing with other sweeteners) such as a powdered syrup,
glucose, isomerized sugar, sucrose, maltose, a,a-trehalose,
honey, maple sugar, sorbitol, maltitol, dihydrocharcone,
stevioside, a-glycosyl stevioside, rebaudioside, glycyrrhizin,
thaumatin, L-aspartyl L-phenylalanine methyl ester, acesulfame
K, sucralose, saccharin, glycine, and alanine; and fillers such
as dextrin, starch, and lactose.
The cyclotetrasaccharide with dehydrating ability i.s
a non-reducing saccharide which has a high quality sweetness
inherent to cyclotetrasaccharide; well harmonizes with other
tastable materials having sour-, acid-, salty-, astringent-,
delicious-tastes, and bitter-tastes: and has a relatively high
acid- and heat-resistance. Thus, the cyclotetrasaccharide can
be favorably used in food products in general as a sweetener,
taste-improving agent, quality-improving agent, or flavor-
improving agent.
The cyclotetrasaccharide can be used as a dehydrating
agent in seasonings such as a soy sauce, powdered soy sauce,
"miso", "funmatsu-miso" (a powdered miso), "moromi" (a refined
- 28 -

CA 02434284 2003-07-09
sake), "hishio" (a refined soy sauce), "furikake" (a seasoned
fish meal), mayonnaise, dressing, vinegar, "sanbai-zu" (a sauce
of sugar, soy sauce and vinegar), "funmatsu-sushi-su" (powdered
vinegar for sushi), "chuka-no-moto" (an instant mix for Chinese
dish), "tentsuyu" (a sauce for Japanese deep-fat fried food),
"mentsuyu" (a sauce for Japanese vermicelli), sauce, catsup,
"yakiniku-no-tare" (a sauce for Japanese grilled meat), curry
roux, instant stew mix, instant soup mix, "dashi-no-moto" (an
instant stock mix), "mirin" (a sweet sake), "shin-mirin" (a
synthetic mirin), table sugar, and coffee sugar. Also, the
cyclotetrasaccharide can be arbitrarily used as a sweetener,
taste-improving agent, quality-improving agent, or taste/flavor-
iittproving agent. Further, the cyclotetrasaccharide can be
freely used as a dehydrating agent, sweetener, taste-improving
agent, quality-improving agent, or taste/flavor-improving agent
in "wagashi" ( Japanese cakes ) such as "senbei" ( a rice cracker ) ,
"arare-mochi" (a rice-cake cube), "okoshi" (a millet-and-rice
cake ) , "gyuhi" ( a rice paste with sugar ) , "mochi" ( a rice paste )
or the like, "manju" (a bun with a bean-jam), "uiro" (a sweet
rice jelly), "an" (a bean jam) or the like, "yokan" (a sweet
jelly of beans), "mizu-yokan" (a soft adzuki-bean jelly),
"kingyoku" (a kind of yokan), jelly, pao de Castella, and
"amedama" (a Japanese toffee); confectioneries such as a bun,
biscuit, cracker, cookie, pie, pudding, butter cream, custard
cream, cream puff, waffle, sponge cake, doughnut, chocolate,
chewing gum, caramel, nougat, and candy; frozen desserts such
as an ice cream and sherbet; syrups such as "kajitsu-no-syrup-
- 29 -

CA 02434284 2003-07-09
zuke" (a preserved fruit) and "korimitsu" (a sugar syrup for
shaved ice); pastes such as a flour paste, peanut paste, and
fruit paste; processed fruits and vegetables such as a jam,
marmalade, "syrup-zuke" (fruit pickles), and "toka" (conserves);
pickles and pickled products such as "fukujin-zuke" ( red colored
radish pickles), "bettara-zuke" (a kind of whole fresh radish
pickles ) , "seniriai-zuke" ( a kind of sliced fresh radish pickles )
and "rakkyo-zuke" (pickled shallots); premixes for pickles and
pickled products such as "takuan-zuke-no-moto" (a premix for
pickled radish) and "hakusai-zuke-no-raoto" (a premix for fresh
white rape pickles); meat products such as a ham and sausage;
products of fish meat such as a fish ham, fish sausage,
"kamaboko" (a steamed fish paste), "chikuwa" (a kind of fish
paste), and "tenpura" (a Japanese deep-fat fried fish paste);
"chinmi" (relishes) such as "uni-no-shiokara" (salted guts of
sea urchin), "ika-no-shiokara" (salted guts of squid), "su-
konbu" (processed tangle), "saki-surume" (dried squid strips)
and "fugu-no-mirin-boshi" (a dried mirin-seasoned swellfish);
"denpu" (a fish meet boiled down, seasoned, and dried) such as
those of cod, sea bream, and shrimp; "tsukudani" (foods boiled
down in soy sauce) such as those of layer, edible wild plants,
dried squid, fish, and shellfish; daily dishes such as "nimame"
( a cooked bean ) , potato salad, and "konbu-maki" ( a tangle roll ) ;
milk products; canned and bottled products such as those of
meat, fish meat, fruit, and vegetable; alcoholic beverages such
as a synthetic sake, wine, and liquors; soft drinks such as
coffee, tea, cocoa, juice, carbonated beverage, sour milk
beverage, and beverage containing lactic acid bacteria; and
- 30 -

CA 02434284 2003-07-09
instant food products such as an instant pudding mix, instant
hot cake mix, "sokuseki-shiruco" (an instant mix of adzuki-bean
soup with rice cake), and instant soup mix.
The following explain the process for producing the
cyclotetrasaccharides usable in the present invention and
properties thereof:
Experiment 1
Preparation of cyclotetrasaccharide from culture
A liquid culture medium consisting of 50 (w/v) of
"PINE-DEX #1", a partial starch hydrolysate commercialized by
Matsutani Chemical Ind., Tokyo, Japan, 1.5s (wjv) of
"ASAHIMEAST", a yeast extract commercialized by Asahi Breweries,
Ltd., Tokyo, Japan, 0.1~ (w/v) of sodium dihydrogen phosphate,
dodecahydrate, 0.06% (w/v) of magnesium sulfate, dodecahydrate,
and water was placed in a 500-ml Erlenmeyer flask in an amount
0
of 100 ml, sterilized by autoclaving at 121 C for 20 min,
cooled, and then seeded with Bacillus globisporus C9 strain,
FERM BP-7143, followed by culturing under rotary-shaking
a
conditions at 27 C and 230 rpm for 48 hours and centrifuging the
resulting culture to remove cells to obtain a supernatant. The
a
supernatant was autoclaved at 120 C for 15 min and then cooled,
and the resulting insoluble substances were removed by
centrifugation to obtain a supernatant.
To examine the saccharides in the resulting
supernatant, they were separated from the supernatant on silica
gel thin-layer chromatography (abbreviated as "TLC" hereinafter)
using, as a developer, a mixture solution of n-butanol,
pyridine, and water (=6:4:1 by volume), and, as a thin-layer
- 31 -

CA 02434284 2003-07-09
plate, "KIESELGEL 60", an aluminum plate (20 x 20 cm) for TLC
commercialized by Merck & Co., Inc., Rahway, USA. Whole of the
separated sugars and the reducing sugars among them were
respectively examined by coloring with the sulfuric acid-
s methanol method and the diphenylamine-aniline method. The
examination detected a non-reducing saccharide, positively
detected on the former detection method at a position with an
Rf value of about 0.31 but negative on the latter detection
method.
About 90 ml of the above supernatant was adjusted to
0
pH 5.0 and 45 C and then treated for 24 hours with 1, 500 units/g
solids of "TRANSGLUCOSIDASE L AMANOTM", an a-glucosidase
commercialized by Amano Pharmaceutical Co., Ltd., Aichi, Japan,
and 75 units/g solids of a glucoamylase commercialized by Nagase
Biochemicals, Ltd., Kyoto, Japan. Then, the resulting mixture
was adjusted to pH 12 by the addition of sodium hydroxide and
boiled for two hours to decompose the remaining reducing sugars.
After removing insoluble substances by filtration, the resulting
solution was decolored and desalted with "DIAION PK218" and
"DIAION WA30", cation exchange resins commercialized by
Mitsubishi Chemical Industries, Ltd., Tokyo, Japan, and further
desalted with "DIAION SK-1B", commercialized by Mitsubishi
Chemical Industries, Ltd., Tokyo, Japan, and "AMBERLITE IRA411",
an anion exchange resin commercialized by Japan Organo Co.,
Ltd., Tokyo, Japan, followed by successive decoloration with an
activated charcoal, membrane filtration, concentration by an
evaporator, and lyophilization in vacuo to obtain about 0.6 g,
d.s.b., of a saccharide powder.
The analysis of the saccharide on high-performance
- 32 -

CA 02434284 2003-07-09
liquid chromatography (abbreviated as "HPLC" hereinafter)
detected only a single peak at an elution time of 10.84 min as
shown in FIG. 1, revealing that the saccharide had a
significantly high purity of 99.90 or higher. The HPLC was run
using a column of "SHOWDEX KS-801", Showa Denko K.K., Tokyo,
0
Japan, at a column temperature of 60 C and a flow rate of 0.5
ml/min of water, and using "RI-8012", a differential
refractometer commercialized by Tosoh Corporation, Tokyo, Japan.
When measured for reducing power on the Somogyi-
Nelson's method, the specimen had a reducing power below a
detectable level, revealing that the specimen was a
substantially non-reducing saccharide.
Experiment 2
Structure analysis of cyclotetrasaccharide
Fast atom bombardment mass spectrometry (called "FAB-
MS" ) on a non-reducing saccharide, obtained by the method in
Experiment 1, clearly detected a proton-addition-molecular ion
with a mass number of 649, revealing that the saccharide had a
mass number of 648.
According to conventional manner, the saccharide was
hydrolyzed with sulfuric acid and analyzed for sugar composition
on gas chromatography. As a result, only D-glucose was
detected, revealing that the saccharide tested was composed of
D-glucose molecules. Based on the data and the above mass
number, the saccharide was estimated to be a cyclotetra-
saccharide, composed of four D-glucose molecules.
Nuclear magnetic resonance analysis (called "NMR") on
the saccharide gave a 1H-NMR spectrum in FIG. 2 and a 13C-NMR
spectrum in FIG. 3, and these spectra were compared with those
33 -

CA 02434284 2003-07-09
of authentic saccharides, revealing that they were coincided
with a non-reducing cyclic saccharide, cyclof~6)-a-D-
glucopyranosyl-(1-~3)-a-D-glucopyranosyl-(1~6)-a-D-
glucopyranosyl-(1-~3)-a-D-glucopyranosyl-(1--~} as disclosed in
"European Journal of Biochemistry", pp. 641-648 (1994). The
data confirmed that the saccharide was a cyclotetrasaccharide
in FIG. 4, i.e., cyclo~-~6)-a-D-glucopyranosyl-(1-~3)-a-D-
glucopyranosyl-(1-~6)-a-D-glucopyranosyl-(1-~3)-a-D-
glucopyranosyl- ( 1--~} .
Experiment 3
Production of a-isomaltosylglucosaccharide-formina enzyme from
Bacillus _ I~obisporus C9 strain
A liquid culture medium consisting of 4.0% (w/v) of
"PINE-DEX #4", a partial starch hydrolysate commercialized by
Matsutani Chemical Ind., Tokyo, Japan, 1.8% (w/v) of
"ASAHIMEAST", a yeast extract commercialized by Asahi Breweries,
Ltd., Tokyo, Japan, 0.1% (w/v) of dipotassium phosphate, 0.06%
(w/v) of sodium dihydrogen phosphate, dodecahydrate, 0.05% (w/v)
magnesium sulfate, heptahydrate, and water was placed in 500-ml
Erlenmeyer flasks respectively in an amount of 100 ml,
0
sterilized by autoclaving at 121 C for 20 min, cooled, and then
seeded with a stock culture of Bacillus globisporus C9 strain,
FERM BP-7143, followed by culturing under rotary-shaking
0
conditions at 27 C and 230 rpm for 48 hours for a seed culture.
About 20 L of a fresh preparation of the same liquid
culture medium as used in the above seed culture was placed in
a 30-L fermentor, sterilized by heating, and then cooled to 27~ C
and inoculated with 1% (v/v) of the seed culture, followed by
- 34 -

CA 02434284 2003-07-09
0
culturing at 27 C and a pH of 6.0 to 8.0 for 48 hours under
aeration-agitation conditions. After completion of the culture,
the resulting culture, which had about 0.45 unit/ml of a-
isomaltosylglucosaccharide-forming enzyme activity, about 1.5
units/ml of a-isomaltosyl-transferring enzyme activity, and
about 0.95 unit/ml of cyclotetrasaccharide-forming enzyme
activity, was centrifuged at 10, 000 rpm for 30 min to obtain
about 18 L of a supernatant. When measured for enzymatic
activity, the supernatant had an activity of about 0.45 unit/ml
of a-isomaltosylglucosaccharide-forming enzyme, i.e., a total
enzyme activity of about 8,110 units; about 1.5 units/ml of a-
isomaltosyl-transferring enzyme, i.e., a total enzyme activity
of about 26,900 units; and about 0.95 unit/ml of
cyclotetrasaccharide-forming activity, i.e., a total enzyme
activity of about 17,100 units.
The activities of these enzymes were assayed as
follows: The activity of a-isomaltosylglucosaccharide-forming
enzyme was assayed by dissolving maltotriose in 100 mM acetate
buffer (pH 6.0) to give a concentration of 2% (w/v) for a
substrate solution, adding 0.5 ml of an enzyme solution to 0.5
ml of the substrate solution, enzymatically reacting the mixture
solution at 35~C for 60 min, boiling the reaction mixture for
10 min to suspend the enzymatic reaction, and quantifying
maltose, among the isomaltosyl maltose and maltose formed in the
reaction mixture, on HPLC as described in Experiment 1. One
unit activity of the a-isomaltosylglucosaccharide-forming enzyme
was defined as the enzyme amount that forms one micromole of
maltose per minute under the above enzymatic reaction
conditions.
- 35 -

CA 02434284 2003-07-09
The activity of a-isomaltosyl-transferring enzyme was
assayed by dissolving panose in 100 mM acetate buffer (pH 6.0)
to give a concentration of 2$ (w/v) for a substrate solution,
adding 0.5 ml of an enzyme solution to 0.5 ml of the substrate
0
solution, enzymatically reacting the mixture solution at 35 C
for 30 min, boiling the reaction mixture for 10 min to suspend
the enzymatic reaction, and quantifying glucose, among the
cyclotetrasaccharide and glucose mainly formed in the reaction
mixture, by the glucose oxidase method. One unit activity of
the a-isomaltosyl-transferring enzyme was defined as the enzyme
amount that forms one micromole of glucose per minute under the
above enzymatic reaction conditions.
The cyclotetrasaccharide-forming activity was assayed
by dissolving "PINE-DEX #100", a partial starch hydrolysate
commercialized by Matsutani Chemical Ind., Tokyo, Japan, in 50
mM acetate buffer (pH 6.0) to give a concentration of 2~ (w/v)
for a substrate solution, adding 0.5 ml of an enzyme solution
to 0.5 ml of the substrate solution, enzymatically reacting the
mixture solution at 35~C for 60 min, boiling the reaction
0
mixture at 100 C for 10 min to suspend the enzymatic reaction,
and then further adding to the resulting mixture one milliliter
of 50 mM acetate buffer (pH 5.0) with 70 units/ml of
"TRANSGLUCOSIDASE L AMANOT"", an a-glucosidase commercialized by
Amano Pharmaceutical Co., Ltd., Aichi, Japan, and 27 units/ml
of glucoamylase commercialized by Nagase Biochemicals, Ltd.,
Kyoto, Japan, incubating the mixture at 50~C for 60 min,
0
inactivating the remaining enzymes by heating at 100 C for 10
min, and quantifying cyclotetrasaccharide on HPLC described in
Experiment 1. One unit of cyclotetrasaccharide-forming activity
- 36 -

CA 02434284 2003-07-09
was defined as the enzyme amount that forms one micromole of
cyclotetrasaccharide per minute under the above enzymatic
reaction conditions.
Experiment 4
Preparation of enzyme from Bacillus globi.sporus C9 strain
Experiment 4-1
Purification of enzyme from Bacillus qlobisporus C9 strain
About 18 L of the supernatant in Experiment 3 was
salted out under 80~ saturated ammonium sulfate and allowed to
stand at 4~C for 24 hours, and the formed sediments were
collected by centrifugation at 10,000 rpm for 30 min, dissolved
in 10 mM phosphate buf fer ( pH 7 . 5 ) , and dialyzed against a fresh
preparation of the same buffer to obtain about 400 ml of a crude
enzyme solution with 8,110 units of the a-
isomaltosylglucosaccharide-forming enzyme, 24,700 units of a-
isomaltosyl-transferring enzyme, and about 15,600 units of
cyclotetrasaccharide-forming activity. The crude enzyme
solution was subjected to ion-exchange chromatography using
1,000 ml of "SEPABEADS FP-DA13" gel, an ion-exchange resin
commercialized by Mitsubishi Chemical Industries, Ltd., Tokyo,
Japan. a-Isomaltosylglucosaccharide-forming enzyme and
cyclotetrasaccharide were eluted as non-adsorbed fractions
without adsorbing on the gel. The resulting enzyme solution was
dialyzed against 10 mM phosphate buffer (pH 7.0) with 1 M
ammonium sulfate, and the dialyzed solution was centrifuged to
remove impurities, and subjected to affinity chromatography
using 500 ml of "SEPHACRYL HR S-200", a gel commercialized by
Amersham Corp., Div. Amersham International, Arlington Heights,
IL, USA. Enzymatically active components adsorbed on the gel
- 37 _

CA 02434284 2003-07-09
and, when sequentially eluted with a linear gradient decreasing
from 1 M to O M of ammonium sulfate and a linear gradient
increasing from 0 mM to 100 mM of maltotetraose, a-
isomaltosylglucosaccharide-forming enzyme and a-isomaltosyl-
transferring enzyme were separately eluted, i . e. , the former was
eluted with the linear gradient of maltotetraose at about 30 mM
and the latter was eluted with the linear gradient of ammonium
sulfate at about 0 M. Fractions with a-isomaltosyl-transferring
activity and those with a-isomaltosylglucosaccharide-forming
activity were separatory collected. No cyclotetrasaccharide-
forming activity was found in any of the above fractions and
this revealed that a mixture solution of both of the above
fractions with a-isomaltosylglucosaccharide-forming enzyme and
a-isomaltosyl-transferring enzyme exhibited
cyclotetrasaccharide-forming activity, showing that the activity
of forming cyclotetrasaccharide from partial starch hydrolyzates
was exerted by the coaction of the activities of the above two
types of enzymes.
Methods for separatory purifying a-isomaltosylgluco-
saccharide-forming enzyme and a-isomaltosyl-transferring enzyme
are explained below:
Experiment 4-2
Purification of a-isomaltosylqlucosaccharide-forming enzyme
A fraction of the a-isomaltosylglucosaccharide-forming
enzyme, obtained in Experiment 4-l, was dialyzed against 10 mM
phosphate buffer (pH 7.0) with 1 M ammonium sulfate. The
dialyzed solution was centrifuged to remove insoluble
substances, and the resulting supernatant was fed to hydrophobic
chromatography using 350 ml of "BUTYL-TOYOPEARL 650 M", a gel
- 38 -

CA 02434284 2003-07-09
commercialized by Tosoh Corporation, Tokyo, Japan. The enzyme
adsorbed on the gel and was eluted therefrom at about 0.3 M
ammonium sulfate with a linear gradient decreasing from 1 M to
0 M of ammonium sulfate, followed by collecting fractions with
the enzyme activity. The fractions were pooled and dialyzed
against 10 mM phosphate buffer (pH 7.0) with 1 M ammonium
sulfate. The resulting dialyzed solution was centrifuged to
remove insoluble substances and fed to affinity chromatography
using "SEPHACRYL HR S-200" gel to purify the enzyme. The amount
of enzyme activity, the specific activity, and the yield of the
a-isomaltosylglucosaccharide-forming enzyme in each purification
step are in Table 1.
- 39 -

CA 02434284 2003-07-09
b Ov .~-1 oD CO ~-I
'-S ~ O
O r1 N ~ L~ M
-ri ~r r1 O~ L~ d~ Ch N
,7y O
~
-r1 Jr
r1
t
+' N
E O
~
N ~o c~ N >~
O .-It17 O Cw 0 v0
~ E
w w O O ~-I ~ O c~7 is
W
-~I r-t ~ O
O
+~
U -~I w
N 0 I
R~ U
~
U7 'b
v
N
ro
U
U
O
O
ro ~ U
E
+~
r-I
O
9 E
O ~ ~ ~
I O
d~ n O O ao
ao
O -I
N .. ao cm n d~ 07 ,1 ro
O
N UJ
O ri
W I
O
O
0 N N
i-t O~ U E
-~
O G
~
+~ N ~r ~r .L7 ~r
O ~r
+~ b U
~
o, ~ ro x ro ~ c~ -~I
ro ro ro
N ro f~ U S-I O O G ri
~.I S-a S.~
+~ O I fT ~I N -a O
.~ O trl b~
u1 ro ~ G O w Tf w -ca
+~ O O O
G +.~ O ~ w ~, w E
-~ +~ +~ +~
~ ~ ro ~ ~ m
3 E E
O ~ E E
fl,O E O E E E
+~ O O O
+~ 0 u1 O f~ 0 O O O
O H N ~I
c0 U1 O N .C N N i-t .C
.O .~ .G
U 23 ~+~ w w w E
U U U U
-~I N N
O
Ql
w S~ ~ N O N O U ..
1~ s~ O O
+a
a. .~ +~ +~ +~
-~ E E E ~
ro
+~ ~ b ~ ro ro ro ro
+~ ~ ~ ro
w
ro~~ ~~ ~~ ~~ o~
w ~ -~I ~ o ~ ~ .~ 0
ro o o 0
~
U A W U W W W Z
U1 U U U
UI
-4~
u, o In o ~ o
.1 .-i N N

CA 02434284 2003-07-09
The finally purified a-isomaltosylglucosaccharide-
forming enzyme specimen was assayed for purity on gel
electrophoresis using a 7.5$ (w/v) polyacrylamide gel and
detected on the gel as a single protein band, meaning a high
purity enzyme specimen.
Experiment 4-3
Purification of a-isomaltosyl-transferring enzyme
A fraction with a-isomaltosyl-transferring enzyme,
which had been separated from a fraction with a-
isomaltosylglucosaccharide-forming enzyme by affinity
chromatography in Experiment 4-1, was dialyzed against 10 mM
phosphate buffer (pH 7.0) with 1 M ammonium sulfate. The
resulting dialyzed solution was centrifuged to remove insoluble
substances and subjected to affinity chromatography using 350
ml of "BUTYL-TOYOPEARL 650 M" , a gel commercialized by Tasoh
Corporation, Tokyo, Japan. The enzyme adsorbed on the gel and
was eluted therefrom at about 0.3 M ammonium sulfate with a
linear gradient decreasing from 1 M to 0 M of ammonium sulfate,
followed by collecting fractions with the enzyme activity. The
fractions were pooled and dialyzed against 10 mM phosphate
buffer (pH 7.0) with 1 M ammonium sulfate. The resulting
dialyzed solution was centrifuged to remove insoluble substances
and fed to affinity chromatography using "SEPHACRYL HR S-200"
gel to purify the enzyme. The amount of enzyme activity, the
specific activity, and the yield of a-isomaltosyl-transferring
enzyme in each purification step are in Table 2.
- 41 -

CA 02434284 2003-07-09
O ~ ~ 00 N O
..
O~ L~ d~ O7 N
O
ri
-rl
~.
N
-~i
O
~
U ~
0
f
-II
(I1
N
p,
L~. ~ lf~ ri
U N d~ ao d~ ~ c~ o~
b~
U
W W O ~ M ao w o
w
~-I N N
N
1~
N
b1
G
N N
N O
r-I W
E ~ N
~~I +~
I
O O O O O O ~r
U +~
O O O O O ~o m .
o W~ d~ d~ O d~ O
N O~ O v0 r-I
~
~ ~ c0
B
O
N
G
r1
W I
N O
C
.~ ~r O ~r -1c
.C .C ~ .~
+~ m U a +~ x +~ =
a a a c~
a ~ c~ x co -~I a~ .~,
m m m
a~ b o a~ ~ o a
s~ s~ N N
+~ +~ o I rn .~ N -~I o
x ~ ~ a~
-~ o o w b W
+~ o o o
O +~ o +~ w Dr w E
.~I +~ +~ +~
N ~ -~ Iri .~ c0 >,
3 m t~ rt1 c0
~ O O O O
- +~ E E E E
O O
+' ~ UJ O S~ O O O N
~ f-I H N
rt1 Ul O N .~ ~ N f-I
.~ .G .C
U ~ w U w w 4-I E
U U U
O ~
O
4-1 !-1N O G N N O ..
C G ~ O
+.~
-ri :~ ,'y ~ E ~ ~ ~1-~
-ri E 6 ~.,
(d
H ~ ri f0 b c0 Id N
~ ~ ~ ~ ~
W
:7 r1 (d ~ ~i ~ ~ ~
r~ r1 r1 r-I
ri
P. ~ -.i rl ri r1 rl O
d1 O O O O
~
U fa W U W W W z
UI U U U
U1
-42-
In o In O In O
N N M

CA 02434284 2003-07-09
Experiment 5
Property of a-isomaltosylglucosaccharide-forming enzyme and
a-isomaltosyl-transferring enzyme
Experiment 5-1
Property of a-isomaltosylg~lucosaccharide-forming' enzyme
A purified specimen of a-isomaltosylglucosaccharide-
forming enzyme, obtained by the method in Experiment 4-2, was
subjected to SDS-PAGE using a 7.5$ (w/v) of polyacrylamide gel
and then determined for molecular weight in comparison with the
dynamics of standard molecular markers electrophoresed in
parallel, commercialized by Bio-Rad Laboratories Inc., Brussels,
Belgium, revealing that the enzyme had a molecular weight of
about 140,000~20,000 daltons.
A fresh preparation of the above purified specimen was
subjected to isoelectrophoresis using a gel containing 2$ (w/v)
ampholine commercialized by Amersham Corp., Div. Amersham
International, Arlington Heights, IL, USA, and then measured for
pHs of protein bands and gel to determine the isoelectric point
of the enzyme, revealing that the enzyme had an isoelectric
point of about 5.2~0.5.
The influence of temperature and pH on the activity
of a-isomaltosylglucosaccharide-forming enzyme was examined in
accordance with the assay for the enzyme activity, where the
influence of temperature was conducted in the presence or
absence of 1 mM Caz'. These results are in FIG. 5 (influence of
temperature) and FIG. 6 (influence of pH). The optimum
temperature of the enzyme was about 40~C (in the absence of
Caz+ ) and about 45~ C ( in the presence of 1 mM Caz+ ) when
incubated at pH 6.0 for 60 min, and the optimum pH of the enzyme
- 43 -

CA 02434284 2003-07-09
0
was about 6.0 to about 6.5 when incubated at 35 C for 60 min.
The thermal stability of the enzyme was determined by incubating
it in 20 mM acetate buffers (pH 6.0) at prescribed temperatures
for 60 min in the presence or absence of 1 mM Ca2+, cooling the
resulting enzyme solutions with water, and assaying the
remaining enzyme activity for each solution. The pH stability
of the enzyme was determined by keeping it in 50 mM buffers
0
having prescribed pHs at 4 C for 24 hours, adjusting the pH of
each solution to 6.0, and assaying the remaining enzyme activity
for each solution. These results are respectively in FIG. 7
( thermal stability) and FIG. 8 ( pH stability ) . As a result, the
enzyme was thermally stable up to about 35~C in the absence of
CaZ+ and about 40~ C in the presence of 1 mM Cap', and was stable
at pHs from about 4.5 to about 9Ø
The influence of metal ions on the activity of a-
isomaltosylglucosaccharide-forming enzyme was examined in the
presence of 1 mM of any of metal salts according to the assay
for the enzyme activity. The results are in Table 3.
Table 3
Metal ion Relative activity Metal ion Relative activity
None 100 Hgz' 4
Znz+ 92 Ba2+ 65
Mg2+ 100 Srz' 80
Ca2' 115 PbZ+ 103
Coz+ 100 Fez+ 9 8
Cuz' 15 Fe3+ 97
Niz+ 98 Mnz' 111
- 44 -

CA 02434284 2003-07-09
(Continued)
Metal ion Relative activity Metal ion Relative activity
(~) (%)
A13' 99 EDTA 20
As evident form the results in Table 3, the enzyme
activity was significantly inhibited by Hg2+, Cu2+, and EDTA, and
was also inhibited by Ba2' and SrZ'. It was also found that the
enzyme was activated by Ca~+ and Mnz' .
Amino acid analysis of the N-terminal amino acid
sequence of the enzyme by "PROTEIN SEQUENCER MODEL 473A", an
apparatus of Applied Biosystems, Inc., Foster City, USA,
revealed that the enzyme had a partial amino acid sequence of
SEQ ID NO:1, i.e., tyrosine-valine-serine-serine-leucine-
glycine-asparagine-leucine-isoleucine in the N-terminal region.
Experiment 5-2
Property of a-isomaltosyl-transferring enzyme
A purified specimen of a-isomaltosyl-transferring
enzyme, obtained by the method in Experiment 4-3, was subjected
to SDS-PAGE using a 7.5s (w/v) of polyacrylamide gel and then
determined for molecular weight in comparison with the dynamics
of standard molecular markers electrophoresed in parallel,
commercialized by Hio-Rad Laboratories Inc., Brussels, Belgium,
revealing that the enzyme had a molecular weight of about
112,000~20,000 daltons.
A fresh preparation of the above purified specimen was
subjected to isoelectrophoresis using a gel containing 2% (w/v)
ampholine commercialized by Amersham Corp., Div. Amersham
International, Arlington Heights, IL, USA, and then measured for
pHs of protein bands and gel to determine the isoelectric point
- 45 -

CA 02434284 2003-07-09
of the enzyme, revealing that the enzyme had an isoelectric
point of about 5.5~0.5.
The influence of temperature and pH on the activity
of a-isomaltosyl-transferring enzyme was examined in accordance
with the assay for the enzyme activity. These results are
respectively in FIG. 9 (influence of temperature) and FIG. 10
(influence of pH). The optimum temperature of the enzyme was
about 45~C when incubated at pH 6.0 for 30 min, and the optimum
pH of the enzyme was about 6. 0 when incubated at 35~ C for 30
min. The thermal stability of the enzyme was determined by
incubating it in 20 mM acetate buffers (pH 6.0) at prescribed
temperatures for 60 min, cooling the resulting enzyme solutions
with water, and assaying the remaining enzyme activity of each
solution. The pH stability of the enzyme was determined by
keeping it in 50 mM buffers having prescribed pHs at 4~C for 24
hours, adjusting the pH of each solution to 6.0, and assaying
the remaining enzyme activity for each solution. These results
are respectively in FIG. 11 (thermal stability) and FIG. 12 (pH
stability). As a result, the enzyme was thermally stable up to
about 40~C and was stable at pHs of about 4.0 to about 9Ø
The influence of metal ions on the activity of a-
isomaltosyl-transferring enzyme was examined in the presence of
1 mM of any of metal salts according to the assay for the enzyme
activity. The results are in Table 4.
- 46 -

CA 02434284 2003-07-09
Table 4
Metal ion Relative activity Metal ion Relative activity
(%) (%)
None 100 Hgz+ 1
Zn2' 88 Ba~+ 102
MgZ+ 9 8 Sr~+ 101
Ca2+ 101 Pbz+ 89
Co2+ 103 Fe2' 96
Cu2+ 57 Fe3+ 105
NiZ' 102 MnZ+ 106
A13' 103 EDTA 104
As evident form the results in Table 4, the enzyme
activity was significantly inhibited by HgZ+ and was also
inhibited by CuZ'. It was also found that the enzyme was not
activated by CaZ+ and not inhibited by EDTA.
Amino acid analysis of the N-terminal amino acid
sequence of the enzyme by "PROTEIN SEQUENCER MODEL 473A" , an
apparatus of Applied Biosystems, Inc., Foster City, USA,
revealed that the enzyme had a partial amino acid sequence of
SEQ ID N0:2, i.e, isoleucine-aspartic acid-glycine-valine-
tyrosine-histidine-alanine-proline-asparagine-glycine in the N-
terminal region.
Experiment 6
Production of a-isomaltosylglucosaccharide-forming enzyme from
Bacillus globisporus C11 strain
A liquid nutrient culture medium, consisting of 4.0%
( w/v ) of "PINE-DEX #4" , a partial starch hydrolysate, 1 . 8 % ( w/v )
of "ASAHIMEAST", a yeast extract, 0.1% (w/v) of dipotassium
- 47

CA 02434284 2003-07-09
phosphate, 0.06% (w/v) of sodium dihydrogen phosphate,
dodecahydrate, 0.05 (w/v) magnesium sulfate, heptahydrate, and
water was placed in 500-m1 Erlenmeyer flasks respectively in an
0
amount of 100 ml, autoclaved at 121 C for 20 minutes to effect
sterilization, cooled, inoculated with a stock culture of
Bacillus globisporus C11 strain, FERM BP-7144, and incubated at
27~C for 48 hours under rotary shaking conditions of 230 rpm.
The resulting cultures were pooled and used as a seed culture.
About 20 L of a fresh preparation of the same nutrient
culture medium as used in the above culture was placed in a 30-L
0
fermentor, sterilized by heating, cooled to 27 C, inoculated
with 1~ (v/v) of the seed culture, and incubated for about 48
hours while stirring under aeration agitation conditions at 27~ C
and pH 6.0 to 8Ø The resultant culture, having about 0.55
unit/ml of a-isomaltosylglucosaccharide-forming enzyme activity,
about 1.8 units/ml of a-isomaltosyl-transferring enzyme
activity, and about 1.1 units/ml of cyclotetrasaccharide-forming
enzyme activity, was centrifuged at 10,000 rpm for 30 min to
obtain about 18 L of a supernatant. Measurement of the
supernatant revealed that it had about 0.51 unit/ml of a-
isomaltosylglucosaccharide-forming enzyme activity, i.e., a
total enzyme activity of about 9,180 units; about 1.7 units/ml
of a-isomaltosyl-transferring enzyme activity, i.e., a total
enzyme activity of about 30,400 units; and about 1.1 units/ml
of cyclotetrasaccharide-forming enzyme activity, i.e., a total
enzyme activity of about 19,400 units.
Experiment 7
Preparation of enzyme from Bacillus qlobisporus C11 strain
An 18 L of the supernatant obtained in Experiment 6
- 48 -

CA 02434284 2003-07-09
was salted out with an 80~ saturated ammonium sulfate solution
0
and allowed to stand at 4 C for 24 hours. Then the salted out
sediments were collected by centrifugation at 10, 000 for 30 min,
dissolved in 10 mM phosphate buffer (pH 7.5), dialyzed against
a fresh preparation of the same buffer to obtain about 416 ml
of a crude enzyme solution. The crude enzyme solution was
revealed to have 8,440 units of the a-
isomaltosylglucosaccharide-forming enzyme, about 28,000 units
of a-isomaltosyl-transferring enzyme, and about 17,700 units of
cyclotetrasaccharide-forming enzyme. When subjected to ion-
exchange chromatography using "SEPABEADS FP-DA13" gel, disclosed
in Experiment 4-1, any of the above three types of enzymes were
eluted as non-adsorbed fractions without adsorbing on the gel.
The non-adsorbed fractions with these enzymes were pooled and
dialyzed against 10 mM phosphate buffer (pH 7.0) containing 1
M ammonium sulfate, and the dialyzed solution was centrifuged
to remove insoluble substances. The resulting supernatant was
fed to affinity chromatography using 500 ml of "SEPHACRYL HR S-
200" gel to purify the enzymes. Active enzymes were adsorbed
on the gel and sequentially eluted therefrom with a linear
gradient decreasing from 1 M to O M of ammonium sulfate and a
linear gradient increasing from 0 mM to 100 mM of maltotetraose,
resulting in a separate elution of a-isomaltosyl-transferring
enzyme or a-isomaltosylglucosaccharide-forming enzyme, where the
former enzyme was eluted with the linear gradient of ammonium
sulfate at a concentration of about 0.3 M and the latter enzyme
was eluted with a linear gradient of maltotetraose at a
concentration of about 30 mM. Then the fractions with a-
isomaltosyl-transferring enzyme and those with a -
- 49 -

CA 02434284 2003-07-09
isomaltosylglucosaccharide-forming enzyme were separately
collected and recovered. Similarly as in the case of Bacillus
globisporus C9 strain in Experiment 4, it was found that no
cyclotetrasaccharide-forming activity was found in any fraction
in this column chromatography, and that an enzyme mixture
solution of both fractions of a-isomaltosyl-transferring enzyme
and a-isomaltosylglucosaccharide-forming enzyme showed
cyclotetrasaccharide-forming activity, revealing that the
activity of forming cyclotetrasaccharide from partial starch
hydrolyzates was exerted in collaboration with the enzyme
activities of the two types of enzymes.
Methods for separately purifying a-
isomaltosylglucosaccharide-forming enzyme and a-isomaltosyl-
transferring enzyme are explained below:
Experiment 7-2
Purification of a-isomaltosvlQlucosaccharide-formincr enzvme
A fraction of a-isomaltosylglucosaccharide-forming
enzyme was dialyzed against 10 mM phosphate buffer (pH 7.0)
containing 1 M ammonium sulfate. The dialyzed solution was
centrifuged to remove insoluble substances, and the resulting
supernatant was fed to hydrophobic chromatography using 350 ml
of "BUTYL-TOYOPEARL 650 M", a gel commercialized by Tosoh
Corporation, Tokyo, Japan. The enzyme adsorbed on the gel was
eluted therefrom at about 0.3 M ammonium sulfate with a linear
gradient decreasing from 1 M to 0 M of ammonium sulfate,
followed by collecting fractions with the enzyme activity. The
fractions were pooled and dialyzed against 10 mM phosphate
buffer (pH 7.0) containing 1 M ammonium sulfate. The resulting
dialyzed solution was centrifuged to remove insoluble substances
- 50 -

CA 02434284 2003-07-09
and fed to affinity chromatography using "SEPHACRYL HR S-200"
gel to purify the enzyme. The amount of enzyme activity, the
specific activity, and the yield of a-isomaltosylgluco-
saccharide-forming enzyme in each purification step are in Table
5.
- 51 -

CA 02434284 2003-07-09
o~ r1 O ~ ao
-,O~ dvP ~ p~ (w cr M N
O
O
N
O
N +~ N
td N
CL
-1 v0 O o0 O 'd~
O O
--rl ri r1 O
O +~
w
O G I
N
a b
N
t~
m U
U
N b
N
O
?,
O O O O O O
r1 M O
.r ~ CO ~ d~ M N
O
N
O -rl
W 1
O
S~
(d
47
f-I b~ U B
~
N G
G
~ ~
~ a
+~ c0 U i- -
~ ~ ~
>~ ~ x -.~ s~
ro ~a m
N t0 G N t~ O G rl
!r !.a N f-I
+~ +~ O I -~I S-I -~I O
.~ C7t b1 trl b~
N c0 -~I G w b w ,c7
+~ O O O O
t~ +~ O w ~ w E
~~I +~ +~ .1~ +~
O N a -ri rt1 .C t0 ~r
3 t0 l~ t0 l0
O O O O
~ O+~ ~ E E E
a U1 O O O O N
a N N i-1 S-I
t0 U1 O i.1 f-a f.~ S-I
.~ ~ .s~ .r~
N U U w '~ E
U U
4l CrN
w S-IN N ~ N N ..
G t~ G G t~
+~
-ri a ~r d-~ i-~ ~ ~
w1 ~ ~ E E
Id
~, +~ r1 m m m m a~
+~ a a a a
w
a ~I m a a a a +~
~I ~I ~I .~ .~
.~
w a ~a .~ ~I ~, ~ 0
m o o o 0
a
U A W W W W Z
N U U U U
U1
-52-
m o In o m o
N N M

CA 02434284 2003-07-09
The finally purified a-isomaltosylglucosaccharide-
forming enzyme specimen was assayed for purity on gel
electrophoresis using a 7.5$ (w/v) polyacrylamide gel and
detected on the gel as a single protein band, meaning a high
purity enzyme specimen.
Experiment 7-3
Purification of a-isomaltosyl-transferring enzyme
A fraction of a-isomaltosyl-transferring enzyme, which
had been separated from a fraction with a-
isomaltosylglucosaccharide-forming enzyme by the affinity
chromatography in Experiment 7-1, was dialyzed against 10 mM
phosphate buffer (pH 7.0) containing 1 M ammonium sulfate. The
dialyzed solution was centrifuged to remove insoluble
substances, and the resulting supernatant was fed to hydrophobic
chromatography using 350 ml of "BUTYL-TOYOPEARL 650 M", a gel
commercialized by Tosoh Corporation, Tokyo, Japan. The enzyme
adsorbed on the gel and was eluted therefrom at about 0.3 M
ammonium sulfate with a linear gradient decreasing from 1 M to
0 M of ammonium sulfate, followed by collecting fractions with
the enzyme activity. The fractions were pooled and dialyzed
against 10 mM phosphate buffer (pH 7.0) containing 1 M ammonium
sulfate. The resulting dialyzed solution was centrifuged to
remove insoluble substances and fed to affinity chromatography
using "SEPHACRYL HR S-200" gel to purify the enzyme. The amount
of enzyme activity, the specific activity, and the yield of the
a-isomaltosyl-transferring enzyme in each purification step are
in Table 6.
- 53 -

CA 02434284 2003-07-09
T1 ~I L~ ,-I 0v .-1
.-I ~-~ O
N o~ O N '-1 tn c~7 CO
-~ v '-i Oi L~ d~ ('0 '-1
~ G
~x
'r1
~
~~
U
c0
N
a
G In OD v0 O~ d~ t0
U d d~ ow n
b~
w 8 ~-I cn av N
O .-1 (h N N N
U W N
N G C
a ~ a~
.r.,
~,
a~ a~
w
<n
o
b
E
+~ N
+~
0 0 0 0 0 0
V +~ O O O O O .--I U1
d~ O co C~ cn tn
x ~ O 00 .-I (~'7O In r-~
N ~ (~ N N r1 .-a t0
~r O
N i~
C r1
W I
C
6 cd
O O
i-a b~ U E
~I
O G t~
+~ td >, .C1 ~,
O ~, ~
~ U ~ ~ ~
R O ~ a
td ~ . .
c m x -~ a -~
m ~ m ca
a m ~ a~ G o G .-I
N ~ s~ s~
a~ +~ o ,~ I '~I N ~ o
a~ a~ c~ rn
+~ m .~ G w ~ w ,~
+~ o o o o
~n c +.~ o w ~ w
'~I ~ +~ +~ +~
N ~ 3 _ ~ ~ ~
~
t~ E E E E U
O a O+~ E E E E
O O O O
W ~ U1 O O O O N
O S.a f-a 4a N
U1 O t-I !.a f-I N .i~
,r~ .~ ,~ .C
a1 Z1 w w w W E
U U U U
U N N tr~
O
wi f-1N G N N N N ..
+~ G G O O
w ~ ~.,-~ +~ +~ +> +~
m E E E E
+~ r, m m m it o
+~ ~ ~ ~ ~
w
f.1 ri (d ~ ~ ~ ~ ~
e-i r1 ri ri r-1
r~l
a ~ -~I ~ ~ ~I ~ 0
m o o o 0
a
LL U f~ W W W W z
u1 U U U U
tO
-54-
m o m o m o
~I N N M

CA 02434284 2003-07-09
Experiment 8
Preparation of a-isomaltosylg~lucosaccharide-forming enzyme
Experiment 8-1
Property of a-isomaltosylglucosaccharide-forming enzyme
A purified specimen of a-isomaltosylglucosaccharide-
forming enzyme, obtained by the method in Experiment 7-2, was
subjected to SDS-PAGE using a 7.5% (w/v) of polyacrylamide gel
and then determined for molecular weight in comparison with the
dynamics of standard molecular markers electrophoresed in
parallel, commercialized by Bio-Rad Laboratories Inc., Brussels,
Belgium, revealing that the enzyme had a molecular weight of
about 137,000~20,000 daltons.
A fresh preparation of the above purified specimen was
subjected to isoelectrophoresis using a gel containing 2% (w/v)
ampholine commercialized by Amersham Corp., Div. Amersham
International, Arlington Heights, IL, USA, and then measured for
pHs of protein bands and gel to determine the isoelectric point
of the enzyme, revealing that the enzyme had an isoelectric
point of about 5.2~0.5.
The influence of temperature and pH on the activity
of a-isomaltosylglucosaccharide-forming enzyme was examined in
accordance with the assay for the enzyme activity, where the
influence of temperature was conducted in the presence or
absence of 1 mM Ca2+. These results are in FIG. 13 (influence
of temperature) and FIG. 14 (influence of pH). The optimum
temperature of the enzyme was about 45~C in the absence of Ca2+
and about 50~C in the presence of 1 mM Ca~+ when incubated at pH
6.0 for 60 min. The optimum pH of the enzyme was about 6.0 when
0
incubated at 35 C for 60 min. The thermal stability of the
- 55 -

CA 02434284 2003-07-09
enzyme was determined by incubating it in 20 mM acetate buffers
(pH 6.0) in the presence or absence of 1 mM Caz' at prescribed
temperatures for 60 min, cooling the resulting enzyme solutions
with water, and assaying the remaining enzyme activity of each
solution. The pH stability of the enzyme was determined by
keeping it in 50 mM buffers having prescribed pHs at 4~C for 24
hours, adjusting the pH of each solution to 6.0, and assaying
the remaining enzyme activity of each solution. These results
are respectively in FIG. 15 (thermal stability) and FIG. 16 (pH
stability). As a result, the enzyme was thermally stable up to
about 40~C in the absence of Caz' and about 45~C in the presence
of 1 mM Caz+. The pH stability of enzyme was in the range of
about 5.0 to about 10Ø
The influence of metal ions on the activity of a
isomaltosylglucosaccharide-forming enzyme was examined in the
presence of 1 mM of any of metal salts according to the assay
for the enzyme activity. The results are in Table 7.
Table 7
Metal ion Relative activity Metal ion Relative activity
(o) (~)
None 100 Hgz' 4
2 5 Znz+ 91 Baz+ 6 5
Mgz' 98 Srz' 83
Caz' 109 Pbz+ 101
Coz+ 9 6 Fez' 100
Cuz+ 23 Fe3' 102
Niz+ 93 Mnz' 142
A13' 100 EDTA 24
- 56 -

CA 02434284 2003-07-09
As evident form the results in Table 7, the enzyme
activity was greatly inhibited by Hgz', Cu2', and EDTA and was
also inhibited by Baz' and Srz+. It was also found that the
enzyme was activated by Caz' and Mnz+.
Amino acid analysis of the N-terminal amino acid
sequence of the enzyme by "PROTEIN SEQUENCER MODEL 473A" , an
apparatus of Applied Biosystems, Inc., Foster City, USA,
revealed that the enzyme had a partial amino acid sequence of
SEQID NO:1, i.e, tyrosine-valine-serine-serine-leucine-glycine-
asparagine-leucine-isoleucine in the N-terminal region.
The comparison of the partial amino acid sequence in
the N-terminal region with that derived from the a-
isomaltosylglucosaccharide-forming enzyme from Bacillus
globisporus C9 strain in Experiment 5-1 revealed that they were
the same and that the N-terminal amino acid sequence, commonly
found in a-isomaltosylglucosaccharide-forming enzymes, was an
amino acid sequence of tyrosine-valine-serine-serine-leucine-
glycine-asparagine-leucine-isoleucine of SEQ ID NO:1 in the N-
terminal region.
Experiment 8-2
Property of a-isomaltosyl-transferring enzyme
A purified specimen of a-isomaltosyl-transferring
enzyme, obtained by the method in Experiment 7-3, was subjected
to SDS-PAGE using a 7.5~ (w/v) of polyacrylamide gel and then
determined for molecular weight by comparing with the dynamics
of standard molecular markers electrophoresed in parallel,
commercialized by Bio-Rad Laboratories Inc., Brussels, Belgium,
revealing that the enzyme had a molecular weight of about
102,000~20,000 daltons.
- 57 -

CA 02434284 2003-07-09
A fresh preparation of the above purified specimen was
subj ected to isoelectrophoresis using a gel containing 2$ ( w/v )
ampholine commercialized by Amersham Corp., Div. Amersham
International, Arlington Heights, IL, USA, and then measured for
pHs of protein bands and gel to determine the isoelectric point
of the enzyme, revealing that the enzyme had an isoelectric
point of about 5.6~0.5.
The influence of temperature and pH on the activity
of a-isomaltosyl-transferring enzyme was examined in accordance
with the assay for the enzyme activity. These results are
respectively in FIG. 17 (influence of temperature) and FIG. 18
(influence of pH). The optimum temperature of the enzyme was
about 50~C when incubated at pH 6.0 for 30 min. The optimum pH
of the enzyme was about 5.5 to about 6.0 when incubated at 35~C
for 30 min. The thermal stability of the enzyme was determined
by incubating it in 20 mM acetate buffers ( pH 6 . 0 ) at prescribed
temperatures for 60 min, cooling the resulting enzyme solutions
with water, and assaying the remaining enzyme activity of each
solution. The pH stability of the enzyme was determined by
keeping it in 50 mM buffers having prescribed pHs at 4~C for 24
hours, adjusting the pH of each solution to 6.0, and assaying
the remaining enzyme activity of each solution. These results
are respectively in FIG. 19 (thermal stability) and FIG. 20 (pH
stability). As a result, the enzyme was thermally stable up to
0
about 40 C and was stable at pHs of about 4.5 to about 9Ø
The influence of metal ions on the activity of a-
isomaltosyl-transferring enzyme was examined in the presence of
1 mM of any of metal salts according to the assay for the enzyme
activity. The results are in Table 8.
- 58 -

CA 02434284 2003-07-09
Table 8
Metal ion Relative activity Metal ion Relative activity
(%) (%)
None 100 Hg2+ 2
Znz' 83 Baz+ 90
Mg2' 91 Srz+ 93
Ca2+ 91 Pbz+ 74
Coz' 89 Fe2' 104
Cuz+ 56 Fe3+ 88
Niz+ 89 Mnz+ 93
A13+ 89 EDTA 98
As evident form the results in Table 8, the enzyme
activity was significantly inhibited by Hgz' and was also
inhibited by Cuz+. It was also found that the enzyme was not
activated by Caz' and not inhibited by EDTA.
Amino acid analysis of the N-terminal amino acid
sequence of the enzyme by "PROTEIN SEQUENCER MODEL 473A", an
apparatus of Applied Biosystems, Inc., Foster City, USA,
revealed that the enzyme had a partial amino acid sequence of
SEQ ID N0:3, i.e., isoleucine-aspartic acid-glycine-valine-
tyrosine-histidine-alanine-proline-tyrosine-glycine in the N-
terminal region.
The comparison of the partial amino acid sequence in
the N-terminal region with that derived from the a-isomaltosyl
transferring enzyme from Bacillus globisporus C9 strain in
Experiment 5-2 revealed that they had a common amino acid
sequence of isoleucine-aspartic acid-glycine-valine-tyrosine
histidine-alanine-proline, as shown in SEQ ID N0:4 at the N
- 59

CA 02434284 2003-07-09
terminal region.
Experiment 9
Amino acid sectuence of a-isomaltosylg~lucosaccharide-forming
enzyme
Experiment 9-1
Internal amino acid secruence of a-isomaltosylglucosaccharide-
forming enzyme
A part of a purified specimen of a-isomaltosylgluco-
saccharide-forming enzyme, obtained by the method in Experiment
7-2, was dialyzed against 10 mM Tris-HC1 buffer (pH 9.0), and
the dialyzed solution was diluted with a fresh preparation of
the same buffer to give a concentration of about one milligram
per milliliter. One milliliter of the dilute as a test sample
was admixed with 10 ug of a trypsin commercialized by Wako Pure
Chemical Industries, Ltd., Tokyo, Japan, and incubated at 30~C
for 22 hours to hydrolyze into peptides. To isolate the
peptides, the above hydrolyzates were subjected to reverse-phase
HPLC using "u-Bondapak C18 column" with a diameter of 2.1 mm and
a length of 150 mm, a product of Waters Chromatography Div. ,
MILLIPORE Corp., Milford, USA, at a flow rate of 0.9 ml/min and
at ambient temperature, and using a liner gradient of
acetonitrile increasing from 8~ ( v/v ) to 40~ ( v/v ) in 0 .1% ( v/v )
trifluoroacetate over 120 min. The peptides eluted from the
column were detected by monitoring the absorbance at a
wavelength of 210 nm. Three peptide specimens named P64 with
a retention time of about 64 min, P88 with a retention time of
about 88 min, and P99 with a retention time of about 99 min,
which had been well separated from other peptides, were
separately collected and dried in vacuo and then dissolved in
- 60 -

CA 02434284 2003-07-09
200 p1 of a solution containing O.l~s (v/v) trifluoroacetate and
50~ (v/v) acetonitrile. Each peptide specimen was subjected to
a protein sequencer for analyzing amino acid sequence up to
eight amino acid residues to obtain amino acid sequences of SEQ
ID NOs: 5 to 7. The analyzed internal partial amino acid
sequences are in Table 9.
Table 9
Peptide name Internal partial amino acid sequence
P64 aspartic acid-alanine-serine-alanine
asparagine-valine-threonine-threonine
P88 tryptophane-serine-leucine-glycine
phenylalanine-methionine-asparagine-
phenylalanine
P99 asparagine-tyrosine-threonine-aspartic acid
alanine-tryptophane-methionine-phenylalanine
Experiment 9-2
Internal amino acid secruence of a-isomaltosyl-transferring
enzyme
A part of a purified specimen of a-isomaltosyl-
transferring enzyme, obtained by the method in Experiment 7-3,
was dialyzed against 10 mM Tris-HC1 buffer ( pH 9 . 0 ) , and the
dialyzed solution was diluted with a fresh preparation of the
same buffer to give a concentration of about one milligram per
milliliter. One milliliter of the dilute as a test sample was
admixed with 10 ug of "Lysyl Endopeptidase" commercialized by
Wako Pure Chemical Industries, Ltd., Tokyo, Japan, and allowed
0
to react at 30 C for 22 hours to form peptides. The resultant
mixtures were subjected to reverse-phase HPLC to separate the
peptides using "~a-Bondapak C18 column" having a diameter of 2.1
mm and a length of 150 mm, a product of Waters Chromatography
- 61 -

CA 02434284 2003-07-09
Div., MILLIPORE Corp., Milford, USA, at a flow rate of 0.9
ml/min and at ambient temperature, and using a liner gradient
of acetonitrile increasing from 8~ (v/v) to 40$ (v/v) in 0.1$
(v/v) trifluoroacetate over 120 min. The peptides eluted from
the column were detected by monitoring the absorbance at a
wavelength of 210 nm. Three peptide specimens named P22 with
a retention time of about 22 min, P63 with a retention time of
about 63 min, and P71 with a retention time of about 71 min,
which had been well separated from other peptides, were
separately collected and dried in vacuo and then dissolved in
200 p1 of a solution of 0.1~ (v/v) trifluoroacetate and 50~
(v/v) acetonitrile. Each peptide specimen was subjected to a
protein sequences for analyzing amino acid sequence up to eight
amino acid residues to obtain amino acid sequences of SEQ ID
NOs : 8 to 10 . The analyzed internal partial amino acid sequences
are in Table 10.
Table 10
Peptide name Internal partial amino acid sequence
P22 glycine-asparagine-glutamic acid-methionine-
arginine-asparagine-glutamine-tyrosine
P63 isoleucine-threonine-threonine-tryptophane-
proline-isoleucine-glutamic acid-serine
P71 tryptophane-alanine-phenylalanine-glycine-
leucine-tryptophane-methionine-serine
Experiment 10
Action on saccharides
It was tested whether the following saccharides could
be used as substrates for a-isomaltosylglucosaccharide-forming
enzyme. For the purpose, a solution of maltose, maltotriose,
- 62 -

CA 02434284 2003-07-09
maltotetraose, maltopentaose, maltohexaose, maltoheptaose,
isomaltose, isomaltotriose, panose, isopanose, a,a-trehalose,
kojibiose, nigerose, neotrehalose, cellobiose, gentibiose,
maltitol, maltotriitol, lactose, sucrose, erlose, selaginose,
maltosyl glucoside, or isomaltosyl glucoside was prepared.
To each of the above solutions was added two units/g
substrate of a purified specimen of a-isomaltosylgluco-
saccharide-forming enzyme from either Bacillus globisporus C9
strain obtained by the method in Experiment 4-2, or Bacillus
globisporus C11 strain obtained by the method in Experiment 7-2,
and the resulting solutions were adjusted to give a substrate
concentration of 2~ (w/v) and incubated at 30~C and pH 6.0 for
24 hours. The enzyme solutions before and after the enzymatic
reactions were respectively analyzed on TLC disclosed in
Experiment 1 to confirm whether the enzymes act on these
substrates. The results are in Table 11.
- 63 -

CA 02434284 2003-07-09
+~ U N
rl
G c0 ,C +~
a1 +~
W -~I .>~ +~
t0 -~I
U
+
+ + I I I + I I + t t ~ ~ ~ ~
p
~ E O U~l
+ ~
~ ~ 0
-i
b W ~
U O O
~
+ u
l
-
U + ~ O ~
U
c
0
roNO~~
Wo b
a
U 3
5r O c
-~I n
:a
N t0 +
t t t I I + I 1 + I + I
+ W W O
Goo _ O O+~W
W U N , ~ G '~
O
O
O
O
''~
+ ~-~1
O O
' O U
~
' O t
G
U
~ rt1
~
N E
O ~-iI ~ N S.a
O
p N N ~ ~ H ~r N W
<v r r ~ p ~
~ -I i I O
0 O -
+ N rt1O O ~ -~IN U O ~r +~ ,
l0 tJJ,~ -rl-~-1O S-I ~ ~
,~ ~ ~
~'I +~
S-I O U ,t7.t7+~ ~ U1 UI N -~iU) ~-I~ p f.~
+~ N N O -~I~~i0 0 0 U~ O~ O c~
N N +~ ~ +~ +~ +~ +~ i 0 c0 +~ E ~
b~ O H t~ rI r1 U s rl r-I.-aO cn +
U U
-~IN N O t0 10 t0 ~ i-1N b v? N ~
'
c4 z z U U ~ E ~7 (!aW U7 ~ H
p
rl >~ +~ ~
N
0
ca ~
-~ S.i
.1-
O b
c .
0 ~
+
H C ~ ~
W -ri N
U r1 +~
~
p N + + + + + ,
+ I I I I +
+ + + + + + S-I ~
In
~ f"1
N r-I -r1
G~ W W
U W c~00G00
N ~ .>~ O
U (..I
UI -rl
+~ 0
+~ U -~OI
O
_
O N
U
W G b
O ~
~ O ~ f
N t + + t I I I + I + -I
c0 +
W ~~ t t t + + +
N
N
U O
W U N O
C O ~
O
~b ob:a
~
a N
N ~ ~ O
N N N N O tn E
~ b G~
cn <n N m O O oa~~
a~ o o m o -~, o ~+~
u~ m m o ~o a~ :a r.1 ~ -~I W
~n b s~
U O N +~ c0 +~ u1 +~ N t0 N
+~ ~~I+~ t~ x a o o m x m ..
m a~ :a a~ a~ a~ a~ +~ +~ o a~ o
:a <n +~ +~ n, x .o ~ ~-Ia~ s~ :a -~-ta~
+' O O O O O O c0 c0 N t0 E. ,~
U7 +~ +~ +~ +~ +~ +~ E E O C1 I -rlO
.O r-I~-trl ~ ~-I~ O O C O ti -n Z
fl) ~ ~ ~ ~ ~ ~ H H I1,H i;j,Y,
-6 4-
m o tn o m o m
r i ,..i N N C'~ M

CA 02434284 2003-07-09
As evident from Table 1l, it was revealed that the a-
isomaltosylglucosaccharide-forming enzyme well acted on
saccharides having a glucose polymerization degree of at least
three and having a maltose structure at their non-reducing ends,
among the saccharides tested. It was also found that the enzyme
slightly acted on saccharides, having a glucose polymerization
degree of two, such as maltose, kojibiose, nigerose,
neotrehalose, maltotriitol, and erlose.
Experiment 11
Reaction product from maltoolig~osaccharide
Experiment 11-1
Preparation of reaction product
To an aqueous solution containing one percent (w/v)
of maltose, maltotriose, maltotetraose, or maltopentaose as a
substrate was added a purified specimen of a-isomaltosyl
glucosaccharide-forming enzyme obtained by the method in
Experiment 7-2 in an amount of two units/g solid for maltose and
maltotriose, 0.2 unit/g solid for maltotetraose for
maltotetraose, and 0.1 unit/g solid for maltopentaose, followed
by the incubation at 35~C and pH 6.0 for eight hours. After a
10-min incubation at 100~C, the enzymatic reaction was
suspended. The resulting reaction solutions were respectively
measured for saccharide composition on HPLC using "YMC PACK ODS-
AQ303", a column commercialized by YMC Co., Ltd., Tokyo, Japan,
at a column temperature of 40~C and a flow rate of 0.5 ml/min
of water, and using as a detector "RI-8012", a differential
refractometer commercialized by Tosoh Corporation, Tokyo, Japan.
The results are in Table 12.
- 65 -

CA 02434284 2003-07-09
.. I
UI
O N i3
ro
N I -r1
N ~ OOrI
-~ I
ro
ro +~ +~
.o
O O O~ N d~ t~ O O O d~ a0 L~ O ~
O O O ~w ~ M d~ O O O ~ N .~ O ~ ro
~ .
N U UI
ro p
U
N
~
I x
.r1
O ti
r1 W
r-1 ~I
I
I
~
U ~ U
O ~ 4l
U
~
~ i
ro c
0
-
~" p
ro
-r1 W
t
ll
~rorom
~ O C~ C~ ~ ~c7 O O O oo O d~ O N ro
O O O N In M O O O v0 O ml O O ~
i~ N ('0 M O
-1 x O
r U Ul
U ~
+'
O ~ Cf1'O
Op
Ul r-1
'~
~
N
U7 O ~r
O
N ~ ~ ~ ~ ~
G
~ ro
~
cn ~~
m ro ro
ro ~~ o0
.-I N r1o~ c~ oo O O O N tn r1 O O .-I.,~ O
~ ~
ro O O I~ In r1 O O O ~ ~ N O O O I
E, .-Id W ''~ ~ ~ ~
N
tll
ro ro
E
~
~
N E O
~
~ m ~
E O
~
N t
ro 0
E ~ ro
O ~ O a0 O O O In N d~ O O O vO ~ O -~I
N
r1 o000 O O O O O CO N O O O O N ~ ~
O yp~
~ E
ro
~
~ O ~
O (n
''~ U
p
p ro O~~'~
O
O N ' I
O ~ 4I
~ fO
I
m ~ ~ ~
O
G E ~
O ~ b b ~ ''ib p
O
N U N +~ ro N t E
'O I Ul 0 H c~
W O E x a~.o
.,~ -~I+~ o x o ~I ,~
+~
s~ a~a~ s~ a~ a~ a~ +~ ~
U
ro <nro +~ +~ a~ x .~ u~ ro m o
ro 0 0 0 0 0 o m o o s +~
~ a~
. U -N +~ +~ +~ +~ E U U ~ O
U N N
U ~ ~-I.-Ir-1.-I '-1O
cn ~ ~ ~ E E ~ H ~ ~ ~c ~ n~ o
ro
~ 6-
m o In o u ~ o w
ri '- i N N c'~ C~

CA 02434284 2003-07-09
As evident from the results in Table 12, it was
revealed that, after the action of the a-isomaltosylgluco-
saccharide-forming enzyme, glucose and a-isomaltosylglucose
alias 6z-O-a-glucosylmaltose or panose were mainly formed from
maltose as a substrate; and from maltotriose as a substrate,
maltose and a-isomaltosylglucose alias 63-O-a-
glucosylmaltotriose were mainly formed along with small amounts
of glucose, maltotetraose, a-isomaltosylglucose alias 6~-O-a-
glucosylmaltose or panose, and the product X. Also, it was
revealed that maltotriose and the product X were mainly formed
from maltotetraose as a substrate along with small amounts of
maltose, maltopentaose, a-isomaltosylglucose alias 63-O-a-
glucosylmaltotriose, and the product Y; and that maltotetraose
and the product Y were mainly formed from maltopentaose as a
substrate along with small amounts of maltotriose, maltohexaose,
and the products X and Z.
The product X as a main product from maltotetraose as
a substrate and the product Y as a main product from
maltopentaose as a substrate were respectively isolated and
purified as follows: The products X and Y were respectively
purified on HPLC using "YMC PACK ODS-A 8355-15S-15 12A", a
separatory HPLC column commercialized by YMC Co., Ltd., Tokyo,
Japan, to isolate a specimen of the product X having a purity
of at least 99.9% from the reaction product of maltotetraose in
a yield of about 8.3%, d.s.b., and a specimen of the product Y
having a purity of at least 99.9% from the reaction product of
maltopentaose in a yield of about 11.5%, d.s.b.
Experiment 11-2
Structural analysis on reaction product
- 67 -

CA 02434284 2003-07-09
Using the products X and Y obtained by the method in
Experiment 11-l, they were subjected to methyl analysis and NMR
analysis in a usual manner. The results on their methyl
analyses are in Table 13. For the results on their NMR
analyses, FIG. 21 is a 1H-NMR spectrum for the product X and
FIG. 22 is for the product Y. The 13C-NMR spectra for the
products X and Y are respectively FIGs. 23 and 24. The
assignment of the products X and Y are tabulated in Table 14.
Table 13
Analyzed Ratio
methyl compound
Product X Product Y
2,3,4-Trimethyl compound 1.00 1.00
2,3,6-Trimethyl compound 3.05 3.98
2,3,4,6-Tetramethyl compound 0.82 0.85
Based on these results, the product X, formed from
maltotetraose via the action of the a-
isomaltosylglucosaccharide-forming enzyme, was revealed as a
pentasaccharide, in which a glucose residue bounds via the a-
linkage to OH-6 of glucose at the non-reducing end of
maltotetraose, i.e., a-isomaltosylmaltotriose alias 64-O-a-
glucosylmaltotetraose, represented by Formula 1.
Formula 1:
a-D-Glcp-(1-~6)-a-D-Glcp-(1~4)-a-D-Glcp-(1-~4)-a-D-Glcp-(1~4)-D-
Glcp
The product Y formed from maltopentaose was revealed
as a hexasaccharide, in which a glucosyl residue bounds via the
a-linkage to OH-6 of glucose at the non-reducing end of
- 68 -

CA 02434284 2003-07-09
maltopentaose, i.e., a-isomaltosylmaltotetraose alias 65-O-a-
glucosylmaltopentaose, represented by Formula 2.
Formula 2:
a-D-Glcp-(1-~6)-a-D-Glcp-(1-~4)-a-D-Glcp-(1-~4)-a-D-Glcp-(1~4)-a-D-
Glcp-(1~4)-D-Glcp
- 69 -

CA 02434284 2003-07-09
Table 14
Glu~ose Cargon l Chemical shift NMR
num er num on (ppm)~
er Product
X Product
Y
la 100. 100.
8 8
2a 74. 2 74. 2
a 3a 75. 8 75. 7
4:a 7 2. 7 2.
2 2
5 a 7 4. 7 4.
5 5
6 a 6 3. 6 3.
2 1
1 b 1 0 2. 1 0 2.
6 6
2b 74. 2 74. 2
b 3b 75. 8 75. 7
4 b 7 2. 7 2.
1 1
5b 74. 0 74. 0
6 b 6 8. 6,8.
6 6
1 c I 0 2. 1 0 2.
3 3
2 c 7 4. 7 4.
2 2
c 3 c 7 6. 7 6 .
0 0
4 c 7 9. 7 9.
6 5
5 c 7 3. 7 3.
9 9
6 c 6 3. 6 3.
2 1
1 d 1 0 2.. 1 0 2.
2 3
2d 74. 0 (a), 4 (,B) 74. 2
74.
3 d 7 6. 7 6.
d 0 0
4 .d 7 9 . 7 '9
8 . 5
5 d 7 3. 7 3,
9 g
6 d 6 3. 6 3.
2 1
1 a 9 4. 6 ( a). 5 (,9) 1 0 2.
9 8'. 1
2e 74. 2 (a), 7 (,3) 74. 0 (a), (~9)
76. 74.
4
a
3 a 7 5 9 ( a 9 ( 7 6 .
. ), 7 ,6 0
8 . )
4a 79. 6 (a), 4 (,3) 79. $
79.
5e 72. 6. (a), 2 (~) 73. 9
77.
6 a 6 3. 4 (a), 4 (,~) 6 3.
6 3. 1
1 f 94. 6 (a), (~)
98.
S
2 f 74. 2 (a), (,9)
76.
7
3 f 76. 0 (a), (d)
f 78.
9
4 f 7 6 (a). (/3)
9. 7 9.
5
5 f 72. 6 (a). (;3)
77.
2
6 f I 6 3 (a), (,~)
~ 3. 6 3.
3
- 70 -

CA 02434284 2003-07-09
Based on these results, it was concluded that the a-
isomaltosylglucosaccharide-forming enzyme acts on maltooligo-
saccharides as shown below:
(1) The enzyme acts on, as a substrate, a
maltooligosaccharide having a glucose
polymerization degree of at least two, where
glucose residues are linked via the a-1,4
linkage; and catalyzes the intermolecular 6-
glucosyl-transferring reaction in such a manner
of transferring a glucosyl residue at the non-
reducing end of a maltooligosaccharide molecule
to C-6 of the glucosyl residue at the non-
reducing end of another maltooligosaccharide
molecule to form both an a-isomaltosylgluco-
saccharide alias 6-O-a-glucosylmalto-
oligosaccharide, having a 6-O-a-glucosyl residue
and a higher glucose polymerization degree by
one as compared with the intact substrate, and
a maltooligosaccharide with a lower glucose
polymerization degree by one as compared with
the intact substrate; and
(2) The enzyme slightly catalyzes the 4-glucosyl-
transferring reaction and forms both a
maltooligosaccharide, having a higher glucose
polymerization degree by one as compared with
the intact substrate, and a maltooligo-
saccharide having a lower glucose polymerization
degree by one as compared with the intact
substrate.
- 71 -

CA 02434284 2003-07-09
Experiment 12
Test on the formation of reducing power
The following test was carried out to examine whether
a-isomaltosylglucosaccharide-formation enzyme had an ability of
forming reducing power. To a 1$ (w/v) aqueous solution of
maltotetraose as a substrate was added 0.25 unit/g substrate,
d.s.b., of either of purified specimens of a-
isomaltosylglucosaccharide-forming enzyme from Bacillus
globisporus C9 strain obtained by the method in Experiment 4-2
and Bacillus globisporus C11 strain obtained by the method in
Experiment 7-2, and incubated at 35~C and pH 6Ø During the
enzymatic reaction, a portion of each reaction solution was
sampled at prescribed time intervals and measured for reducing
powder after keeping the sampled solutions at 100~C for 10 min
to suspend the enzymatic reaction. Before and after the
enzymatic reaction, the reducing saccharide content and the
total sugar content were respectively quantified by the Somogyi-
Nelson's method and the anthrone-sulfuric acid reaction method.
The percentage of forming reducing power was calculated by the
following equation:
Equation:
AR BR
Percentage of forming - - x 100
reducing power (o) AT BT
AR . Reducing sugar content after enzymatic reaction.
AT . Total sugar content after enzymatic reaction.
BR . Reducing sugar content before enzymatic reaction.
BT . Total sugar content before enzymatic reaction.
- 72 -

CA 02434284 2003-07-09
The results are in Table 15.
Table 15
Reaction Percentage of forming
time reducing power (%)
(hour)
Enzyme of Enzyme of
C9 strain C11 strain
0 0.0 0.0
1 0.0 0.1
2 0.1 0.0
4 0.1 0.1
8 0.0 0.0
As evident from the results in Table 15, it was
revealed that a-isomaltosylglucosaccharide-forming enzyme does
not substantially increase the reducing power of the reaction
product when allowed to act on maltotetraose as a substrate; the
enzyme does not exhibit hydrolyzing activity or only has an
undetectable level of such activity.
Experiment 13
Test on the formation of dextran
To study whether a-isomaltosylglucosaccharide-forming
enzyme has the ability of forming dextran, it was tested in
accordance with the method in Bioscience Biotechnology and
Biochemistry, Vol. 56, pp. 169-173 (1992). To a 1~ (w/v)
aqueous solution of maltotetraose as a substrate was added 0.25
unit/g substrate, d.s.b., of either of purified specimens of a
isomaltosylglucosaccharide-forming enzyme from Bacillus
globisporus C9 strain obtained by the method in Experiment 4-2
or Bacillus globisporus C11 strain obtained by the method in
- 73

CA 02434284 2003-07-09
Experiment 7-2 and incubated at 35~C and pH 6.0 for four or
eight hours. After completion of the enzymatic reaction, the
reaction was suspended by heating at 100~C for 15 min. Fifty
microliters of each of the reaction mixtures were placed in a
centrifugation tube and then admixed and sufficiently stirred
with 3-fold volumes of ethanol, followed by standing at 4~C for
30 min. Thereafter, each of the resulting mixtures was
centrifuged at 15,000 rpm for five minutes and, after removing
the supernatant, the resulting sediment was admixed with one
milliliter of 75~ (v/v) ethanol solution and stirred for
washing. The resulting each solution was centrifuged to remove
supernatant, dried in vacuo, and then admixed and sufficiently
stirred with one milliliter of deionized water. The total sugar
content, in terms of glucose, of each resulting solution was
quantified by the phenol-sulfuric acid method. As a control,
the total sugar content was determined similarly as in the above
except for using either of purified specimens of a-
isomaltosylglucosaccharide-forming enzyme from Bacillus
globisporus C9 strain and Bacillus globisporus C11 strain, which
had been inactivated at 100~C for 10 min. The content of
dextran formed was calculated by the following equation:
Equation:
Content of dextran formed (mg/ml) - [(Total sugar content for
test sample) - (Total sugar content for control sample)] x 20
The results are in Table 16.
- 74 -

CA 02434284 2003-07-09
Table 16
Reaction Content of dextran formed (mg/ml)
time
(hour) Enzyme of Enzyme of
C9 strain C11 strain
4 0.0 0.0
8 0.0 0.0
As evident from the results in Table 16, it was
revealed that the a-isomaltosylglucosaccharide-forming enzyme
does not substantially have the action of forming dextran or
only has an undetectable level of such activity because it did
not form dextran when allowed to act on maltotetraose.
Experiment 14
Specificity of transfer acceptor
A variety of saccharides were tested whether they
could be used as transferring-acceptors for the a-
isomaltosylglucosaccharide-forming enzyme. A solution of D-
glucose, D-xylose, L-xylose, D-galactose, D-fructose, D-mannose,
D-arabinose, D-fucose, L-sorbose, L-rhamnose, methyl-a-
glucopyranoside, methyl-(3-glucopyranoside, N-acetyl-glucosamine,
sorbitol, a,a-trehalose, isomaltose, isomaltotriose, cellobiose,
gentibiose, maltitol, lactose, sucrose, a-cyclodextrin, ~3-
cyclodextrin, or y-cyclodextrin was prepared.
To each solution with a saccharide concentration of
1.6% was added "PINE-DEX #100", a partial starch hydrolysate,
as a saccharide donor, to give a concentration of 40, and
admixed with one unit/g saccharide donor, d.s.b., of either of
purified specimens of a-isomaltosylglucosaccharide-forming
- 75 -

CA 02434284 2003-07-09
enzyme from Bacillus globisporus C9 strain obtained by the
method in Experiment 4-2 and Bacillus globisporus C11 strain
obtained by the method in Experiment 7-2, and incubated at 30~C
and pH 6.0 for 24 hours. The reaction mixtures after the
enzymatic reactions were analyzed on gas chromatography
(abbreviated as "GLC" hereinafter) for monosaccharides and
disaccharides as acceptors, and on HPLC for trisaccharides and
higher saccharides as acceptors to confirm whether these
saccharides could be used as their transfer acceptors. In the
case of performing GLC, the following apparatuses and conditions
were used: GLC apparatus, "GC-16A" commercialized by Shimadzu
Corporation, Tokyo, Japan; column, a stainless-steel column, 3
mm in diameter and 2 m in length, packed with 2$ "SILICONE OV-
17/CHROMOSOLV W", commercialized by GL Sciences Inc., Tokyo,
Japan; carrier gas, nitrogen gas at a flow rate of 40 ml/min
under temperature conditions of increasing from 160~C to 320~C
at an increasing temperature rate of 7.5~C/min; and detection,
a hydrogen flame ionization detector. In the case of HPLC
analysis, the apparatuses and conditions used were: HPLC
apparatus, "CCPD" commercialized by Tosoh Corporation, Tokyo,
Japan; column, "ODS-AQ-303" commercialized by YMC Co., Ltd.,
Tokyo, Japan; eluent, water at a flow rate of 0.5 ml/min; and
detection, a differential refractometer. The results are in
Table 17.
- 76 -

CA 02434284 2003-07-09
'O 'O O ~1-~ ~
N N +~ G O G
fa 1r U '~ w
W -~I N f.a O U W S~
O cd N 4l O S-i N f-i
U~ ++++++++ fWl~fWlJ~p,~~W
o stn i + + + + + + + + ~ ~ i U
~r1 ~ri N .1 i-1 S-1 ~ C: f0 (If
~ cUG U N N +'
N
w b~
~ t7~ t~O c~O N
O
O ~N w O U U ~
N O~~ ~ ro ~ N
U~NS~-~ ++++++++ 00,~0~
+ + + + + + + + ~ t
Ot0 N O O U
+~.~ WU b ~ ~ p U N
~ R7 C1~
G
N a1 ~ ~.O~ -~ m U ~
O ~ +~ +~ +~ E b ~-1 ~ O N
b t0 N .4~ UI UI N N N + O p, ,d ~
rl ~~ O O O O rl b 'd '~ + +~ p U ,-~
N O N +~ +~ ~~i ~~i O O O O O O p
Id +~ N ri r-1 la ,!7 +~ fn U) r~I r-I r~1 '
.O ~~ Ea cG c0 O ~~1 -~I O O U U U b O O
U .f7 i E E r1 +~ +~ +~ S~~ ~, ~, ~'' ~ .4 N p) W
U N ti O O ~ O .-a U U U U U
b O N UI N N b rt1 ~ i i i O
U7 U1 t3 H H U Ch E a (O ti e2
N
- O 3 N ~
'b'U ~ tn E
E 4.a ~~ +~ ~ ,~ ~ G rt1
O ~ ~ w O ~ b
a~ c a~ +~ + + + +
bo ~~n + + + + + ~ +~ + + ~ + + + _
coo G~ ' m~'~~w
o ~ W ~ .~ ~ o ~ ° '~
~Na~
~ .~ ~ 40-i +~ U
G +~
W ~ v~1 ~ ~ N
O f.~a O ~ O o N ~ 'O
U
+~ N c0 .C .'~ ~ ~ ~ U!
U w N is + + + + +' U t0
~ + + + + + i +I + + i + + + ~ ~ b a 3
~ ~ o~ ,~ +~ +~ i~ p +' O
LL~ WU ~~ ~ ~ ~'d N
O U
,~ ~ '° m ro ~ ~
ro_ b ro ~ '~ ~' m +°~
°
tin u~1 H3 S~~NO
N N N N N G ~ G .. U U ~ U W
'C5 N O UI ~ O ~ U1 Wd WO ~ ~r1 ~ ~ C1,'~~~ u1 +~
~~1 fO O N +~ O i!1 G N UI O ti S-i c2 i-i .-i E U 'd 'O U C U
N O N t11 U +~ O W U1 O G i ~ ~ ~ ~, O +~ O O U +~ t0 td
rtf U O O c0 U O ~1 O .L7 E ri f1 rI t1 +~ U1 O i-a N U ~ f-i U
.O O ~ r1 .-~ ~ O b U f~~ t0 ~, O ~ O U O z ~ 04 cC .s7 +~ H
U rI >, ~ N f~~ rt1 N ~ O ~~ .C U ~C U U U
U C7 >C ?C C7 Li. ~ FC f=. U7 t~ ~ ~ +~ ~ ~
c0 ii~iiii~iiNr-INr-lir-I
u~ Ca C~ a A Ca Ca A Ca a a ~ O ~ ~ z b~
m O ~n O ~n O ~n O ~n
ri N W1 M M d~ d~

CA 02434284 2003-07-09
As evident from the results in Table 17, it was
revealed that the a-isomaltosylglucosaccharide utilizes
different types of saccharides as transfer acceptors,
particularly, the enzyme most preferably transfers a saccharide
to D-/L-xylose, methyl-a-glucopyranoside, methyl-(3-
glucopyranoside, a,a-trehalose, isomaltose, isomaltotriose,
cellobiose, gentibiose, maltitol, lactose, and sucrose; next to
D-glucose, D-fructose, D-fucose, L-sorbose, and N-
acetylglucosamine; and then to D-arabinose.
The properties of the a-isomaltosylglucosaccharide-
forming enzyme described above were compared with those of a
previously reported enzyme having 6-glucosyl-transferring
action; a dextrin dextranase disclosed in "Bioscience
Biotechnology and Biochemistry", Vol. 56, pp. 169-173 (1992);
and a transglucosidase disclosed in "Nippon Nogeikagaku Kaishi",
Vol. 37, pp. 668-672 (1963). The results are in Table 18.
- 78 _

CA 02434284 2003-07-09
O I
fn
b
b
ni ri
~
O !~
O
U t0
f-I
~ U N N
+~ N
r-I -~I D m >
C ~
b1 W
O ~I
U1 -.-I +~ c~ +~
U +~
td td
~N O
S-I ..I U O
O
E U7 z z
f.7,
N
U
b
G
cd
~I N N N
~
W-i y ~ N
xo
m +~ +~ ~ +~
c~
b ro -~I I m
+~
~n o t~
0 a~ o a~
o
-~I z a. ~ z
U
+~
x
a~
A
I r1
a~ ~ a~ a~ a~
b
b -~I +~ -~I
E f-I UI ~ ~ O
c0 (~ c0 -~I
O b~ ~ N
U ~-I N N O
U U z z 0..
N
O
O
U
b~
N
s~
fn r~ N N O
N
O c0 ~ ~ tn
~
~1 -rl r1 r1
r1 ~ ~ W D
10 U! (0 r0 I r1
O
E tr~ b) O m
C
O O~ O O O
r1
~n U z z ~o w
~
H
N
I
O
~
W
1~
N
N
cn x
a w x G
o
o a. o
b
m
~ ~ ~ ~ gi
~ E
1 ~ rl
-I -
N O -~I E .t7
'i -~ A
O b ~
~ ~
-. +~
1
S
-I
w x ~w O H.~
m
-79-
m o In o m o
.1 N N

CA 02434284 2003-07-09
As evident from Table 18, the a-isomaltosylgluco-
saccharide-forming enzyme had outstandingly novel
physicochemical properties completely different from those of
known dextrin dextranase and transglucosidase.
Experiment 15
Formation of cyclotetrasaccharide
Using different saccharides, the formation of
cyclotetrasaccharide by a-isomaltosylglucosaccharide-forming
enzyme and a-isomaltosyl-transferring enzyme was tested: It was
prepared a solution of maltose, maltotriose, maltotetraose,
maltopentaose, amylose, soluble starch, "PINE-DEX #100" (a
partial starch hydrolyzate commercialized by Matsutani Chemical
Ind., Tokyo, Japan), or glycogen from oyster commercialized by
Wako Pure Chemical Industries Ltd., Tokyo, Japan. To each of
these solutions with a respective concentration of 0.5% were
added one unit/g solid of a purified specimen of a-
isomaltosylglucosaccharide-forming enzyme from Bacillus
globisporus C11 strain obtained by the method in Experiment 7-2,
and 10 units/g solid of a purified specimen of a-isomaltosyl-
transferring enzyme from Bacillus globisporus C11 strain
obtained by the method in Experiment 7-3, and the resulting
mixtures were subjected to an enzymatic reaction at 30~C and pH
6Ø The enzymatic conditions were the following four systems:
(1) After 24-hour incubation of the a-
isomaltosylglucosaccharide-forming enzyme
with any of the saccharide solutions, the
enzyme was inactivated by heating, and then
the a-isomaltosyl-transferring enzyme was
- 80 -

CA 02434284 2003-07-09
allowed to act on any of the resulting
mixtures for 24 hours and inactivated by
heating;
(2) After 24-hour simultaneous incubation of
the a-isomaltosylglucosaccharide-forming
enzyme and the a-isomaltosyl-transferring
enzyme with any of the saccharide
solutions, then the enzymes were
inactivated by heating;
(3) After 24-hour incubation of the a-
isomaltosylglucosaccharide-forming enzyme
alone with any of the saccharide solutions,
then the enzyme was inactivated by heating;
and
(4) After 24-hour incubation of the a-
isomaltosyl-transferring enzyme alone with
any of the saccharide solutions, then the
enzyme was inactivated by heating.
To determine the formation level of cyclotetra
saccharide in each reaction mixture after the heating, the
reaction mixtures were subjected to a similar treatment with a
glucosidase and glucoamylase as in Experiment 1 to hydrolyze the
remaining reducing oligosaccharides, followed by the
quantitation of cyclotetrasaccharide on HPLC. The results are
in Table 19.
- 81 -

CA 02434284 2003-07-09
N U1 N
~
3 ~ ~ C
N N ~y
O
r-I
.p
N ~
p t0
G ~ p
b
O G O
s~
w .~ w
s~
~ U
b N b
O O O O O O O O ~
-~ p
p O O O O O O O O ~
.~ c0 ~
~
U f~ U
c~
U +~ U
~ ~ f-i
b i c~
p +~
~ O
p
oW ~ ~ ~ U
l
O
~ ~U O
c~
U
O O O O O O O O O UI O
~'O O
U O O O O O O O O ~ .~I ~
'd 3 U
U o m
ti
~
E 3
taro ~
3 3
N
~
~ U E ~
.C
3
~
ri ~ N d~ ~f)00 v0 N C~ O~ ~ N
O N
~ U ~ ~ ~ ~ N
b
t w d~ N r-IL~ '-1a0 M v0 ~
0 r1 N M M M ~O o0 N ~ ~ ~
E 3
O E UI ~
N 01
xo
~
a~
.~ o
e~
~G
m
~- w
N
G
~., ~ w
O N M tn In '-io0 N .,~ .,~
U
d~ O O M m ~O p N ~
~ ~ .
U W
~ i-~ ~
~ U U1
_ ~ ~ t~f
G
N p ~O
N
a o 0 0
~+~
- ~ ~~
rn~
o+~~~~
.~.,
w 3 ~ ~
O
~
~ m
ro o
~ ro~ o
~ .
rUn~ b ~,~,~ H 3 rt1
~ ca -~
tS
a~ O s~ +~ tn m ..
m
-r1~ (," N .~..
td U ~ N N U N .-1 U U
~.,
cn +~ +~ a u~ ~ b tr +~
+~ o 0 0 0 0 .~ ~ 0 0
.~
o
u~ +~ +~ +~ +~ ~ ~ +~ o z
s~
a ~ E E ~ ~
c E c p
n n .
-82-
m o m o m o
r l .-I N N M

CA 02434284 2003-07-09
As evident from the results in Table 19, no
cyclotetrasaccharide was formed from any of the saccharides
tested by the action of either of the a-
isomaltosylglucosaccharide-forming enzyme or the a-isomaltosyl-
transferring enzyme, but cyclotetrasaccharide was formed by the
coaction of these enzymes. It was revealed that the formation
level was relatively low as about 11$ or lower when the a-
isomaltosyl-transferring enzyme was allowed to act on the
saccharides after the action of a-isomaltosylglucosaccharide-
forming enzyme, while the level increased when the enzymes were
simultaneously allowed to act on any of the saccharides tested,
particularly, it increased to about 87$ and about 64o when
allowed to act on glycogen and partial starch hydrolyzate,
respectively.
Based on the reaction properties of the a-
isomaltosylglucosaccharide-forming enzyme and the a-isomaltosyl-
transferring enzyme, the formation mechanism of
cyclotetrasaccharide by the coaction of the above enzymes is
estimated as follows:
(1) The a-isomaltosylglucosaccharide-forming
enzyme acts on a glucose residue at the
non-reducing end of an a-1,4 glucan chain
of glycogen, partial starch hydrolyzates,
etc., and intermolecularly transfers the
glucose residue to OH-6 of a glucose
residue at the non-reducing end of another
intact a-1,4 glucan chain of glycogen,
partial starch hydrolyzates, etc., to form
an a-1,4 glucan chain having an a-
- 83 -

CA 02434284 2003-07-09
isomaltosyl residue at the non-reducing
end;
(2) The a-isomaltosyl-transferring enzyme acts
on the a-1,4 glucan chain having an a-
isomaltosyl residue at the non-reducing end
and intermolecularly transfers the
isomaltosyl residue to C-3 of glucose
residue at the non-reducing end of another
intact a-1,4 glucan chain having an
isomaltosyl residue at the non-reducing end
to form -an a-1,4 glucan chain having an
isomaltosyl-1,3-isomaltosyl residue at the
non-reducing end;
(3) Then, the a-isomaltosyl-transferring enzyme
acts on the a-1,4 glucan chain having an
isomaltosyl-1,3-isomaltosyl residue at the
non-reducing end and releases the
isomaltosyl-1,3-isomaltosyl residue from
the a-1,4 glucan chain via the
intramolecular transferring reaction to
cyclize the released isomaltosyl-1,3-
isomaltosyl residue into cyclotetra-
saccharide;
(4) From the remaining released a-1,4 glucan
chain, cyclotetrasaccharide is formed
through the sequential steps (1) to (3),
resulting in an estimation that the
coaction of a-isomaltosylglucosaccharide-
forming enzyme and a-isomaltosyl-
- 84 -

CA 02434284 2003-07-09
transferring enzyme in such a cyclic manner
as indicated above increases the yield of
cyclotetrasaccharide.
Experiment 16
Influence of licruefaction degree of starch
A 15~ corn starch suspension was prepared, admixed
with 0.1$ calcium carbonate, adjusted to pH 6.0, and then mixed
with 0.2 to 2.0 ~ per gram starch of "TERMAMYL 60L", an a-
amylase commercialized by Novo Indutri A/S, Copenhagen, Denmark,
followed by an enzymatic reaction at 95 C for 10 min.
Thereafter, the reaction mixture was autoclaved at 120~C for 20
min, promptly cooled to about 35~C to obtain a liquefied starch
with a DE (dextrose equivalent) of 3.2 to 20.5. To the
liquefied starch were added two units/g solid of a purified
specimen of a-isomaltosylglucosaccharide-forming enzyme from
Bacillus globisporus C11 strain obtained by the method in
Experiment 7-2, and 20 units/g solid of a purified specimen of
a-isomaltosyl-transferring enzyme from Bacillus globisporus C11
strain obtained by the method in Experiment 7-3, followed by the
incubation at 35~C for 24 hours. After completion of the
reaction, the reaction mixture was heated at 100~C for 15 min
to inactivate the remaining enzymes. Then, the reaction mixture
thus obtained was treated with a-glucosidase and glucoamylase
similarly as in Experiment 1 to hydrolyze the remaining reducing
oligosaccharides, followed by quantifying the formed
cyclotetrasaccharide on HPLC. The results are in Table 20.
- 85 -

CA 02434284 2003-07-09
Table 20
Amount of a-amylase DE Yield of
per starch (%) cyclotetrasaccharide (%)
0.2 3.2 54.5
0.4 4.8 50.5
0.6 7.8 44.1
1.0 12.5 39.8
1.5 17.3 34.4
2.0 20.5 30.8
As evident from the results in Table 20, it was
revealed that the formation of cyclotetrasaccharide by the
coaction of a-isomaltosylglucosaccharide-forming enzyme and a-
isomaltosyl-transferring enzyme is influenced by the
liquefaction degree of starch, i.e., the lower the liquefaction
degree or the lower the DE, the higher the yield of
cyclotetrasaccharide from starch becomes. On the contrary, the
higher the liquefaction degree or the higher the DE, the lower
the yield of cyclotetrasaccharide from starch becomes. It was
revealed that a suitable liquefaction degree is a DE of about
20 or lower, preferably, a DE of about 12 or lower, more
preferably, a DE of about 5 or lower.
Experiment 17
Influence of concentration of partial starch hydrolyzate
Aqueous solutions of "PINE-DEX #100" , a partial starch
hydrolyzate with a DE of about 2 to about 5, having a final
concentration of 0.5 to 40%, were prepared and respectively
admixed with one unit/g solid of a purified specimen of a
isomaltosylglucosaccharide-forming enzyme from Bacillus
- 86

CA 02434284 2003-07-09
globisporus C11 strain obtained by the method in Experiment 7-2,
and 10 units/g solid of a purified specimen of a-isomaltosyl-
transferring enzyme from Bacillus globisporus C11 strain
obtained by the method in Experiment 7-3, followed by the
coaction of these enzymes at 30 C and pH 6.0 for 48 hours.
After completion of the reaction, each reaction mixture was
heated at 100~C for 15 min to inactivate the remaining enzymes,
and then treated with a-glucosidase and glucoamylase similarly
as in Experiment 1 to hydrolyze the remaining reducing
oligosaccharides, followed by quantifying the formed
cyclotetrasaccharide on HPLC. The results are in Table 18.
Table 18
Concentration of Yield of
PINE-DEX (%) cyclotetrasaccharide
0.5 63.6
2.5 62.0
5 60.4
10 57.3
15 54.6
20 51.3
45.9
30
39.5
As evident from the results in Table 21, the yield of
35 cyclotetrasaccharide was about 64o at a low concentration of
0 . 5$, while it was about 40% at a high concentration of 40 % .
The fact showed that the yield of cyclotetrasaccharide increases
depending on the concentration of partial starch hydrolyzate as
a substrate. The result revealed that the yield of
- 87 _

CA 02434284 2003-07-09
cyclotetrasaccharide increases as the concentration of partial
starch hydrolyzate decreases.
Experiment 18
Influence of the addition of cyclodextrin glucanotransferase
Fifteen percent of aqueous solutions of "PINE-DEX
#100", a partial starch hydrolyzate, were prepared and admixed
with one unit/g solid of a purified specimen of a-
isomaltosylglucosaccharide-forming enzyme from Bacillus
globisporus C11 strain obtained by the method in Experiment 7-2,
10 units/g solid of a purified specimen of a-isomaltosyl-
transferring enzyme from Bacillus globisporus C11 strain
obtained by the method in Experiment 7-3, , and 0-0. 5 unit/g solid
of a cyclodextrin glucanotransferase (CGTase) from a
microorganism of the species Bacillus stearothermophilus,
followed by the coaction of these enzymes at 30~ C and pH 6 . 0 for
48 hours. After completion of the reaction, the reaction
mixture was heated at 100~C for 15 min to inactivate the
remaining enzymes, and then treated with a-glucosidase and
glucoamylase similarly as in Experiment 1 to hydrolyze the
remaining reducing oligosaccharides, followed by quantifying the
formed cyclotetrasaccharide on HPLC. The results are in Table
22.
Table 22
Amount of CGTase added Yield of
(unit) cyclotetrasaccharide
0 54.6
2.5 60.1
63.1
10 65.2
- 88 _

CA 02434284 2003-07-09
As evident from the Table 22, it was revealed that the
addition of CGTase increases the yield of cyclotetrasaccharide.
Experiment 19
Preparation of cyclotetrasaccharide
About 100 L of a 4$ (w/v) aqueous solution of a corn
phytoglycogen commercialized by Q.P. Corporation, Tokyo, Japan,
was prepared, adjusted to pH 6.0 and 30~ C, and then admixed with
one unit/g solid of a purified specimen of a-
isomaltosylglucosaccharide-forming enzyme from Bacillus
globisporus C11 strain obtained by the method in Experiment 7-2,
10 units/g solid of a purified specimen of a-isomaltosyl-
transferring enzyme from Bacillus globisporus C11 strain
obtained by the method in Experiment 7-3, followed by the
incubation for 48 hours. After completion of the reaction, the
reaction mixture was heated at 100~C for 10 min to inactivate
the remaining enzymes, and a portion of the reaction mixture was
sampled and then quantified on HPLC to calculate the yield of
cyclotetrasaccharide, revealing that it contained 84$
cyclotetrasaccharide with respect to saccharides, d.s.b. The
reaction mixture was adjusted to pH 5.0 and 45~C, and then
treated with a-glucosidase and glucoamylase similarly as in
Experiment 1 to hydrolyze the remaining reducing
oligosaccharides, etc. The resulting mixture was adjusted to
pH 5.8 by the addition of sodium hydroxide and then incubated
0
at 90 C for one hour to inactivate the remaining enzymes and
filtered to remove insoluble substances. The filtrate was
_ 89 -

CA 02434284 2003-07-09
concentrated using a reverse osmosis membrane to give a
concentration of about 16$, d.s.b., and the concentrate was in
a usual manner decolored, desalted, filtered, and concentrated
to obtain about 6.2 kg of a saccharide solution with a solid
content of about 3,700 g.
The saccharide solution was fed to a column packed
with about 225 L of "AMBERLITE CR-1310 (Na-form)", an ion-
exchange resin commercialized by Japan Organo Co., Ltd., Tokyo,
Japan, and chromatographed at a column temperature of 60~C and
a flow rate of about 45 L/h. While the saccharide composition
of the eluate from the column was being monitored by HPLC as
described in Experiment 1, fractions of cyclotetrasaccharide
with a purity of at least 98% were collected, and in a usual
manner desalted, decolored, filtered, and concentrated to obtain
about 7.5 kg of a saccharide solution with a solid content of
about 2,500 g solids. HPLC measurement for saccharide
composition of the saccharide solution revealed that it
contained cyclotetrasaccharide with a purity of about 99.5$.
Experiment 20
Crystallization of cyclotetrasaccharide in acrueous solution
A fraction of cyclotetrasaccharide with a purity of
at least 98%, obtained by the method in Experiment 19, was
concentrated by evaporation to give a concentration of about
50$, d.s.b. About five kilograms of the concentrate was placed
in a cylindrical plastic vessel and then crystallized to obtain
a white crystalline powder by lowering the temperature of the
0
concentrate from 65~C to 20 C over about 20 hours under gentle
rotatory conditions. FIG. 25 is a microscopic photograph of
such cyclotetrasaccharide. The above crystallized concentrate
- 90 -

CA 02434284 2003-07-09
was separated by a centrifugal filter to obtain 1, 360 g of a
crystalline product by wet weight, which was then further dried
at 60~C for three hours to obtain 1,170 g of a crystalline
powder of cyclotetrasaccharide. HPLC measurement of the
crystalline powder revealed that it contained cyclotetra-
saccharide with a quite high purity of 99.9 or over.
When analyzed on powder x-ray diffraction analysis,
the cyclotetrasaccharide in a crystalline powder form had a
diffraction spectrum having characteristic main diffraction
angles (2A) of 10.1, 15.2, 20.3, and 25.5 in FIG. 26. The
Karl Fischer method of the crystalline powder revealed that it
had a moisture content of 13.0%, resulting in a finding that it
was a crystal of cyclotetrasaccharide having five or six moles
of water per one mole of cyclotetrasaccharide.
The thermogravimetric analysis of the cyclotetra-
saccharide in a crystalline form gave a thermogravimetric curve
in FIG. 27. Based on the relationship between the weight change
and the temperature, it was successively found that the weight
reduction corresponding to four or five moles of water was
observed up to a temperature of 150~C, the weight reduction
corresponding to one mole of water at around 250~C, and the
weight reduction corresponding to the decomposition of
cyclotetrasaccharide at a temperature of about 280~C or higher.
These results confirmed that the crystalline cyclotetra-
saccharide, penta- or hexa-hydrate, of the present invention
releases four or five moles of water to change into its
crystalline monohydrate form when heated up to 150~C at normal
pressure, and further releases one mole of water to change into
its anhydrous crystal form until reaching 250~C.
- 91 -

CA 02434284 2003-07-09
Experiment 21
Conversion into crystalline cyclotetrasaccharide monohydrate
Crystalline cyclotetrasaccharide, penta- or hexa
hydrate, in a powder form, obtained by the method in Experiment
20, was placed in a glass vessel, and kept in an oil bath, which
0
had been preheated to 140 C, for 30 min. Being quite different
from the result from the powder x-ray diffraction analysis of
intact cyclotetrasaccharide, penta- or hexa-hydrate, free from
heat treatment, the powder x-ray analysis of the
cyclotetrasaccharide powder thus obtained gave a characteristic
diffraction spectrum having main diffraction angles (2A) of
0
8.3~, 16.6, 17.0 , and 18.2 in FIG. 28. The Karl Fischer
method of the crystalline powder revealed that it had a moisture
content of about 2.7$, revealing that it was a crystal of
cyclotetrasaccharide having one mole of water per one mole of
cyclotetrasaccharide. The thermogravimetric analysis of the
cyclotetrasaccharide in a crystalline powder form gave a
thermogravimetric curve in FIG. 29. Based on the relationship
between the weight change and the temperature, it was found that
the weight reduction corresponding to one mole of water was
observed at a temperature of about 270~C and further observed
the weight reduction corresponding to the decomposition of
cyclotetrasaccharide per se at a temperature of about 290~C or
higher. These results confirmed that the cyclotetrasaccharide
crystal in this experiment was crystalline cyclotetrasaccharide,
monohydrate.
Experiment 22
Conversion into anhydrous crystal
Crystalline cyclotetrasaccharide, penta- or hexa-
- 92 -

CA 02434284 2003-07-09
hydrate, in a powder form, obtained by the method in Experiment
20, was dried in vacuo at 40~C or 120~C for 16 hours. The Karl
Fischer method of the resulting crystalline powders revealed
that the one dried at 40~ C had a moisture content of about 4. 2%,
0
while the other dried at 120 C had a moisture content of about
0.2~, meaning that it was substantially anhydrous. Being quite
different from the results from the powder x-ray diffraction
analyses of the crystalline cyclotetrasaccharide, penta- or
hexa-hydrate, and the crystalline cyclotetrasaccharide,
monohydrate, before drying in vacuo, the powder x-ray analysis
of the above cyclotetrasaccharide, dried in vacuo at 40~C and
120~C, gave characteristic diffraction spectra having main
diffraction angles ( 28 ) of 10. 8~ , 14. 7~ , 15 .0~ , 15. 7~ , and 21. 5~
in FIG. 30 for 40~ C and FIG. 31 for 120 C. Although there found
difference in peak levels between the two diffraction spectra,
they had substantially the same peak diffraction angles and they
were crystallographically judged to be substantially the same
crystalline monohydrate. The fact that the base lines of the
diffraction spectra exhibited a mountain-like pattern and the
crystallinity of the crystalline monohydrate was lower than
those of crystalline cyclotetrasaccharide, penta- or hexa-
hydrate, and crystalline cyclotetrasaccharide, monohydrate,
before drying in vacuo. This revealed the existence of an
amorphous cyclotetrasaccharide. Based on this, the
cyclotetrasaccharide powder with a moisture content of about
4.2~, obtained by drying in vacuo at 40~C, was estimated to be
a mixture powder of an amorphous cyclotetrasaccharide with such
a moisture content and anhydrous crystalline cyclotetra-
- 93 -

CA 02434284 2003-07-09
saccharide. These data revealed that crystalline
cyclotetrasaccharide, penta- or hexa-hydrate, was converted into
those in an anhydrous amorphous- and an anhydrous crystalline-
forms when dried in vacuo. The thermogravimetric analysis of
anhydrous crystalline cyclotetrasaccharide with a moisture
content of 0.2$, which was conducted similarly as in Experiment
20, observed only the weight reduction as shown in FIG. 32,
deemed to be induced by the heat decomposition at a temperature
of about 270~C or higher.
Experiment 23
Saturation concentration of cvclotetrasaccharide in water
To study the saturation concentration of
cyclotetrasaccharide in water at 10-90~C, 10 ml of water was
placed in a glass vessel with a seal cap, and then mixed with
cyclotetrasaccharide, penta- or hexa-hydrate, obtained by the
method in Experiment 20, in an excessive amount over a level of
complete dissolution at respective temperatures, cap-sealed, and
stirred for two days while keeping at respective temperatures
of 10-90~C until reaching saturation. The resulting each
saturated solution of cyclotetrasaccharide was membrane filtered
to remove undissolved cyclotetrasaccharide, and each filtrate
was then examined for moisture content by the drying loss method
to determine a saturation concentration of cyclotetrasaccharide
at respective temperatures. The results are in Table 23.
Table 23
Temperature (~C) Saturation concentration (~)
10 30.3
30 34.2
- 94 -

CA 02434284 2003-07-09
(Continued)
0
Temperature ( C) Saturation concentration (~)
50 42.6
70 53.0
90 70.5
Experiment 24
Thermostabilitv
A crystalline cyclotetrasaccharide, penta- or hexa-
hydrate, obtained by the method in Experiment 20, was dissolved
in water into a 10~ ( w/v ) aqueous cyclotetrasaccharide solution,
and eight milliliter aliquots of which were placed in glass test
tubes, followed by sealing and then heating the test tubes at
120~C for 30 to 90 min. After the heating, the aqueous
solutions were cooled under atmospheric conditions and measured
for coloration degree and determined for purity on HPLC. The
coloration degree of each solution was evaluated based on the
absorbance in a cell with a 1-cm light pass at a wavelength of
480 nm. The results are in Table 24.
Table 24
Heating time Coloration degree Purity
( min ) ( A480 nm )
0 0.00 100
30 0.00 100
60 0.00 100
90 0.00 100
As evident from the results in Table 24, it was
- 95 -

CA 02434284 2003-07-09
revealed that cyclotetrasaccharide is a thermostable saccharide
because an aqueous cyclotetrasaccharide solution was not
colored, and the purity of the saccharide composition in the
solution was not lowered even when heated at a high temperature
0
of 120 C.
Experiment 25
pH Stability
A crystalline cyclotetrasaccharide, penta- or hexa
hydrate, obtained by the method in Experiment 20, was dissolved
in 20 mM buffers with different pHs into 4~ (w/v)
cyclotetrasaccharide solutions with pHs of 2 to 10. Eight
milliliters of each solution was placed in a glass test tube,
followed by sealing and then heating the test tube at 100~C for
24 hours. After the heating, each solution was cooled and
measured for coloration degree and determined for purity on
HPLC. The coloration degree was evaluated based on the
absorbance in a cell with a 1-cm light pass at a wavelength of
480 nm. The results are in Table 25.
Table 25
pH Coloration degree Purity
( type of buf fer ) ( A48o nm )
2.0 (Acetate buffer) 0.00 93
3.0 (Acetate buffer) 0.00 100
4.0 (Acetate buffer) 0.00 100
5.0 (Acetate buffer) 0.00 100
6.0 (Tris-HC1 buffer) 0.00 100
7.0 (Tris-HC1 buffer) 0.00 100
8.0 (iris-HC1 buffer) 0.00 100
- 96 -

CA 02434284 2003-07-09
(Continued)
9.0 (Ammonium buffer) 0.00 100
10.0 (Ammonium buffer) 0.00 100
As evident from the results in Table 25, a
cyclotetrasaccharide aqueous solution was not colored even when
0
heated at 100 C for 24 hours in a wide pH range from 2 to 10,
and the purity of the saccharide composition in each solution
was not lowered at all in a pH range from 3 to 10, even though
the purity was slightly lowered at pH 2. These facts revealed
that cyclotetrasaccharide is highly stable in a relatively wide
pH range, i.e., an acid pH range from 3 to 5, a neutral pH range
from 6 to 8, and an alkaline pH range from 9 to 10.
Experiment 26
Amino carbon~~l reaction
A crystalline cyclotetrasaccharide, penta- or hexa
hydrate, obtained by the method in Experiment 20, was dissolved
in water, and then admixed with a commercialized special grade
glycine and phosphate buffer, and the resulting mixture was then
adjusted to pH 7.0 with 50 mM phosphate buffer to obtain a 10~
(w/v) cyclotetrasaccharide solution containing 1~ (w/v) glycine.
Four milliliter aliquots of the resulting solution were placed
in glass test tubes, sealed, and heated at 120 C for 30 to 90
min. After allowing to stand for cooling at ambient
temperature, each of the resulting solutions was measured for
coloration degree to examine their amino carbonyl reactivity.
The coloration degree was evaluated based on the absorbance in
a cell with 1-cm light pass at a wavelength of 480 nm. The
results are in Table 26.
_ 97 _

CA 02434284 2003-07-09
Table 26
Heating time ( min ) Coloration degree ( A48on~ )
0 0.00
30 0.00
60 0.00
90 0.00
As evident from the results in Table 26,
cyclotetrasaccharide was not colored even when heated in the
presence of glycine, meaning that the saccharide does not induce
browning with glycine, i.e., cyclotetrasaccharide is a stable
saccharide which does not induce the amino carbonyl reaction,
also known as the Maillard reaction.
Experiment 27
Amino carbonyl reaction
A crystalline cyclotetrasaccharide, penta- or hexa-
hydrate, obtained by the method in Experiment 20, and a
polypeptone commercialized by Nihonseiyaku K.K., Tokyo, Japan,
were dissolved in deionized water to obtain a 10~ (w/v)
cyclotetrasaccharide solution containing 5~ (w/v) polypeptone.
Four milliliter aliquots of the resulting solution were placed
in glass test tubes, sealed, and heated at 100~C for 30 to 90
min. After allowing to stand for cooling at ambient
temperature, each of the resulting solution was measured for
coloration degree to examine their amino carbonyl reactivity.
In parallel, as a control, a solution with only polypeptone was
_ 98 _

CA 02434284 2003-07-09
provided and treated similarly as above. The coloration degree
was evaluated based on the level of the absorbance, which had
been measured in a cell with 1-cm light pass at a wavelength of
480 nm, minused that of the control. The results are in Table
27.
Table 27
Heating time ( min ) Coloration degree ( A48onm )
0 0.00
30 0.00
60 0.00
90 0.00
As evident from the results in Table 27, it was
revealed that cyclotetrasaccharide did not induce browning with
polypeptone when heated in the presence of polypeptone, i.e.,
the saccharide is a stable saccharide which substantially does
not induce the amino carbonyl reaction.
Experiment 28
Inclusion action
A crystalline cyclotetrasaccharide, penta- or hexa-
hydrate, obtained by the method in Experiment 20, was dissolved
in deionized water into a 20 0 ( w/v ) aqueous cyclotetrasaccharide
solution. To 100 g aliquots of the aqueous solution was added
2 g of methanol, 3 g of ethanol, or 4.6 g acetic acid to be
included by the cyclotetrasaccharide. Thereafter, each of the
resulting solutions was filtered to remove non-inclusion
products, and the filtrates were dried in vacuo. As a control,
similar inclusion products were prepared by using "ISOELITETM
P", a branched cyclodextrin commercialized by Maruha K.K.,
_ 99 _

CA 02434284 2003-07-09
Tokyo, Japan, which were known to have inclusion ability.
To measure the amount of the inclusion products in the
resulting lyophilized powders, one gram of each of the powders
was dissolved in five milliliters of water and extracted after
admixing with five milliliters of diethylether. The extraction
was repeated, and the resulting extracts were quantified on gas
chromatography. The results are in Table 28.
Table 28
Inclusion Inclusion amount (mg/g lyophilized powder)
product
Cyclotetrasaccharide ISOELITE P (control)
Methanol 6.71 2.92
Ethanol 17.26 8.92
Acetic acid 67.74 30.57
As evident from the results in Table 28, it was
revealed that cyclotetrasaccharide has an inclusion ability of
about 2-folds higher than that of the branched cyclodextrin by
weight.
Experiment 29
Sweetening power
A crystalline cyclotetrasaccharide, penta- or hexa-
hydrate, obtained by the method in Experiment 20, was dissolved
in deionized water into a 10~ ( w/v ) aqueous cyclotetrasaccharide
solution for a standard solution. Varying the concentration of
sucrose, e.g., a commercialized granulated sugar, a sensory test
was done with five panelists. As a result, the sweetening power
of cyclotetrasaccharide was about 20~ of that of sucrose.
Experiment 30
Digestion test
- 100 -

CA 02434284 2003-07-09
Using a crystalline cyclotetrasaccharide, penta- or
hexa-hydrate, obtained by the method in Experiment 20, the
digestibility of cyclotetrasaccharide in vitro by salivary
amylase, synthetic gastric juice, amylopsin, or intestinal
mucosal enzyme was tested in accordance with the method as
reported by K. Okada et al. in JOURNAL OF JAPANESE SOCIETY OF
NUTRITION AND FOOD SCIENCE, Vol. 43, No. 1, pp. 23-29 (1990).
As a control, maltitol known as a substantially non-digestive
saccharide was used. The results are in Table 29.
Table 29
Decomposition percentage (~)
by digestive enzyme
Digestive enzyme
Cyclotetrasaccharide Maltitol
(Control)
Salivary amylase 0.0 0.0
Synthetic 0.0 0.0
gastric juice
Amylopsin 0.0 0.0
Small intestinal 0.74 4.0
mucosal enzyme
As evident from the results in Table 29,
cyclotetrasaccharide was not completely digested by salivary
amylase, synthetic gastric juice, and amylopsin, but slightly
digested by intestinal mucosal enzyme in a digestibility level
as low as 0.740 that corresponded to 1/5 of that of maltitol as
a control. These results confirmed that cyclotetrasaccharide
is a quite undigestible saccharide.
Experiment 31
Fermentation test
- 101 -

CA 02434284 2003-07-09
Using a crystalline cyclotetrasaccharide, penta- or
hexa-hydrate, obtained by the method in Experiment 20, the
fermentability of cyclotetrasaccharide using an internal content
of rat cecum was tested in accordance with the method by T. Oku
in "Journal of Nutritional Science and Vitaminology", Vol. 37,
pp. 529-544 (1991). The internal content of rat cecum was
collected by anesthetizing a Wister male rat with ether,
anatomizing the rat, collecting the internal content under
anaerobic conditions, and suspending the resultant with 4-fold
volumes of a 0.1 M aqueous solution of sodium bicarbonate. The
cyclotetrasaccharide was added to the internal content of rat
cecum in an amount of about 7~ by weight, and the levels of
cyclotetrasaccharide remained just after and 12 hours after the
addition of the internal content were quantified on gas
chromatography. As a result, the levels of cyclotetra
saccharide of the former and the latter were respectively 68.0
mg and 63.0 mg per one gram of the internal content of rat
cecum, meaning that 93~ of cyclotetrasaccharide remained intact.
These data confirmed that cyclotetrasaccharide is a
substantially non-fermentable saccharide.
Experiment 32
Assimilation test
Using a crystalline cyclotetrasaccharide, penta- or
hexa-hydrate, obtained by the method in Experiment 20, the
assimilability of cyclotetrasaccharide by an internal content
of rat cecum was studied in accordance with the method disclosed
in "Intestinal Flora and Dietary Factors", edited by Tomotari
MITSUOKA, published by Japan Scientific Societies Press, Tokyo,
Japan, (1984). About 10' CFU (colony forming units) of pre
- 102

CA 02434284 2003-07-09
cultured fresh microorganisms were inoculated into five
milliliters of PYF medium with 0.5o cyclotetrasaccharide, and
cultured at 37~C for four days under anaerobic conditions. As
a control, glucose was used as an easily assimilable saccharide.
The assimilability was judged as negative (-) when the post
culture had a pH of 6.0 or higher, and judged as positive (+)
when the post culture had a pH of below 6Ø The judgement of
assimilability was confirmed by measuring the content of
saccharide, which remained in the culture, on the anthrone
method to determine the reduction level of saccharide. The
results are in Table 30.
- 103 -

CA 02434284 2003-07-09
N
O
G
O + + + + + +
U
N
N
O
U
Ch
.A
.a
I
I
N
z7
O S~
M c~
O U
.-i U
c0 u1 i i i i i i
E cG
N
O
O
U
U
N
N
U u1 u1 r-I
v1 ~ ~ '.i
N GI N
~ U
c0 O ~ O
ro '~ ro ro
b ro s~ w
+~ 0~ w '~i O U
N N
N ~ O
+~ 'J 'r'~~ U 4'1 u1
E
N L m ~
~ .-i ~O N
4-1 ro U '-I .C, n-I -r1
(0 a0
O 'r1 it ro U ~ Sr U
tn ~O m ~ o~ N
O ~ '-l 'r1 N Q1
N C~ .-I O tn M
f-1 O f1 ~ ('~ d..7r4
a0 N CO N e-~
-~ a~~n ro~ +~M a~M U o~
o
~
~ U ~
U
U W O O U U
E ~ ~ ~ ~
~ rtf '~1 ~i v? Ea ~
-~I U U U f=. U
cO E W W U W H W N
h h h ~ h
-104-
m o m o m o
r1 .1 N N

CA 02434284 2003-07-09
As evident from the results in Table 30, it was
confirmed that cyclotetrasaccharide was not assimilated by any
of the strains tested, but glucose as a control was assimilated
by all the strains tested. The data confirmed that
cyclotetrasaccharide is a saccharide which is not substantially
assimilated by intestinal microorganisms.
Experiment 33
Acute toxicity test
The acute toxicity of a crystalline cyclotetra-
saccharide, penta- or hexa-hydrate, obtained by the method in
Experiment 20, was tested by orally administering to mice. As
a result, it was revealed that cyclotetrasaccharide had
relatively low toxicity and did not cause the death of mice even
when administered at the highest possible dose. Based on this,
the LDSo of cyclotetrasaccharide was at least 50 g/kg mouse body
weight, though the value was so accurate.
Based on the results in Experiments 30 to 33,
cyclotetrasaccharide is not substantially assimilated or
absorbed by living bodies when orally taken, and it can be
expected to be used as a non- or low-caloric edible material in
diet sweeteners; fillers for sweeteners with a relatively high
sweetening power; viscosity agents, fillers, and bodies for diet
food products; and further it can be used as an edible fiber and
a food material for substituting fats.
Experiment 34
Comparative experiment on the dehydration dectree of moisture and
pulverization of dehydrated product by non-reducing' saccharide
The non-reducing saccharides used in this experiment
were anhydrous crystalline cyclotetrasaccharide; crystalline
- 105 -

CA 02434284 2003-07-09
cyclotetrasaccharide, monohydrate; anhydrous amorphous
cyclotetrasaccharide; crystalline cyclotetrasaccharide, penta-
or hexa-hydrate; anhydrous crystalline a,a-trehaose, anhydrous
amorphous a,a-trehaose; and crystalline a,a-trehaose, dihydrate.
The crystalline cyclotetrasaccharide, penta- or hexa-hydrate,
was prepared by the method in Experiment 20. The anhydrous
crystalline cyclotetrasaccharide; crystalline
cyclotetrasaccharide, monohydrate; and anhydrous amorphous
cyclotetrasaccharide were respectively prepared by the methods
in Examples A-1, A-2, and A-3. As the crystalline a,a-
trehalose, dihydrate, a commercially available "TREHA~"
commercialized by Hayashibara Shoji Inc., Okayama, Japan, was
used. The anhydrous crystalline a,a-trehalose and the anhydrous
amorphous a,a-trehalose used in this experiment were prepared
from a commercialized crystalline a,a-trehalose, dihydrate,
using the methods disclosed in Examples for Reference 1 and 3
in Japanese Patent Kokai No. 170,221/94.
To four parts by weight of a plain yogurt with a
moisture content of about 77~ was added either of the above
saccharides in an amount of 11 to 16 parts by weight. The
resultant mixtures were respectively placed in vats, allowed to
0
stand at 25 C for 24 hours, and macroscopically observed their
change on standing. The judgement was conducted in such a
manner of sufficiently dehydrating the resulting mixtures to be
solidified, subjected to a pulverizer for pulverization, and
evaluated as "O", when the solids were easily pulverized; "0 ",
when the dehydration of the resulting mixtures was rather
insufficient and the pulverization of solids was substantially
- 106 -

CA 02434284 2003-07-09
difficult, though the resulting mixtures were solidified; and
"x", when the dehydration of the resulting mixtures was
insufficient and could not be pulverized by a pulverizer. The
results are in Table 31.
- 107 -

CA 02434284 2003-07-09
W
O
d1 r1
-
~
3 O O O x O O x
G 4l
U ~
p N
. ~
N U
O
O
U ~ b
O O O ~C a a PC ~
O O ~ ~
00
W ,A U c0
N
b
W U
U
b ~ O a O x x x x ~ U~~
~
b ~ U ~ N
U O ~ ~
U1 .
U U t0 C1,C
N
U
~ ~
w O x O x x x x
~
.c
m
- ,
~n
~ O
M C U ~
.
E
ro~
G ~ ~
b 3 ~ ~ m ~
~ ~
a x a x x x x
E ~ 3 ~
~'
c
0
i-' U
O
-
b ~ N U
~
fly +~
U
O
O t
0 b
~ ro
+~ x x x x x x x ~b~
~
rn~
~
~ a .~ o
~
~
~
ro
~
~
u~ ai
o
aro~
~
rt1 -~
U
i ~
t E c
n 0 U w
W
S-i U N .
G
UON N L~ M O M ao L~ aUGU
+.~ _ m ..~
+~ ~n
s~
(0 C, O N O M O O O~ UJ r1
O O
3 O .-i
W
U N O S-~
m n1
N
.O ~7 +~
+~ .C
+~
-- E N U1
N N
~r +~
Pr S~
Sr
N O f-~
+~ ro
r-1 U
i ~r
ro Ul U
ti .C
W
N E U to
ti ro
c0
a W U Ca W Lt. C9
U N
U +~
(0 O
cn z
-108-
m o ~n o m o
r1 ~- 1 N N M

CA 02434284 2003-07-09
As evident from the results in Table 31, it was
revealed that anhydrous crystalline cyclotetrasaccharide;
crystalline cyclotetrasaccharide, monohydrate; and anhydrous
amorphous cyclotetrasaccharide solidified the plain yogurt in
a lesser amount than those required in anhydrous crystalline
a,a-trehalose and anhydrous amorphous a,a-trehalose; and
facilitated the pulverization of the solidified yogurts. The
resulting powders had satisfactory properties. Based on these,
anhydrous crystalline cyclotetrasaccharide; crystalline
cyclotetrasaccharide, monohydrate; and anhydrous amorphous
cyclotetrasaccharide, which are the cyclotetrasaccharides with
dehydrating ability, are suitably used as dehydrating agents,
particularly, anhydrous crystalline cyclotetrasaccharide and
anhydrous amorphous cyclotetrasaccharide have a superior
dehydrating ability.
Experiment 35
Dehydrating- action by cyclotetrasaccharide with dehydrating
ability
Anhydrous crystalline cyclotetrasaccharide;
crystalline cyclotetrasaccharide, monohydrate; anhydrous
amorphous cyclotetrasaccharide; and crystalline
cyclotetrasaccharide, penta- or hexa-hydrate were experimented
in detail on their dehydrating actions, particularly, moisture
absorption abilities against saccharides and changes on
standing. As a control, anhydrous crystalline a,a-trehalose,
anhydrous amorphous a,a-trehalose, and crystalline a,a-
trehalose, dihydrate, were used as saccharides. The experiments
were as follows: Cyclotetrasaccharide and a,a-trehalose
preparations, prepared by the method in Experiment 34, were
- 109 -

CA 02434284 2003-07-09
respectively sieved into a powder with a granular size of about
100-150 Vim. One gram of each of the resulting powders was
placed in a plastic petri dish, 5 cm in diameter, placed in a
desiccator controlled at a relative humidity of 60$ or 750, and
0
allowed to stand at 25 C for a week while sampling the
saccharides at a prescribed time interval for quantifying the
moisture content ( ~ ) by the Karl Fisher method. The results are
in Table 32.
- 110 -

CA 02434284 2003-07-09
N
G
O
.~
d~ ~ r-i N CO L~ 00
M .-1 L~ .-~I
1 1 1 r-I .4
. . .
O N M ~ Ov Ov
~ ~
r-1 ri
-I .-I .-
-I
O N N
~
b
I
.-I
N
~
rl f-II
U
~ C U
+~
+ M ao o~ -I ~ ~ ~ .
d~ ~-I t~ ,-I N
U O U
I I I .,
~
O
E O N (h t~7 O~ O~ O~ S.I t0
M d~ d~ (~7 M N .,
i
r1 r1 ,-I ri
.-1 r1 ,-I
+~
N c'0 c0 o0 ,--I lo t~ C~ ~ ~ W
d~ O vo r ~
I I I -rl U
4-1 O N (~7 (~7 O~ O~ O~ N ~
N d~ d~ (~ (~
(d .-I ~--I .-I .-1 ~ U ~
r1 ,--I r-i Cry
~ U
O
O
c t
G 0
b
A
b a.~
N L~ t~ r1 C~ 00 t~ 1-I 41
O~ O N '-i I
I I 1 ~ O (l3
.-i o c~i cri cYi ~ o. o. u~ a x
c~i ~ d~ ri ~
o
~ +.~ ca
~., a~
~
o .c
m
U~f..l
p~c
r7 Uro ~+'
~
I
.-I N t~ ('~ O ('~ CO L~ G .>~
N l~ f0 O ~ ~ fn
'~ I I I
c O O N O M O O O~ r1 c0
0 O N O (~ O ~ +~
E ~-I fl, U1
.1
~
t0 .
U
G
~
~~
+~
.
U
c
O
bOG
m N~ ~
c0
~'O U
b O
N
~bUIE
.
~
'
dOtll
=
~ I
,C O N
~
E
b ,rl
b
N
y +~ .C
O
E O O O O O O O tn N O
O m m m u~ m m In O .s7
~ o o o ~ o o o t~ o r1
W w w t\ w tw tw ~ ~
.~ W 0 -~1
+ U
cd N Sa ~r
(O
O 8 td U
47 fs.~
5~ x O
-.~ U U ~
+~
+~ ~ U S~
N E
cOG _ IOwm
~ m .-i
O O
N ~-1 t0
.C ~ r1
(x O ~I c0
3 N N
.G +~
+~ .~
+~
ENNNb
~r+~ ?,
i-1 H
U1 O f.1
+~'C1
N ~ U I
~,
'd N U Li
.>~
-r~ 1i ~r
~ -rl
N E U Ia
t3'C1
.C ~ a1 U A W Gr C9
U N
U +~
c0 O
cn z
-111-
In o m o m o m o
.- I .-I N N M C'~

CA 02434284 2003-07-09
As evident from the results in Table 32, both
crystalline cyclotetrasaccharide, monohydrate; and crystalline
cyclotetrasaccharide, penta- or hexa-hydrate, did not
substantially absorb moisture even after 1-week standing at a
relatively humidity of 60~, while anhydrous crystalline
cyclotetrasaccharide and anhydrous amorphous cyclotetra-
saccharide reached almost their saturated moisture absorption
levels on day 1. The moisture absorption level of anhydrous
crystalline cyclotetrasaccharide is about l00 of its weight,
while that of anhydrous amorphous cyclotetrasaccharide is about
140 of its weight. Powder X-ray diffraction analysis of each
saccharide after 1-week standing revealed that they showed the
same predominant diffraction angles as those of them before
standing tests and did not change in their crystalline forms.
It was revealed that the saccharides absorbed moisture at a
relative humidity of 60$ or lower, but they did not contain
water as a crystal water.
When allowed to stand at a relative humidity of 75~,
anhydrous crystalline cyclotetrasaccharide, crystalline
cyclotetrasaccharide, monohydrate, and anhydrous amorphous
cyclotetrasaccharide reached almost their saturated moisture
absorption levels after 1-day standing, similarly as in
anhydrous crystalline a,a-trehalose and anhydrous amorphous a,a-
trehalose. In this case, the moisture absorption levels of
these cyclotetrasaccharides were about 14~ of each of their
weights, while that of a,a-trehalose was not higher than 10% of
its weight, revealing that the former is superior to the latter.
All the saccharides tested kept their powder forms and did not
become sticky or flowing. Powder X-ray diffraction analysis of
- 112 -

CA 02434284 2003-07-09
anhydrous crystalline cyclotetrasaccharide, crystalline
cyclotetrasaccharide, monohydrate; and anhydrous amorphous
cyclotetrasaccharide, penta- or hepta-hydrate, after 1-week
standing revealed that these saccharides showed a different
predominant diffraction pattern from those of them before
standing tests, which corresponded to the diffraction pattern
of crystalline cyclotetrasaccharide, penta- or hexa-hydrate.
Based on the results, it was revealed that anhydrous
cyclotetrasaccharides are converted into crystalline
cyclotetrasaccharide, penta- or hexa-hydrate, after
incorporating water as a crystal water at a relative humidity
of at least 75$.
Thus, it was concluded that the cyclotetrasaccharide
with an effective dehydrating ability according to the present
invention can be advantageously used as a strong dehydrating
agent for food products, pharmaceuticals, cosmetics, and their
materials and processing intermediates.
Ex,~eriment 36
Comparison of the effect of anhydrous crystalline
cyclotetrasaccharide and crystalline cyclotetrasaccharide
penta- or hexa-hydrate, on bacterial contamination of
gelatinized starch
Four parts by weight of a rice flour were dissolved
in six parts by weight of water, and the mixture was poured into
a container surrounded with woods whose inner surface was
covered with a wet cloth, and steamed at 105 C for 10 min to
obtain a gelatinized starch. To the resulting gelatinized
starch was added six parts by weight of either crystalline
cyclotetrasaccharide, penta- or hexa-hydrate, prepared by the
- 113 -

CA 02434284 2003-07-09
method in Experiment 20, or anhydrous crystalline
cyclotetrasaccharide prepared by the method in Example A-1. The
mixture was mixed with a mixer and further mixed to homogeneity
with two parts by weight of a starch hydrolyzate, shaped, and
0
roughly dried for two hours, while blowing 40 C hot air to the
contents, to obtain "gyuhi" (a rice paste with sugar).
0
After allowed to stand at ambient temperature of 25 C
under open conditions, there were found colonies of Aspergillus
niger in gyuhi prepared with crystalline cyclotetrasaccharide,
penta- or hexa-hydrate, at 15 days on standing, but found no
bacterial contamination in gyuhi with anhydrous crystalline
cyclotetrasaccharide even at 30 days on standing.
Gyuhi, prepared with anhydrous cyclotetrasaccharide,
at 30 days on standing was cut and macroscopically observed its
cross section, revealing that the surface of the product
slightly solidified and had crystallized cyclotetrasaccharide
but the internal texture kept its semi-transparency, adequate
gloss and viscosity similarly as in the product just after
processed. Upon X-ray diffraction pattern of the crystal on the
surface of the product revealed that anhydrous crystalline
cyclotetrasaccharide was converted into crystalline
cyclotetrasaccharide, penta- or hexa-hydrate.
Based on the results, it was concluded that the
cyclotetrasaccharide with dehydrating ability acts as a
dehydrating agent for, prevents bacterial contamination of, and
inhibits the retrogradation of gelatinized starch. These
characteristics can be advantageously used in products with
gelatinized starch such as a gyuhi or flour paste.
- 114 -

CA 02434284 2003-07-09
The following Examples A explain the cyclotetra-
saccharide with dehydrating ability used in the present
invention, and Examples B explain the uses of the saccharide in
detail:
Example A-1
Process for producing~anhydrous crystalline cyclotetrasaccharide
A microorganism of the species Bacillus globisporus
C11 strain, FERM BP-7144, was cultured by a fermentor for 48
hours in accordance with the method in Experiment 6. After
completion of the culture, the resulting culture was filtered
with an SF membrane to remove cells and to collect about 18 L
of a culture supernatant. Then the culture supernatant was
concentrated with a OF membrane to collect about one liter of
a concentrated enzyme solution containing 9.0 units/ml of a-
isomaltosylglucosaccharide-forming enzyme and 30.2 units/ml of
a-isomaltosyl-transferring enzyme. A tapioca starch was
prepared into an about 25$ starch suspension which was then
admixed with 0.2$ per gram starch, d.s.b., of "NEO-SPITASE", an
a-amylase commercialized by Nagase Biochemicals, Ltd., Kyoto,
Japan, and enzymatically reacted at 85~C to 90~C for about 20
min. Thereafter, the reaction mixture was autoclaved at 120~C
for 20 min and then promptly cooled to about 35~C to obtain a
liquefied solution with a DE of about four. To the liquefied
solution was added 0.25 ml per gram starch, d. s.b. , of the above
concentrated enzyme solution, containing a-
isomaltosylglucosaccharide-forming enzyme and a-isomaltosyl-
transferring enzyme, and further added 10 units/g starch,
d.s.b., of a CGTase commercialized by Hayashibara Biochemical
Laboratories, Inc., Okayama, Japan, followed by the enzymatic
- 115 -

CA 02434284 2003-07-09
0
reaction at pH 6.0 and 35 C for 48 hours. The reaction mixture
was heated to and kept at 95~C for 30 min and then adjusted to
0
pH 5.0 and 50 C and admixed with 300 units/g starch, d.s.b., of
"TRANSGLUCOSIDASE L AMANOTM" , an a-glucosidase commercialized by
Amano Pharmaceutical Co., Ltd., Aichi, Japan, followed by an
enzymatic reaction for 24 hours. Further, the reaction mixture
was mixed with 30 units/g starch, d.s.b., "GLUCOZYME", a
glucoamylase commercialized by Nagase Biochemicals, Ltd., Kyoto,
Japan, and then enzymatically reacted for 17 hours. The
reaction mixture thus obtained was heated to and kept at 95~C
for 30 min, and then cooled and filtered to obtain a filtrate.
The resulting filtrate was in a conventional manner decolored
with an activated charcoal, desalted and purified with ion
exchangers in H- and OH-forms, and then concentrated to obtain
a 60% cyclotetrasaccharide syrup in a yield of about 90% to the
material starch, d.s.b. According to Experiment 19, the syrup
containing cyclotetrasaccharide was subjected to a column packed
with 225 L of "AMBERLITE CR-1310 (Na-form)", a strong-acid
canon-exchange resin commercialized by Japan Organo Co., Ltd.,
Tokyo, Japan, and chromatographed at a flow rate of about 45
L/min while keeping the inner column temperature at 60~ C. While
the saccharide composition of the eluate was monitoring on HPLC
described in Experiment 1, fractions rich in cyclotetra-
saccharide were collected, pooled, and purified to obtain a high
cyclotetrasaccharide content solution in a yield of about 21%
to the material starch, d.s.b. The solution contained about 98%
cyclotetrasaccharide, d.s.b. After concentrated into an about
90% solution, the resulting concentrate was placed in a
crystallizer, admixed with two percent of anhydrous crystalline
- 116 -

CA 02434284 2003-07-09
cyclotetrasaccharide as a seed, and dried in vacuo while keeping
0
at 120 C for 16 hours to obtain anhydrous crystalline
cyclotetrasaccharide with a moisture content of about 0.2%.
Since the product has a strong dehydrating ability, it can be
advantageously used in dehydrating methods for food products,
chemical products, pharmaceuticals, and their materials and
processing intermediates.
Example A-2
Process for producing crystalline cyclotetrasaccharide,
monohydrate
A potato starch was prepared into an about 20~ starch
suspension, admixed with calcium carbonate to give a final
concentration of 0.1~, adjusted to pH 6.5, further admixed with
0.3a per gram starch, d.s.b., of "TERMAMYL 60L", an a-amylase
commercialized by Novo Industri A/S, Copenhagen, Denmark, and
then enzymatically reacted at 95~C for about 15 min.
0
Thereafter, the mixture was autoclaved at 120 C for 20 min and
0
then promptly cooled to about 35 C to obtain a liquefied
solution with a DE of about four. To the liquefied solution
were added 0.25 ml per gram starch, d.s.b., of a concentrated
enzyme solution containing a-isomaltosylglucosaccharide-forming
enzyme and a-isomaltosyl-transferring enzyme, and 10 units/g
starch, d.s.b., of a CGTase commercialized by Hayashibara
Biochemical Laboratories Inc., Okayama, Japan, followed by the
enzymatic reaction at pH 6.0 and 35~C for 48 hours. The
reaction mixture was heated to and kept at 95~C for 30 min and
then adjusted to pH 5.0 and 50~C, followed by the enzymatic
reaction for 24 hours after the addition of 300 units/g solid
of "TRANSGLUCOSIDASE L AMANOT"'" , an a-glucosidase commercialized
- 117 -

CA 02434284 2003-07-09
by Amano Pharmaceutical Co., Ltd., Aichi, Japan, and then the
enzymatic reaction for 17 hours after the addition of 30 units/g
solid of "GLUCOZYME", a glucoamylase commercialized by Nagase
Biochemicals, Ltd., Kyoto, Japan. The resulting reaction
0
mixture was heated to and kept at 95 C for 30 min, and then
cooled and filtered. The filtrate thus obtained was in a
conventional manner decolored with an activated charcoal,
desalted, and purified with ion exchangers in H- and OH-forms,
and then concentrated to obtain a 60~ cyclotetrasaccharide syrup
in a yield of about 90~ to the material starch, d.s.b.
According to the method in Example A-1, the syrup was
chromatographed, followed by collecting fractions with a purity
of cyclotetrasaccharide of at least 98%. Then, according to the
method in Experiment 20, the fractions were pooled and
concentrated by an evaporator into a concentrate having a solid
concentration of about 50%. Five kilograms of the concentrate
was placed in a cylindrical plastic container and cooled from
65~C to 20~C over about 20 hours under gentle stirring
conditions to effect crystallization, followed by obtaining a
powdery crystalline cyclotetrasaccharide, penta- or hexa-
hydrate. The powder was placed in a glass container which was
then kept in an oil bath, preheated to 140~C, for 30 min. The
dried product was pulverized by a pulverizer to obtain a powdery
crystalline cyclotetrasaccharide, monohydrate, with a moisture
content of about 7$. Since the product has a strong dehydrating
ability, it can be advantageously used in dehydrating methods
for food products, chemical products, pharmaceuticals, and their
materials and processing intermediates.
Example A-3
- 118 -

CA 02434284 2003-07-09
Process for producing anhydrous amorphous cyclotetrasaccharide
Fractions containing cyclotetrasaccharide with a
purity of at least 98~, obtained according to the method in
Example A-1, were in a usual manner desalted, decolored, and
filtered to obtain a concentrate having a solid concentration
of 50~. The concentrate thus obtained was promptly freezed at
0 0
-80 C, lyophilized, and further dried in vacuo at 80 C for three
hours. The resulting dried product was pulverized by a
pulverizes to obtain a powdery anhydrous amorphous
cyclotetrasaccharide with a moisture content of about 0.3%.
FIG. 33 is an X-ray diffraction pattern of the powder. Since
the product has a strong dehydrating ability, it can be
advantageously used in dehydrating methods for food products,
chemical products, pharmaceuticals, and their materials and
processing intermediates.
Example A-4
Process for producing anh~~drous crystalline tetrasaccharide from
panose
About 100 L of an aqueous solution of panose, produced
from starch and commercialized by Hayashibara Biochemical
Laboratories Inc., Okayama, Japan, was adjusted to give a
concentration of 4~ (w/v), pH 6.0, and to 30~C, admixed with two
units/g panose, d.s.b., of a purified a-isomaltosyl-transferring
enzyme obtained by the method in Experiment 7, and enzymatically
reacted for 48 hours. Thereafter, the reaction mixture was
0
heated at 100 C for 10 min to inactivate the remaining enzyme
and sampled for analyzing the percentage of cyclotetrasaccharide
in the saccharide composition on HPLC, and revealed to be about
44$. The reaction mixture after the heat treatment was adjusted
- 119 -

CA 02434284 2003-07-09
a
to pH 5.0 and 45 C and subjected to an enzymatic reaction for
24 hours after the addition of 1,500 units/g solid of
"TRANSGLUCOSIDASE L AMANOTM" , an a-glucosidase commercialized by
Amano Pharmaceutical Co., Ltd., Aichi, Japan, and 75 units/g
solid of "GLUCOZYME", a glucoamylase commercialized by Nagase
Biochemicals, Ltd., Kyoto, Japan, to hydrolyze the remaining
reducing oligosaccharides, etc. Thereafter, the resulting
mixture was adjusted to pH 5.8 with sodium hydroxide, incubated
at 90~C for one hour to inactivate the remaining enzymes, and
filtered to remove insoluble substances. The filtrate was
concentrated to give a solid concentration of about 16% using
a reverse osmotic membrane, and the concentrate was in a usual
manner decolored, desalted, filtered, and concentrated to obtain
about 6.1 kg of a saccharide solution with a solid content of
about 3,650 g. The saccharide solution was chromatographed
according to the method in Example A-1, followed by collecting
fractions with a purity of cyclotetrasaccharide of at least 98%.
The fractions were pooled and in a usual manner decolored,
desalted, filtered, and concentrated to obtain about 3 kg of a
saccharide solution with a solid content of about 1, 000 g. HPLC
analysis for saccharide composition of the saccharide solution
revealed that the solution contained cyclotetrasaccharide with
a purity of about 99.2%. The cyclotetrasaccharide solution thus
obtained was concentrated by an evaporator into a concentrate
having a solid concentration of about 50%. About two kilograms
of the concentrate was placed in a cylindrical plastic
0
container, and cooled from 65 C to 20~C over about 20 hours
under gently rotatory conditions to effect crystallization,
followed by drying the formed crystal to obtain crystalline
- 120 -

CA 02434284 2003-07-09
cyclotetrasaccharide, penta- or hexa-hydrate. The crystal thus
obtained was further dried in vacuo at 120~C for 16 hours into
anhydrous crystalline cyclotetrasaccharide with a moisture
content of about 0.2%. Since the product has a strong
dehydrating ability, it can be advantageously used in
dehydrating methods for food products, chemical products,
pharmaceuticals, and their materials and processing
intermediates.
Example B-1
Dehydrating agent
Fifteen grams aliquots of a powdery anhydrous
crystalline cyclotetrasaccharide, obtained by the method in
Example A-1, were respectively injected into a moisture
permeable small paper bag to obtain a dehydrating agent. The
product is advantageously used as an agent for dehydrating the
inner atmosphere of moisture-proof containers which house
seasoned sea layers, cookies, etc., and also can be arbitrarily
used in combination with a deoxidizer(s) in dried or oily food
products to stably store them.
Example B-2
Sugar with deh~rdrating agent
To 50 parts by weight of sugar was added one part by
weight of a hydrous crystalline cyclotetrasaccharide powder
obtained by the method in Example A-4, followed by mixing with
a high-speed rotary mixer. One kilogram aliquots of the
resulting mixture were respectively placed in a polyethylene
bag, followed by deaerating the gas space in the bag, heat
sealing the opening of the bag to obtain a sugar composition
with a dehydrating agent. In the product, the dehydrating agent
- 121 -

CA 02434284 2003-07-09
absorbs moisture on the surface of microcrystalline sugars, and
this is credited with preventing them from adhering and
solidifying, and with ensuring its stable shelf-life. The
product can be used as a seasoning in preparing cooked/processed
foods.
Example B-3
Salt with dehydrating agent
To 100 parts by weight of salt was added one part by
weight of a hydrous crystalline cyclotetrasaccharide powder
obtained by the method in Example A-1, followed by mixing on a
high-speed rotary mixer. One kilogram aliquots of the resulting
mixture were respectively placed in a polyethylene bag, followed
by deaerating the gas spaces of the bags and heat sealing their
openings to obtain a salt composition with a dehydrating agent.
In the product, the dehydrating agent absorbs moisture on the
surface of microcrystalline salts, and this is credited with
preventing them from adhering and solidifying and with ensuring
its stable shelf-life. The product can be used as a seasoning
in preparing cooked/processed foods.
Example B-4
"Soboro-Guuhi" (a rice paste like soboro "a dried fish meat
flake")
Four parts by weight of a rice flour were dissolved
in six parts by weight of water, poured into a container
surrounded with woods whose inner surface was covered with a wet
0
cloth, steamed at 100 C for 20 min, kneaded with one part by
weight of sugar and six parts by weight of an anhydrous
crystalline cyclotetrasaccharide powder obtained by the method
in Example A-1, and sufficiently mixed with two parts by weight
- 122 -

CA 02434284 2003-07-09
of a hydrolyzed starch syrup. The mixture was shaped, allowed
to stand at room temperature for 16 hours to convert the
saccharide into crystalline cyclotetrasaccharide, penta- or
hexa-hydrate, lightly rolled to make cracks on the surface of
the resultant product to obtain the captioned product. The
product has a satisfactory flavor and taste, is substantially
free of bacterial contamination, and keeps its high quality for
a relatively long period of time.
Example B-5
Confectionery of sweet potato
A sweet potato was sliced into pieces of about 1-cm
in thickness, steamed, cooled, and sprinkled with an anhydrous
crystalline cyclotetrasaccharide powder obtained by the method
in Example A-3 to convert the saccharide into crystalline
cyclotetrasaccharide, penta- or hexa-hydrate. Thus, a
confectionery of sweet potato, which the converted saccharide
adhered unto the surface, was produced, and it had a
satisfactory stability, flavor, and taste.
Example B-6
Powdered cream
One part by weight of a fresh cream and three parts
by weight of an anhydrous crystalline cyclotetrasaccharide
powder, obtained by the method in Example A-1, were mixed and
transferred to a vat, and allowed to stand for two days to form
a block while converting the saccharide into crystalline
cyclotetrasaccharide, penta- or hexa-hydrate. The block was
pulverized by a cutter and classified to obtain a powdered cream
with a satisfactory flavor and taste. Thus, the product can be
used to sweeten coffee and tea and used as a material for
- 123 -

CA 02434284 2003-07-09
processing premixes, frozen desserts, cakes, and candies, as
well as a therapeutic nutrition for intubation feedings.
Example B-7
Powdered brandy
Two parts by weight of a brandy were mixed with 10
parts by weight of pullulan and seven parts by weight of an
anhydrous crystalline cyclotetrasaccharide powder obtained by
the method in Example A-1. The resulting mixture was allowed
to stand for two days to form a block while converting the
saccharide into crystalline cyclotetrasaccharide, penta- or
hexa-hydrate. The block was subjected to a cutter for
pulverization and classified to obtain a powdered brandy with
a satisfactory flavor and taste, i.e., a powdered flavor with
an adequate sweetness and a sufficient flavor of brandy when
tasted in your mouth. The product can be used for imparting
flavor to tea and advantageously used as a material for
confectioneries such as premixes and candies. Also the product
can be shaped by a granulator or a tabletting machine into a
granule or tablet for use.
Example B-8
Powdered miso
Two parts by weight of akamiso were mixed with four
parts by weight of a powdery crystalline cyclotetrasaccharide,
monohydrate, obtained by the method in Example A-1. The mixture
was poured over a metal plate with a plural semispheric dimples,
allowed to stand at ambient temperature overnight to solidify
the contents. The solids were removed from the dimples to
obtain solid misos, about four grams each, which were then
- 124 -

CA 02434284 2003-07-09
subjected to a pulverizer to obtain the captioned product. The
product can be arbitrarily used as a seasoning for instant soups
and also used as a solid seasoning and a miso confectionery.
Example B-9
Powdered soy sauce
While 3.5 parts by weight of an anhydrous crystalline
cyclotetrasaccharide, obtained by the method in Example A-3, and
0.02 part by weight of crystalline cyclotetrasaccharide, penta-
or hexa-hydrate, obtained by the method in Experiment 20, were
freely-moved over a conveyer, one part by weight of "koikuchi-
shoyu" (a pale-colored soy sauce) was sprayed over the mixture.
The resulting mixture was transferred to an aging tower and
allowed to stand at 30~C overnight to obtain a powdered soy
sauce while converting the saccharide into crystalline
cyclotetrasaccharide, penta- or hexa-hydrate. The product can
be arbitrarily used as a seasoning for instant soups.
Example B-10
Powdered eg~g~ yolk
Yolks prepared from fresh eggs were sterilized by a
plate heating sterilizer at 60 to 64~C, and one part by weight
of the resulting liquid of egg yolks was mixed with 3.5 parts
by weight of an anhydrous crystalline cyclotetrasaccharide,
obtained by the method in Example A-1, and similarly as in
Example B-7, the mixture was shaped into a block, followed by
pulverizing the block into a powdered egg yolk. The product can
be used as a material for confectioneries such as premixes,
frozen deserts, and emulsifiers, as well as diets of weaning and
therapeutic nutrients such as oral fluid diets and foods for
- 125 -

CA 02434284 2003-07-09
intubation feedings. Also it can be used as a skin-beautifying
agent or hair restorer.
Example B-11
Powdered vogwrt
One part by weight of a plain yogurt was mixed with
3.6 parts by weight of an anhydrous amorphous cyclotetra-
saccharide, obtained by the method in Example A-3 and, similarly
as in Example B-7, the mixture was shaped into a block, followed
by pulverizing the block into a powdered yogurt. The product
can be used as a material for confectioneries such as premixes,
frozen deserts, and emulsifiers, as well as diets of weaning and
therapeutic nutrients such as oral fluid diets and foods for
intubation feedings. Also it can be arbitrarily incorporated
into margarines, whipping creams, spreads, cheese cakes, and
jellies into yogurt-flavored products. The powdered yogurt in
this example can be shaped by a granulator or a tabletting
machine into a product with lactic acid bacteria for use as an
intestinal controlling agent.
Example B-12
Hot cake mix
To 200 parts by weight of wheat flour were added 60
parts by weight of a powdered egg yolk obtained by the method
in Example B-10, 25 parts by weight of butter, 10 parts by
weight of sugar, 12 parts by weight of a baking powder, and 0.5
part by weight of salt to obtain a hot cake mix. After
dissolving in water or milk, the product can be baked to easily
obtain a hot cake with a satisfactory taste and flavor.
Example B-13
Powdered g~inseng~ extract
- 126 -

CA 02434284 2003-07-09
A half part by weight of a ginseng extract was mixed
with 1.2 parts by weight of an anhydrous crystalline
cyclotetrasaccharide obtained by the method in Example A-1 and,
similarly as in Example B-7, the mixture was shaped into a block
and pulverized into a powdered ginseng extract. The product was
subjected to a granulator together with adequate amounts of
powders of vitamins B1 and BZ to obtain a vitamin-containing
granule of ginseng extract. The product thus obtained can be
advantageously used as an agent for recovering healthy
conditions from fatigue and for tonic, pickup, or hair restorer.
Example B-14
Powdered propolis extract
A material propolis was extracted with a 95~ ( v/v )
aqueous ethanol solution in a usual manner, and the remaining
residue was washed with a small amount of water. The resulting
extract and the water used for washing the residues were pooled
into an 80% (v/v) aqueous ethanol solution as a crude propolis
extract with a solid content of about 20$ (w/w), d.s.b., which
was then diluted with water to lower the ethanol concentration
0
to 50~ (v/v). The resulting solution was kept at 50 C for one
hour to form an upper layer containing the effective ingredients
of propolis and a lower layer containing viscus sediments, and
allowed to stand at ambient temperature overnight, followed by
separating and collecting the upper layer, i.e., a liquid
propolis extract with a satisfactory color tint, flavor, and
antimicrobial action in a yield of about 48 0 , d . s . b . , to the
crude propolis extract. One part by weight of the purified
propolis extract was sprayed and mixed with 10 parts by weight
of an anhydrous crystalline cyclotetrasaccharide obtained by the
- 127 -

CA 02434284 2003-07-09
method in Example A-1, and the resulting mixture was dried into
a powdered propolis extract with a satisfactory flavor and
taste. The product can be used intact as an antiseptic,
antioxidant, anti-inflammatory, immunoregulatory agent, or
macrophage activating agent; and mixed with other appropriate
materials for use in food products, cosmetics, and anti-
susceptive diseases which can be treated and/or prevented with
the propolis extract.
Example B-15
Powdered extract of Japanese indigo plant
Thirty kilograms of terrestrial parts of an indigo
plant, an annual plant of the genus Polygonum, having a
botanical name of Polygonum tinctorium, were crushed, extracted
with a 90% ( v/v ) aqueous ethanol solution in a usual manner .
The remaining residues were washed with a small amount of water.
The resulting extract and the water used for washing the
residues were pooled into an aqueous solution as a crude indigo
extract which was then diluted with water to lower the ethanol
concentration to 50% (v/v). One part by weight of the crude
indigo extract was mixed with 12 parts by weight of crystalline
cyclotetrasaccharide, monohydrate, obtained by the method in
Example A-2. The mixture was transferred to a vat, allowed to
stand for two days to form a block while converting the
saccharide into crystalline cyclotetrasaccharide, penta- or
hexa-hydrate. The resulting block was pulverized by a cutter
and classified to obtain a powdered indigo extract. The product
has diversified physiological actions such as an antiseptic-,
antiviral-, antitumor-, radical entrapping-, apoptosis
controlling-, and cytokine regulatory-actions, and can be
- 128 -

CA 02434284 2003-07-09
arbitrarily used as a crude drug to be incorporated into food
products, cosmetics, and pharmaceuticals.
Example B-16
Powdered coriander
Terrestrial parts of a coriander (Coriandrum sativum
L.), a plant of the family Umbelliferae and the genus
Coriandrum, were washed with water, drained, and cut into small
pieces by a blender. The pieces were passed through a 150-mesh
sieve using a centrifugal filtration separator, followed by
collecting the extract and treated at 121 C for 10 min to obtain
a coriander extract containing 60 mg/ml solids. One part by
weight of the extract was mixed with nine parts by weight of
anhydrous crystalline cyclotetrasaccharide in Example A-4, and
the mixture was transferred to a vat, allowed to stand for two
days to form a block while converting the saccharide into
crystalline cyclotetrasaccharide, penta- or hexa-hydrate. The
resulting block was pulverized by a cutter and classified to
obtain a powdered coriander extract. The product has an
activity of inhibiting the adhesion of metals such as lead and
can be advantageously used intact or in combination with food
products or pharmaceuticals.
Example B-17
Powdered royal jelly
One part by weight of an intact Brazilian royal jelly
with a moisture content of 65~ (w/w) was mixed with seven parts
by weight of anhydrous crystalline cyclotetrasaccharide obtained
by the method in Example A-1. The resulting mixture was
transferred to a vat and allowed to stand for two days for
- 129 -

CA 02434284 2003-07-09
forming a block while converting the saccharide into crystalline
cyclotetrasaccharide, penta- or hexa-hydrate. The block was
pulverized by a cutter into a powdered royal jelly which was
then classified by passing through a 100-mesh sieve and
tabletted by a tabletting machine to obtain tablets, 300 mg
each. The product has a strong tonic action and cell activating
action and stably retains the royal jelly susceptible to
deterioration for a relatively long period of time even at
ambient temperature. Since the product has an improved flavor
and taste, as well as a mild sweetness and an adequate sour
taste, it can be arbitrarily used as a health food for daily
use.
Example B-18
Solid preparation for fluid food
A composition, consisting of 400 parts by weight of
an anhydrous crystalline cyclotetrasaccharide powder obtained
by the method in Example A-1, 270 parts by weight of a powdered
egg yolk obtained by the method in Example B-7, 209 parts by
weight of a skim milk powder, 4.4 parts by weight of sodium
chloride, 1.85 parts by weight of potassium chloride, 0.01 part
by weight of thiamine, 0.1 part by weight of sodium L-ascorbate,
0.6 part by weight of vitamin E acetate, and 0.04 part by weight
of nicotinic acid amid, was prepared. Twenty-five grams
aliquots of the composition were injected into moisture-proof
laminated small bags which were then heat sealed to obtain a
solid preparation for fluid foods.
The product, wherein the moisture content in its inner
atmosphere is lowed, has a relatively long shelf-live without
a need of cold storage. Also it has a satisfactory
- 130 -

CA 02434284 2003-07-09
dispersibility and solubility in water. In use, one bag of the
product is dissolved in about 150-300 ml water into a fluid food
and then orally administered to a subject or intubationally
administered to the nasal cavity, stomach, intestine, etc.
Example B-19
Tablet preparation for medical use
New born hamsters were injected with an antiserum
prepared from rabbits by a conventional method to reduce their
immunoreaction, subcutaneously transplanted with BALL-1 cells,
and bred for three weeks in a usual manner. Tumor masses formed
subcutaneously were extracted, cut into pieces, and suspended
in physiological saline. The resulting cell suspension was
washed with RPMI 1640 medium (pH 7.2) free of serum, suspended
in a fresh preparation of the same medium to give a cell density
of about 2x106 cells/ml, and incubated at 35~C.
After the addition of 200 IU/ml of a partially
purified human interferon-a, the cell suspension was incubated
for about two hours and then admixed with about 300 HA/ml of
sendai virus (HVJ) and incubated for 20 hours to induce human
interferon-a. The resulting culture was centrifuged at 4~C and
about 1,000 x g, followed by removing sediments. The resulting
supernatant was membrane filtered, and the filtrate was in a
conventional manner fed to a column immobilized with an anti-
interferon-a antibody, followed by removing non-adsorbed
fractions. The interferon adsorbed on the antibody was eluted
as adsorbed fractions which were then concentrated with a
membrane into a 4-ml concentrate, containing about 0.001% (w/v)
proteins and a human interferon-a with a specific activity of
about 2x108 IU/mg protein, per hamster.
- 131 -

CA 02434284 2003-07-09
One kilogram of anhydrous crystalline cyclotetra-
saccharide, obtained by the method in Example A-1, was
pulverized, passed through a 150-mesh sieve, and mixed to
homogeneity with a dilute, which had been prepared by diluting
0.25 ml of the above concentrate having about 1x106 IU of
interferon-a with 100 ml distilled water, while spraying the
dilute over the saccharide powder. The resulting mixture was
in a usual manner tabletted by a tabletting machine to obtain
a 300 mg tablet with 150 IU of interferon-a. The process in
this example easily dehydrates solutions of interferon-a only
by spraying an anhydrous crystalline cyclotetrasaccharide
powder, facilitates homogeneous mixing, and also effectively
stabilizes the interferon-a.
Since the product easily dissolves in water, it can
be advantageously used as an agent for anti-susceptive diseases,
which can be treated and/or prevented with interferon-a, such
as an antiviral-, antitumor-, antirheumatic-, and anti-
immunopathic-agents in the form of an internal or oral agent.
Also the product can be advantageously used as a reagent for
examination.
Example B-20
Granular preparation for medical use
A stock culture of BALL-1 cell, a human lymphoblastoid
cell line, was inoculated into Eagle's minimum essential medium
(pH 7.4) supplemented with 20~ (v/v), and in a usual manner
subjected to an in vitro suspension culture at 37~C. The
resulting cells were washed with Eagle's minimum essential
medium (pH 7.4) free of serum and suspended in a fresh
preparation of the same medium to give a cell density of about
- 132 -

CA 02434284 2003-07-09
1x10' cells/ml. HVJ was added to the cell suspension in an
amount of about 1,000 HA/ml and incubated at 38~C for one day
to induce tumor necrosis factor-a (TNF-a). The resulting
culture was centrifuged at 4~C and about 1,000 x g, and the
supernatant was dialyzed for 15 hours against 0.01 M phosphate
buffer (pH 7.2) in physiological saline, and membrane filtered.
The filtrate was in a usual manner fed to a column of anti-
interferon antibody, and the non-adsorbed fractions were
subjected to affinity chromatography using a column packed with
gels of anti-TNF-a monoclonal antibody to purify the formed TNF-
a, followed by concentrating the desired fractions to obtain a
concentrate having a protein concentration of about 0.01% (w/v)
and TNF-a with a specific activity of about 2x106 JRU/mg protein
in a yield of about 5x104 JRU per L of the culture after the
induction and formation of TNF-a.
A half milliliter of the above TNF-a concentrate with
TNF-a activity of about 1x105 JRU was diluted with 100 ml of
distilled water and then mixed to homogeneity with a
cyclotetrasaccharide powder, which had been prepared by
pulverizing one kilogram of anhydrous crystalline cyclotetra-
saccharide obtained by the method in Example A-1, and passing
through a 150-mesh sieve, while spraying the dilute over the
powder. The resulting mixture was then in a usual manner
granulated by a granulator into a TNF-a preparation in the form
of a granule, containing about 100 JRU/g o~ TNF-a. The process
in this example easily dehydrates solutions of TNF-a only by
spraying an anhydrous crystalline cyclotetrasaccharide powder,
facilitates homogeneous mixing, and also effectively stabilizes
the TNF-a.
- 133 -

CA 02434284 2003-07-09
Since the product easily dissolves in water, it can
be advantageously used as an agent for anti-susceptive diseases,
which can be prevented and/or treated with TNF-a, such as an
antiviral-, antitumor-, antirheumatic-, and anti-immunopathic-
agents in the form of an internal or oral agent. Also the
product can be advantageously used as a reagent for examination.
Example B-21
Ointment for traumatherapy
Four hundred parts by weight of anhydrous crystalline
cyclotetrasaccharide obtained by the method in Example A-1 were
admixed with three parts by weigh of iodine dissolved previously
in 50 parts by weight of methanol, and further admixed with 200
parts by weight of a loo aqueous pullulan solution and 50 parts
by weight of crystalline maltose hydrate. The resulting mixture
was allowed to stand at ambient temperature overnight to convert
the cyclotetrasaccharide into crystalline cyclotetrasaccharide,
penta- or hexa-hydrate, to obtain an ointment for traumatherapy
with an adequate adhesiveness and extendibility.
By applying to affected skin parts directly or after
pasted on gauzes, oilpapers or the like, the product cures
external injuries such as skin ulcers induced by cuts,
excoriations, burns, and dermatophytosises (athlete's foot).
POSSIBILITY OF INDUSTRIAL APPLICABILITY
As evident from the above, the present invention
relates to a dehydrating agent comprising a non-reducing
cyclotetrasaccharide as an effective ingredient, particularly,
cyclotetrasaccharide with dehydrating ability can be
- 134 -

CA 02434284 2003-07-09
advantageously used, as the effective ingredient, to reduce the
moisture content in the inner atmosphere of moisture-proof
containers which house dried food products, etc. , and in hydrous
products such as food products, cosmetics, pharmaceuticals,
industrial chemicals, and their materials and processing
intermediates. The method of the present invention, which
comprises a step of allowing a cyclotetrasaccharide with
dehydrating ability to contact with hydrous matters to
substantially reduce their moisture content through the
conversion of the cyclotetrasaccharide into crystalline
cyclotetrasaccharide, penta- or hexa-hydrate. Since the method
does not need severe conditions such as heat drying, it can
easily dehydrate the following hydrous matters and facilitates
to produce high quality dehydrated products: Examples of the
above hydrous matters include food products susceptible to
deteriorating flavor and taste, and pharmaceuticals with
effective ingredients susceptible to decomposing and lowering
their activities. The dehydrated products, which are well
prevented from bacterial contamination and which the
denaturalization or deterioration such as hydrolysis, rancidity,
and browning are inhibited, have a relatively long, stable
shelf-life.
The present invention with such outstanding effects
and functions is a significant invention that greatly
contributes to this art.
- 135 -

CA 02434284 2003-07-09
SEQUENCE LISTING
<110> Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
<120> Dehydrating agent, method for dehydrating hydrous matters
using the same, and dehydrated products prepared by the method
<130> W0880
<150> JP 010,991/01
<151> 2001-1-19
<160> 10
<210> 1
<211> 9
<212> PRT
<213> Bacillus globisporus
<400> 1
Tyr Val Ser Ser Leu Gly Asn Leu Ile
1 5
<210> 2
<211> 10
<212> PRT
<213> Bacillus globisporus
<400> 2
Ile Asp Gly Val Tyr His Ala Pro Asn Gly
1 5 10
<210> 3
<211> 10
<212> PRT
<213> Bacillus globisporus
<400> 3
Ile Asp Gly Val Tyr His Ala Pro Tyr Gly
1 5 10
<210> 4
<211> 8
<212> PRT
<213> Bacillus globisporus
<400> 4
Ile Asp Gly Val Tyr His Ala Pro
1 5
<210> 5
<211> 8
<212> PRT
<213> Bacillus globisporus
- 1 -

CA 02434284 2003-07-09
<400> 5
Asp Ala Ser Ala Asn Val Thr Thr
1 5
<210> 6
<211> 8
<212> PRT
<213> Bacillus globisporus
<400> 6
Trp Ser Leu Gly Phe Met Asn Phe
1 5
<210> 7
<211> 8
<212> PRT
<213> Bacillus globisporus
<400> 7
Asn Tyr Thr Asp Ala Trp Met Phe
1 5
<210> 8
<211> 8
<212> PRT
<213> Bacillus globisporus
<400> 8
Gly Asn Glu Met Arg Asn Gln Tyr
1 5
<210> 9
<211> 8
<212> PRT
<213> Bacillus globisporus
<400> 9
Ile Thr Thr Trp Pro Ile Glu Ser
1 5
<210> 10
<211> 8
<212> PRT
<213> Bacillus globisporus
<400> 10
Trp Ala Phe Gly Leu Trp Met Ser
1 5
- 2 -

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2008-01-17
Application Not Reinstated by Deadline 2008-01-17
Inactive: Dead - RFE never made 2008-01-17
Inactive: Abandon-RFE+Late fee unpaid-Correspondence sent 2007-01-17
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: IPC from MCD 2006-03-12
Inactive: IPRP received 2003-10-08
Inactive: Cover page published 2003-08-27
Letter Sent 2003-08-25
Inactive: Notice - National entry - No RFE 2003-08-25
Application Received - PCT 2003-08-14
Amendment Received - Voluntary Amendment 2003-07-17
National Entry Requirements Determined Compliant 2003-07-09
Application Published (Open to Public Inspection) 2002-07-25

Abandonment History

Abandonment Date Reason Reinstatement Date
2008-01-17

Maintenance Fee

The last payment was received on 2006-10-26

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Registration of a document 2003-07-09
Basic national fee - standard 2003-07-09
MF (application, 2nd anniv.) - standard 02 2004-01-19 2003-11-12
MF (application, 3rd anniv.) - standard 03 2005-01-17 2004-11-08
MF (application, 4th anniv.) - standard 04 2006-01-17 2005-10-17
MF (application, 5th anniv.) - standard 05 2007-01-17 2006-10-26
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO
Past Owners on Record
HAJIME AGA
MICHIO KUBOTA
SHIGEHARU FUKUDA
TOMOYUKI NISHIMOTO
TOSHIO MIYAKE
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 2003-07-09 137 5,224
Abstract 2003-07-09 2 66
Claims 2003-07-09 2 76
Drawings 2003-07-09 33 313
Representative drawing 2003-07-09 1 8
Cover Page 2003-08-27 1 42
Description 2003-07-17 137 5,223
Notice of National Entry 2003-08-25 1 189
Courtesy - Certificate of registration (related document(s)) 2003-08-25 1 106
Reminder of maintenance fee due 2003-09-18 1 106
Reminder - Request for Examination 2006-09-19 1 116
Courtesy - Abandonment Letter (Request for Examination) 2007-03-28 1 166
Courtesy - Abandonment Letter (Maintenance Fee) 2008-03-13 1 175
PCT 2003-07-09 6 252
PCT 2003-07-10 3 140

Biological Sequence Listings

Choose a BSL submission then click the "Download BSL" button to download the file.

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

Please note that files with extensions .pep and .seq that were created by CIPO as working files might be incomplete and are not to be considered official communication.

BSL Files

To view selected files, please enter reCAPTCHA code :